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Mycobacterium tuberculosis (Mtb), an intracellular pathogen targeting lung 
phagocytes has been reported to manipulate apoptotic and necrotic host cell death. Mtb 
induces necrosis allowing for bacteria to escape from the host cell and infect naive cell 
populations. Mtb genes that influence host cell death responses as well as host cell 
pathways that are implicated in survival outcomes during mycobacterial infection 
represent interesting areas of investigation. In this study we identified the Mtb gene 
Rv3167c to be required for the inhibition of Mtb induced, caspase-independent necrotic 
cell death. The Rv3167c mutant strain (Δ3167c) induced higher levels of necrosis in 
macrophages compared to Mtb or the complement strain. Using a combination of 
chemical inhibitors and bone marrow derived macrophages from different knock-out 
mice, we screened for host factors required for Δ3167c mediated cell death and were able 
to eliminate involvement of known regulated necrosis pathways. Necrosis induction by 
Δ3167c was however found to be dependent on reactive oxygen species (ROS) generated 
by mitochondria and on inhibition of Akt activation. Apart from necrosis, Rv3167c was 
also found to be required for inhibition of host cell autophagy. Mitochondrial ROS, 
inhibition of Akt activation and upregulation of JNK activation were required for 
Δ3167c-induced autophagy. Recent studies on Mtb induced autophagy have shown that 
Mtb co-localizes with autophagosomes, leading to lysosomal mediated bacterial 
destruction. Surprisingly, we did not observe Mtb or Δ3167c co-localization with 
autophagosomes indicating Mtb has the ability to inhibit selective autophagy mediated 
killing. Deletion of Rv3167c results in an increase in Mtb virulence as demonstrated by 
the higher bacterial burden in the lungs and extra-pulmonary organs and the lower 
median survival time observed in Δ3167c infected mice compared to Mtb and 
complement strain infected control animals. In conclusion, this work indicates that Mtb 
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CHAPTER 1 INTRODUCTION 
1.1 Tuberculosis 
Tuberculosis (TB) is an ancient disease – instances have been documented in 
ancient Chinese medical texts dating back to approximately 2700 B.C. (1). Studies using 
on archaeological remains further support the ancient association of TB with humanity, 
DNA from the Mycobacterium tuberculosis complex has been recovered from 
approximately 9000 year old neolithic remains (2). Also otherwise referred to as pthisis 
or the white plague, TB was the leading cause of death by an infectious agent throughout 
the 19th and the early 20th centuries in industrialized countries (3). Currently, most deaths 
on account of TB occur in low and middle-income countries where the disease is 
endemic. About one-third of the world’s population is infected with Mtb and the World 
Health Organization (WHO) reported 9 million new cases and 1.5 million deaths in 2013 
on account of TB (4). TB is second only to HIV in terms of mortality induced by an 
infectious disease. 
1.1.1 Causative agent 
Bacteria belonging to the genus Mycobacterium cause tuberculosis in humans and 
animals such as cattle and fish. The causative agent of human TB, Mycobacterium 
tuberculosis (Mtb), was discovered by Robert Koch in 1882 (5). Mtb belongs to a group 
of closely related members collectively referred to as the Mycobacterium tuberculosis 
complex (MTBC). Members of this complex include Mycobacterium canetti and 
Mycobacterium africanum that infect only humans and Mycobacterium bovis (M.bovis) 
that can infect both humans as well as cattle (6). Mycobacterium marinum (M.marinum) 
does not belong to the MTBC and causes a disseminated disease in its natural hosts 
) 2)
namely fish and frogs and a localized disease in the skin of immunocompetent human 
hosts (7). M.marinum infections in zebrafish have recently been used in several studies to 
model Mtb pathogenesis (8-11). Mycobacterium avium and Mycobacterium kansasii are 
facultative pathogens that cause infections in immunocompromised individuals (12). Mtb 
was thought to have arisen from a zoonotic transmission of M.bovis from cows to humans 
based on evidence that human tuberculosis was coincident with animal domestication 
around 10,000 years ago. However, more recent comparative genomic analysis studies 
indicate that Mtb arose approximately 70,000 years ago and co-evolved and dispersed 
along with humans (1). 
Mycobacteria are characterized by the presence of a very complex, lipid rich cell 
wall comprising of an inner and an outer layer surrounding the plasma membrane. The 
inner layer contains peptidoglycan, arabinogalactan and mycolic acids covalently linked 
to one another. The outer layer includes lipid-linked polysaccharides – 
lipoarabinomannan (LAM), pthicerol dimycoserate (PDIM), dimycolyl trehalose, 
sulfolipids and phosphatidylinositol mannosides (PIM’s). In virulent mycobacteria, LAM 
is capped by mannose residues (ManLAM) while in avirulent mycobacteria LAM is 
either uncapped or is capped with phosphatidylinositol (PILAM) (13,14). Due to their 
unique lipid rich cell wall architecture mycobacteria cannot be stained by Grams stain, a 
different staining procedure termed acid-fast staining or Ziehl-Neelsen’s staining is used 
which is based on the ability of mycobacteria to retain carbol fuschin stain even in 




1.1.2 Treatment and Prevention 
The first anti-mycobacterial drug, streptomycin was discovered by Selman 
Waksman during the Second World War (5). The current treatment regimen for TB was 
introduced in the 1970’s and comprises of four first line drugs – isoniazid, rifampicin, 
pyrazinamide and ethambutol that need to be taken for six months.  While isoniazid and 
ethambutol target the mycobacterial cell wall by inhibiting production of mycolic acid 
and arabinogalactan respectively, rifampicin and pyrazinamide target protein synthesis in 
the bacteria (15). The major issues with anti-TB therapy are the high toxicity of the drugs 
used and non-completion of the prolonged treatment regimen by patients leading to 
development of drug resistance (15,16). Multi-drug resistant Mtb (MDR-TB) refers to TB 
strains that are resistant to the first line drugs isoniazid and rifampicin. Patients infected 
with MDR-TB are treated with a combination of four second line drugs for at least eight 
months. Second line drugs against TB include aminoglycosides and fluoroquinolones. 
Extremely drug resistant TB strains (XDR TB) are defined by their resistance to 
isoniazid, pyrazinamide and to atleast two of the second line drugs (17). While third line 
drugs are available that can be used against XDR-TB, these drugs are expensive and 
associated with more side effects than both the first and second line treatments (15). 
More recently, totally drug resistant TB (TDR-TB) strains resistant to all available first 
and second line drugs have been reported in Iran and India (18). Given the rise of drug 
resistant strains of Mtb, efforts are on to discover new anti-TB drugs and four drugs are 
in Phase III clinical testing at present (15). 
Currently, there is only vaccine in use against TB, the Bacille Calmette Guerin 
(BCG) vaccine. BCG is a live attenuated vaccine and was generated by Albert Calmette 
) 4)
and Camille Guerin in 1919 at the Pasteur Institute in France by the repeated subculturing 
of M.bovis in vitro (19). BCG is one of the most widely administered vaccines in the 
world (5). However, BCG is most useful in preventing TB only in young children, it fails 
to prevent TB in adults. The lower efficacy of the vaccine in adults has been attributed to 
the waning of the cellular immune response elicited by the vaccine along with age. As 
BCG is ineffective in individuals who have been previously exposed to mycobacteria for 
example environmental mycobacteria or by prior vaccination, booster doses cannot be 
administered to improve upon the waning immune response (17). With the emergence of 
HIV, another issue that has arisen is the increased risk of HIV positive children 
developing disseminated disease following BCG vaccination (5). Current efforts in 
research and development of new TB vaccines focus on two strategies – first to replace 
BCG with improved recombinant BCG or with attenuated Mtb strains and second to 
supplement BCG with subunit vaccines (5,17).  
1.1.3 The disease and its progression 
Mtb is spread from one human host to another via the aerosol route. Following 
inhalation of infectious aerosol droplets, the pathogen gains access to the distal parts of 
the lung where it is taken up by phagocytes. The infectious dose has been estimated to be 
as low as a single bacterium (20). Alveolar macrophages were considered to be the 
predominant lung cell population initially infected by Mtb. However a recent study 
reported that monocyte derived macrophages and dendritic cells were also targeted by the 
bacteria in the murine lung (21). There are three possible outcomes following Mtb 
infection. First, the pathogen can be eliminated early on by the innate immune response 
















Fig 1. Possible outcomes of Mtb infection 
 
Three possible outcomes may follow infection of the host by Mtb. In some cases, the innate immune 
response may successfully eliminate the pathogen leading to clearance of infection. More commonly, 
the bacteria multiply within the host cells leading to development of a localized inflammatory response, 
immune cell recruitment and eventually activation of the adaptive immune response.  These events lead 
to formation of the granuloma comprising of infected macrophages at the centre, surrounded by foamy 
macrophages and other phagocytes and lymphocytes at the periphery. Bacteria located within the 
granuloma enter into a persistent state and a latent, asymptomatic infection develops. In about 5-10% of 
latently infected individuals disease reactivation occurs characterized by mulriplication of bacteria 
located within the granuloma and tissue necrosis. Individuals with active disease are symptomatic and 
infectious. Under some conditions (eg: immunodeficiency), active disease may develop immediately 
after infection bypassing the latent srage. 
 
Adapted from (17). 
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adaptive immune response. Second, a latent form of the disease develops in infected 
individuals when the innate immune response is unable to eliminate Mtb. Infected 
macrophages induce a localized inflammatory response that recruits immune cells to the 
site of infection and leads to the activation of the adaptive immune response. This results 
in formation of the granuloma, the signature feature of tuberculosis infection. The 
granuloma comprises of the central core of infected macrophages surrounded lipid rich 
foamy macrophages and other phagocytes. Lymphocytes are seen at the granuloma 
periphery and a fibrous cuff delineates the structure. Within the granuloma the bacteria 
enter a state of persistence. Latency is the most common outcome of the disease and 
affected individuals do not exhibit any overt symptoms nor do they shed bacteria. Third, 
in a small percentage of the infected population (about 5-10% of latently infected 
individuals), the disease is reactivated. In this state, bacteria located within the granuloma 
start multiplying and induce tissue necrosis leading to granuloma caseation. Individuals 
with active disease exhibit symptoms and are infectious. Development of the active 
disease is associated with conditions changing the immune status of the host – old age, 
malnutrition and HIV infection are some factors associated with development of active 
TB disease (Fig 1) (17,20,22,23).  
1.2 Innate immune response to Mtb 
1.2.1 Pattern recognition receptors (PRR’s) 
Toll like receptors (TLR’s), C-type lectin receptors (CLR’s) and NOD like 
receptors (NLR’s) are involved in the recognition of Mtb. The Mtb ligands heat shock 
protein 65KDa (Hsp65), 19KDa lipoprotein and LAM are recognized by TLR2 present 
on macrophage surface. TLR2 mediated recognition of Mtb leads to the production of 
) 7)
pro-inflammatory cytokines such as tumor necrosis factor (TNF) and IL6. Additionally,  
TLR2 signaling is required for the generation of the cathelicidin LL-37 that has anti-
mycobacterial activity (24). The intracellular TLR9 is involved in recognition of Mtb 
genomic DNA and contributes to TLR2 mediated responses (25). TLR2/TLR9 double 
knockout mice are more susceptible to Mtb infection compared to wild type mice. Mice 
deficient in the downstream signaling adaptor MyD88 exhibit an even higher 
susceptibility to Mtb infection compared to the TLR2/TLR9 double knockout mice (23). 
CLR’s implicated in Mtb recognition include the macrophage mannose receptor (MMR) 
and the dendritic cell specific intracellular adhesion molecule 3 – grabbing non-integrin 
(DC-SIGN) which recognize ManLAM, Dectin-1 that recognizes lipoglycans and Mincle 
that recognizes trehalose dimycolate (TDM). While MMR, Dectin-1 and Mincle 
signaling contribute to pro-inflammatory cytokine production, DC-SIGN activation leads 
to synthesis of the anti-inflammatory cytokine IL10 (22),(25). The adaptor protein 
caspase recruitment domain containing protein 9 (CARD9) is involved in signaling 
events downstream of CLR’s. CARD9 deficient mice are extremely susceptible to Mtb 
and succumb within four weeks of aerosol Mtb infection (26). The cytoplasmic PRR 
nucleotide oligomerization domain 2 (NOD2) recognizes the N-glycolylated muramyl 
dipeptide and is required for the optimal production of TNF, IL6 and IL12p40 (22). 
Production of active IL1β and IL18 requires cleavage of pro-forms of these cytokines by 
activated caspase 1. NLR’s form part of complexes termed as inflammasomes assembled 
in response to detection of pathogen associated molecular patterns (PAMP’s) and danger 
associated molecular patterns (DAMP’s) that are needed for caspase 1 activation. IL1β 
production in response to Mtb infection requires the NLRP3 inflammasome (27). 
) 8)
However, mice deficient in NLRP3 do not exhibit increased susceptibility to Mtb 
compared to wild type mice. Rather, mice deficient in the adaptor protein ASC that is 
part of several NLR inflammasomes are highly susceptible to Mtb infection (23). The 
increased susceptibilities of mouse strains lacking adaptors compared to those lacking 
PRR’s to Mtb infection indicates the co-operative and redundant roles these PRR’s play 
in generating immune responses to the pathogen. 
1.2.2 Cytokines  
Several cytokines are produced in response to Mtb infection and they play an 
important role both in the early and late stages of infection. The most important cytokines 
in Mtb control include TNF, IL12, IL1β and interferon γ (IFNγ). The role of TNF in 
controlling Mtb infections has been well documented in both animal models and humans. 
Compared to wild type mice, animals deficient in TNF exhibit increased mortality to Mtb 
infection (28).  TNF is required for the recruitment of cells to the granuloma as mice and 
zebrafish deficient in TNF do not form granulomas in response to Mtb and M.marinum 
infection respectively (28,29). Therapeutic interventions targeted at TNF for treatment of 
rheumatoid arthritis was associated with increased susceptibility to Mtb (25). TNF 
mediated control of Mtb infection is also be associated with its ability to induce apoptosis 
(30). While requirement of TNF for Mtb control is well established, a recent study using 
zebrafish larval infections with M.marinum demonstrated that while excessive TNF 
production was successful at reducing bacterial burden, it was detrimental to the host due 
to the induction of uncontrolled necrotic cell death (9). IL12 p80 is required for the 
migration of infected dendritic cells to the lymphnodes to initiate the adaptive immune 
) 9)
response. IL12p70 production within the lymphnodes is required for the optimal 
induction of IFNγ production (31).  
Both macrophages and dendritic cells produce IL1β in response to Mtb infection 
(32,33). Both Il1r1-/- and IL1β-/- mice are extremely susceptible to Mtb and die within 40 
days of infection compared to infected wild type controls that survive for more than a 
year (34). The exact mechanism by which IL1β exerts a strong anti-mycobacterial effect 
is still not clear. IL1β has been shown to potentiate TNF mediated apoptotic cell death 
(35). Lungs from Mtb infected Il1r1-/- mice exhibit profound necrosis compared to organs 
obtained from wild type controls (31). These two studies point to a role for IL1β in 
modulating host cell death following Mtb infection. Susceptibility of Il1r1-/- mice to Mtb 
infection can also be attributed to IL1α, indeed IL1α deficient mice also exhibit severe 
susceptibility to Mtb (34). Role of IFNγ is described in more detail in section 1.3. 
1.3 Adaptive immune response to Mtb 
The adaptive immune response against Mtb is driven mainly by T-lymphocytes. 
Both CD4+ helper T cells and CD8+ cytotoxic T cells are involved in the control of Mtb 
infection, deficiency of either of the cell types results in an increased mortality of 
infected mice (22,23). CD8+ T cell deficient mice succumb earlier than the wild type 
controls but later than the CD4+ T cell deficient mice in response to Mtb infection (36). 
Studies reveal that the rate of progression of TB disease from latent to active state 
increases by 5 to 10 fold following HIV infection (23). The cytokine response elicited by 
Mtb shapes the adaptive immune response against the pathogen. Following antigen 
presentation in association with Class II MHC molecules, CD4+ T cells can acquire a 
Th1 or a Th2 phenotype. IL12p70 produced by the innate immune cells during Mtb 
) 10)
infection drives the development of a Th1 response (31). Both CD4+ and CD8+ cells 
migrate to the lungs and produce the cytokine IFNγ. IFNγ activates the infected 
macrophages leading to increased killing of phagocytosed mycobacteria. This is achieved 
by upregulating expression of the enzyme inducible nitric oxide synthase (iNOS) and 
increasing generation of reactive nitrogen intermediates (RNI) in the infected 
macrophages. IFNγ can also route endosomal compartments containing mycobacteria to 
fuse with lysosomes by inducing autophagy in infected cells. Antigen presentation by 
infected cells is also enhanced following exposure to IFNγ as it upregulates expression of 
MHC genes (20,22,23,37). CD8+ T cells may also exert direct cytotoxic effects on 
infected macrophages (36).  
1.4 Mtb mediated evasion of the immune response 
Mtb has several ways by which it can inhibit host immune responses. A recent 
study has shown that following inhalation via aerosol droplets, Mtb utlilizes PDIM 
present in its cell wall to avoid phagocytic uptake in the upper airways of the lung. Using 
co-infection models of M.marinum together with the S.aureus and P.aeruginosa, this 
work demonstrated that the presence of commensals and environmental microbes in the 
upper airways leads to the recruitment of microbicidal macrophages with increased iNOS 
activity, avoiding these macrophages is beneficial to mycobacteria. In contrast, more 
permissive macrophages are recruited actively by mycobacteria in the distal regions of 
the lungs using a different surface lipid, phenolic glycolipid (PGL) (8). Following uptake 
by phagocytic cells, Mtb resides in a compartment that resembles the early endosome.  
Mtb mediated phagosomal arrest is dependent on inhibition of Rab7 recruitment and 
phosphatidyl inositol 3 phosphate (PI3P) generation. The secreted Mtb effectors PtpA 
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and Ndk prevent Rab7 activation and convert active GTP bound Rab7 to its inactive GDP 
bound form respectively. ManLAM present on Mtb surface prevents generation of PI3P 
while another effector SapM is required for PI3P degradation (22,23,38). Recruitment of 
the host protein coronin 1 to live Mtb containing phagosomes is also implicated in 
inhibition of phagosome fusion with lysosomes (39). Other bacterial factors such as 
PknG and zmp1 are also involved in preventing phagosome-lysosome fusion via 
unknown mechanisms (38). Mtb also inhibits acidification of the compartment that it is 
present in by preventing recruitment of the proton ATPase and mycobacterial PtpA is 
involved in this process as well. While classical literature supported the view that Mtb 
remained within the modified early endosome like compartment at all times, more 
recently reports have emerged demonstrating that Mtb eventually escapes from the 
phagosome to the cytosol (40). Cytosolic translocation has been found to depend on the 
Mtb protein EsxA secreted via the type VII secretion system ESX1 (41-43).  
During phagocytosis of Mtb, the NADPH oxidase complex 2 (NOX2) is 
assembled on the phagosomal membrane and it generates reactive oxygen species (ROS) 
within the phagosomal compartment by transferring electrons from NADPH to molecular 
oxygen (44). Mtb produces antioxidants such as superoxide dismutases SodA and SodC 
and the catalase KatG that help neutralize phagosomal ROS. The Mtb gene nuoG encodes 
for a type I NADH dehydrogenase that inhibits NOX2 derived ROS production in 
infected cells by uncharacterized mechanisms (45). ROS may exert direct microbicidal 
effects and are required for TNF mediated apopotic cell death of Mtb infected 
macrophages (45). ROS are also required for the generation of inflammatory responses 
downstream to TLR2 recognition of Mtb (24,46). Thus by controlling ROS generation, 
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Mtb inhibits apoptotic cell death and regulates TLR2 driven cytokine production. 
Another example of Mtb mediated control of cytokine generation is in the case of IL1β. 
Mtb mediates NLRP3 inflammasome dependent IL1β production but at the same time 
also inhibits IL1β production by the AIM2 inflammasome (47). Type I IFN’s elicited by 
Mtb also dampen IL1β production (48). While Mtb mediated TNF production of infected 
macrophages, the secreted TNF was less bioactive as Mtb also mediated an IL10 
dependent release of TNF receptor 2 (TNFR2) which bound to and neutralized TNF (30).  
Elimination of infected host cells by apoptosis is yet another innate immune 
mechanism that Mtb interferes with. Mtb inhibits cell death via apoptosis to avoid both 
direct bactericidal effects of the process and via uptake of dying cells by neighboring 
phagocytes. Additionally, uptake of Mtb antigens via phagocytosis of apoptotic bodies by 
dendritic cells allowed for the presentation of extracellular antigens to CD8+ T cells, a 
process termed cross-presentation that led to a more robust CD8+ T cell response (49). 
While it inhibits apoptosis, Mtb induces cell death via necrosis. A more detailed 
description of Mtb mediated necrosis – genes and mechanisms involved and the 
consequences of the phenomenon are described in Section 1.5. Autophagy is an innate 
immune mechanism that exerts direct mycobactericidal effects as well controls the host 
inflammatory response. Mtb mediated modulation of autophagy has been discussed in 
Section 1.6.   
1.5 Cell death – Apoptosis and Necrosis 
The earliest classification of cell death was based on morphology and three types of 
cell death were identified – type I, type II and type III which today are referred to as 
apoptosis, autophagy associated cell death and necrosis respectively (50,51). Historically, 
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apoptosis was considered to be the only regulated cell death mechanism while necrosis 
was thought to be an accidental form of cell death. However, the discovery that TNF can 
induce either apoptotic or necrotic cell death in different cell types raised doubts on 
necrosis being an unregulated process (50). The most recent classification of cell death 
modalities proposed by the Nomenclature Committee on Cell Death (NCCD) is based on 
biochemical parameters and five categories of cell death are recognized – extrinsic 
apoptosis, intrinsic apoptosis, regulated necrosis, autophagic cell death and mitotic 
catastrophe (Table 1) (52).  
Regulated necrosis is defined as a genetically controlled cell death form that results in 
loss of cellular integrity and release of cytoplasmic contents (51,52). Recent research has 
unveiled several examples of necrosis occurring in a controlled, regulated fashion in 
response to death receptors, immune receptors, physico-chemical insults and bacterial 
and viral pathogens (50,53). These triggers initiate specific signaling modules that via 
different mediators lead to activation of executioner mechanisms and cell demise (Fig 2) 
(50,52). As the study of regulated necrosis has evolved, different names have been used 
to refer to specific forms of cell death (necroptosis – RIPK1 and RIPK3 mediated cell 
death, pyroptosis – inflammasome mediated cell death, parthanatos – PARP1 mediated 
cell death), the usage of general terms that describe functional connotations has been 










Table 1. Regulated cell death modes  
 
Adapted from (51,52). 
 
Abbreviations: MOMP- mitochondrial outer membrane permeabilization; RIPK – rest in peace kinase; 
PARP1 – poly ADP ribose polymerase 1; PAR – poly ADP ribose; AIF – apoptosis inducing factor; CypD 
– cyclophilin D; MPTP – mitochondrial permeability transition pore; ROCK1 – RHO associated coiled 
coiled containing protein kinase  
 
 
              
 Alternate names Caspase  
requirement 
Biochemical features 
Extrinsic apoptosis  + Death receptor signaling, activation of 
caspases 3,6,7,8 
Intrinsic apoptosis  + MOMP, activation of caspase 3,6,7,9 
Autophagic cell death  - Accompanies autophagy, LC3 
lipidation 
Mitotic catastrophe  - Mitotic arrest, caspase 2 activation in 
some cases 
Regulated necrosis 
RIPK1 and RIPK3 
dependent 
Necroptosis - RIPK1 & RIPK3 phosphorylation and 
activation. 
Inflammasome 
dependent cell death 
Pyroptosis + Caspase 1 activation, accompanied by 
IL1β and IL18 secretion 
Inflammasome 
dependent cell death 
Pyronecrosis - Dependent on cathepsin activity and 
activation of infllammasomes but 
independent of caspase 1 activity, 
accompanied by IL1β and IL18 
secretion 
PARP1 dependent cell 
death 
Parthanatos - PARP1 activation, PAR generation, 
Translocation of mitochondrial AIF to 
nucleus 
NETosis  - NADPH oxidase activation, release of 
extracellular traps composed of 
histones and chromatins 
Ferroptosis  - Reported to occur in tumor cells via 
inhibition of Cys/Glu antiporter, 
dependent on decreasing concentration 
of glutathione and ROS generated by 
Fenton reactions occurring in 
lysosomes 
Oxytosis  - Reported to occur in neurons via 
inhibition of Cys/Glu antiporter, 




 - Dependent on CypD mediated opening 
of MPTP, loss of mitochondrial 
membrane potential 
Entosis  - RHO and ROCK activation 
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Fig 2. Integrated overview of regulated necrosis pathways  
 
Various stimuli initiate specific signaling modules that via different mediators activate executioner mechanisms. These regulated signaling pathways lead to 
cell death with characteristic necrotic features.  
 
Adapted from (51). 
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1.5.1 Morphological and biochemical features of cell death – apoptosis vs necrosis 
 While apoptotic cells have been associated with distinct morphological features, 
necrosis is identified by the absence of these features. Nuclei of apoptotic cells undergo 
condensation and fragmentation. During apoptosis, genomic DNA is fragmented between 
nucleosomes to generate fragments that are multiples of 180-200 base pairs in size (54). 
Apoptotic cells shrink and plasma membrane blebbing is observed, however plasma 
membrane integrity is not affected. Apoptotic bodies enclosing the contents of the dying 
cell are released that are engulfed by neighboring phagocytes. Apoptosis is considered to 
be immunologically silent, as cellular contents are not spilled into the extracellular milieu 
(55,56). In contrast to apoptotic cells, nuclei of necrotic cells remain mostly unchanged. 
Transmission electron microscopy (TEM) studies show minor chromatin condensation to 
small irregular patches in necrotic cells while in case of apoptotic cells complete 
condensation to crescent shaped forms is observed. Plasma membrane integrity of 
necrotic cells is compromised and intracellular contents are released from the dying cell 
(55,56).  
 The characteristic morphological features of apoptosis are dependent on the 
activity of cysteinyl aspartate-specific proteases (caspases). Caspases target several 
proteins downstream of their activation leading to the characteristic features of apoptosis. 
For instance, caspases cleave and inactivate the inhibitor of caspase activated DNAse 
(iCAD). This in turn leads to CAD activation and fragmentation of genomic DNA into 
oligonucleosomal fragments characteristic of apoptotic cells (54). Another characteristic 
biochemical feature of apoptosis is the exposure of phosphatidyl serine (PS) normally 
present in the inner leaflet of the plasma membrane on the dying cell surface. Necrosis 
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induction is independent of caspase activation and PS is not detected on surface of 
necrotic cells (56).  
 Distinguishing apoptosis from necrosis based on morphological and biochemical 
features is challenging. Apoptotic cells if not phagocytosed go on to acquire features of 
necrotic cells, an event termed as secondary necrosis (56,57). Cells undergoing secondary 
necrosis have permeabilized plasma membranes and could be mistaken for primary 
necrotic cells. A study comparing kinetics of subcellular events in cells dying by primary 
necrosis and secondary necrosis, showed similar sequence of lysosomal membrane 
permeabilization, oxidative burst and plasma membrane permeabilization in both cases 
(57). Cells undergoing primary necrosis may exhibit features of apoptosis as well. For 
instance, monocytes treated with TNF and cycloheximide in presence of the pan caspase 
inhibitor zVAD-fmk undergo RIPK1 dependent necrosis but expose PS on their surface 
prior to losing plasma membrane integrity (58). A similar observation was also made in 
IFNγ treated, M.bovis infected necrotic cells and in cells treated with alkylating DNA 
damage inducing agents causing PARP1 and AIF dependent necrosis (59,60). The 
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL stain) labels 
3’OH ends of DNA fragments and is used frequently for apoptotic cell death detection. 
S.typhimurium infected cells undergoing necrotic cell death however have been shown to 
stain with TUNEL as well (61). Examination of multiple morphological and biochemical 
features of dying cells using different approaches is needed for the proper identification 




1.5.2 Signaling pathways leading to apoptosis  
 Apoptosis pathways can be classified into two categories – extrinsic and intrinsic. 
Extrinsic apoptotic pathways are initiated in response to interaction of death receptors 
belonging to the TNF receptor superfamily with their cognate ligands. Intrinsic apoptotic 
pathways are activated in response to changes in the equilibrium between pro and anti-
apoptotic members of the Bcl2 family induced by stimuli such as oxidative stress, 
genotoxic stress, UV light etc. Both pathways lead to the activation of initiator caspases. 
In the extrinsic pathway, a death inducing signaling complex (DISC) is formed that 
recruits the initiator caspase 8 leading to its oligomerization, autoprocessing and 
activation. In the intrinsic pathway, the preponderance of pro-apoptotic Bcl2 family 
members leads to mitochondrial outer membrane permabilization (MOMP) and release of 
cytochrome C (CytC) from the mitochondrial intermembrane space to the cytosol. CytC 
associates with apoptosis activating factor 1 (Apaf-1) and provides a platform for the 
oligomerization, auto-cleavage and activation of caspase 9. Activated initiator caspases 
lead to the cleavage and activation of the effector caspases 3, 6 and 7 that target a vast 
array of proteins and lead to execution of apoptosis (49,52,55). (Fig 3).  
 The two pathways of apoptosis are not mutually exclusive and activated caspase 8 
can cleave the pro-apoptotic Bcl2 family member Bid to generate tBid (truncated Bid), 
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amino-acid motif, X-X-X-Asp (where X can be any amino 
acid). Activated caspases in turn cleave various intracel-
lular and cytoplasmic membrane substrates [11], leading 
to cellular disintegration. 
There are two major pathways leading to apoptosis in 
the mammalian system: an extrinsic pathway initiated 
by death receptors and an intrinsic pathway that occurs 
through the mitochondria (Figure 1). The extrinsic pathway 
depends on binding of appropriate exogenous mediators to 
death receptors at the cell surface. In contrast, the intrinsic 
pathway responds to signals from within the cell, such as 
damages caused by radiation and various chemotherapeu-
tic agents, to induce apoptotic signaling via the release of 
mitochondrial factors.
Extrinsic apoptosis signaling pathways
The extrinsic pathway of apoptosis signaling is initiated 
when  death  receptors  at  the  cell  surface  encounter  specific  
cognate “death ligands,” inducing a conformational change 
that is transmitted through the cell membrane. These recep-
tors can activate caspases within seconds of ligand binding 
and lead to apoptotic cell death in a matter of hours. Three 
major  specific  cell  death  receptor/ligand  pairs  have  been  de-
scribed, all members of the Tumor Necrosis Factor Recep-
tor Superfamily (TNFRSF): (1) Fas and Fas ligand (FasL) 
(Fas is also called Apo-1, CD95 or TNFRSF6 [12]; FasL 
is also called CD178,CD95L or TNFSF6 [13]); (2) “death 
receptors” (DR4 and DR5) and TNF-related apoptosis 
inducing ligand (TRAIL, also called Apo2L or TNFSF10) 
[14, 15]; and (3) TNF and the TNF receptor (TNF-R1). 
These death receptors, all members of the TNFRSF, are type 
I integral receptors with a conserved extracellular domain 
containing two to four cysteine-rich pseudo-repeats [16], a 
single transmembrane region, and a conserved intracellular 
“death domain” (DD) of about 80 amino acids that interacts 
with adaptor proteins [17]. 
Apoptosis-inducing receptors of the TNFR superfamily 
exist at the cell surface as pre-formed trimers. Ligation of 
the death receptors leads to apoptosis through a common 
transcription/translation-independent pathway: ligand bind-
ing induces the formation of the death-inducing signaling 
complex (DISC), which in turn cleaves and activates the 
initiator caspases (caspase 8 or 10). The initiator caspases 
in turn activate a second group of caspases, known as ef-
fector  caspases,  by  proteolytic  cleavage  at  specific  sites.  
Upon activation, the effector caspases culminate the apop-
totic process through the degradation of key intracellular 
substrates. 
The Fas-FasL pathway
Among all the cell death receptors, Fas is the most 
extensively  studied.  The  specific  interaction  of  Fas  with  
its membrane-bound cognate ligand, FasL, triggers the 
aggregation of Fas trimers. This enables the DD in the 
cytoplasmic tail of Fas to immediately recruit the DISC 
[18]. The DISC is composed of Fas, an accessory protein 
called Fas-associated death domain (FADD) [19] and pro-
caspase 8. FADD is a universal adapter protein that medi-
ates signaling by DD-containing members of the TNFRSF 
[20]. FADD harbors an N-terminal death effector domain 
(DED) along with a C-terminal DD. In response to recep-
tor aggregation, FADD is recruited by Fas, an interaction 
that is coordinated through the highly conserved DD motif 
found in both proteins. The interaction of FADD and Fas 
through their C-terminal DDs unmasks the N-terminal 
DED of FADD, allowing it to recruit pro-caspase 8 to the 
Fas signaling complex [21, 22]. The presence of functional 
FADD protein is critical for Fas-mediated apoptosis as the 
expression of a dominant-negative form of FADD com-
pletely abrogates Fas-induced cell death [23]. Moreover, 
in vivo studies revealed a substantial attenuation of lym-
phocyte death in mice lacking FADD [24]. Formation of 
the DISC triggers the self-cleavage of pro-caspase 8 into 
active caspase 8. Activated caspase 8 (also called FADD-
like IL-1 converting enzyme (FLICE)) then cleaves the 
Figure 1 Schematic diagram of pathways to apoptosis. The left side 
shows the extrinsic apoptotic signaling pathway, and the right side 
shows the intrinsic apoptotic signaling pathway. These pathways 
converge at the activation of caspases. DISC and apoptosome are 
highlighted in yellow.
Death ligands
(FasL, TRAIL or TNF) Stimuli
(Such as cytokine deprivation, 
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amino- cid m tif, X-X-X-Asp (whe e X can be any amino 
acid). Activated caspases in turn cleave various intracel-
lular and cytoplasmic membrane substrates [11], leading 
to cellular disintegration. 
There are two major pathways leading to apoptosis in 
the mammalian system: an extrinsic pathway in tiated 
by death receptors and an intrinsic pathway that occurs 
through the mitochondria (Figure 1). The extrinsic pathway 
depends on binding of appropriate exogenous mediators to 
death receptors at the cell surface. In contrast, the intrinsic 
pathway responds to signals from within the cell, such as 
damages caused by radiation and various chemotherapeu-
tic agents, to induce apoptotic signaling via the release of 
mitochondrial factors.
Extrinsic apoptosis signaling pathways
The extrinsic pathway of apoptosis signaling is initiated 
when  death  receptors  at  the  cell  surface  encounter  specific  
cognate “death ligands,” inducing a conformational change 
that is transmitted through the cell membrane. These recep-
tors can activate caspases within seconds of ligand binding 
and lead to apoptotic cell death in a matter of hours. Three 
major  specific  cell  death  receptor/ligand  pairs  have  been  de-
scribed, all members of the Tumor Necrosis Factor Recep-
tor Superfamily (TNFRSF): (1) Fas and Fas ligand (FasL) 
(Fas is also called Apo-1, CD95 or TNFRSF6 [12]; FasL 
is also called CD178,CD95L or TNFSF6 [13]); (2) “death 
receptors” (DR4 and DR5) and TNF-related apoptosis 
inducing ligand (TRAIL, also called Apo2L or TNFSF10) 
[14, 15]; and (3) TNF and the TNF receptor (TNF-R1). 
These death receptors, all members of the TNFRSF, are type 
I integral receptors with a conserved extracellular domain 
containing two to four cysteine-rich pseudo-repeats [16], a 
single transmembrane region, and a conserved intracellular 
“death domain” (DD) of about 80 amino acids that interacts 
with adaptor proteins [17]. 
Apoptosis-inducing receptors of the TNFR superfamily 
exist at the cell surface as pre-formed trimers. Ligation of 
the death receptors leads to apoptosis through a common 
transcription/translation-independent pathway: ligand bind-
ing induces the formation of the death-inducing signaling 
complex (DISC), which in turn cleaves and activates the 
initiator caspases (caspase 8 or 10). The initiator caspases 
in turn activate a second group of caspases, known as ef-
fector  caspases,  by  proteolytic  cleavage  at  specific  sites.  
Upon activation, the effector caspases culminate the apop-
totic process through the degradation of key intracellular 
substrates. 
The Fas-FasL pathway
Among all the cell death receptors, Fas is the most 
extensively  studied.  The  specific  interaction  of  Fas  with  
its membrane-bound cognate ligand, FasL, triggers the 
aggregation of Fas trimers. This enables the DD in the 
cytoplasmic tail of Fas to immediately recruit the DISC 
[18]. The DISC is composed of Fas, an accessory protein 
called Fas-associated death domain (FADD) [19] and pro-
caspase 8. FADD is a universal adapter protein that medi-
ates signaling by DD-containing members of the TNFRSF 
[20]. FADD harbors an N-terminal death effector domain 
( ED) along with a C-terminal DD. In response to recep-
tor aggregation, FADD is recruited by Fas, an interaction 
that is coordinated through the highly conserved DD motif 
found in both proteins. The interaction of FADD and Fas 
through their C-terminal DDs unmasks the N-terminal 
DED of FADD, allowing it to recruit pro-caspase 8 to the 
Fas signaling complex [21, 22]. The presence of functional 
FADD protein is critical for Fas-mediated apoptosis as the 
expression of a dominant-negative form of FADD com-
pletely abrogates Fas-induced cell death [23]. Moreover, 
in vivo studies revealed a substantial attenuation of lym-
phocyte death in mice lacking FADD [24]. Formation of 
the DISC triggers the self-cleavage of pro-caspase 8 into 
active caspase 8. Activated caspase 8 (also called FADD-
like IL-1 converting enzyme (FLICE)) then cleaves the 
Figure 1 Schematic diagram of pathways to apoptosis. The left side 
shows the extrinsic apoptotic signaling pathway, and the right side 
shows the intrinsic apoptotic signaling pathway. These pathways 
converge at the activation of caspases. DISC and apoptosome are 
highlighted i  yellow.
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Fig 3. Apoptotic signaling pathways 
 
The extrinsic apoptotic pathway is activated following recognition of death ligands by their cognate 
receptors. This results in formation of DISC and cleavage and activation of the initiator caspase 8. The 
intrinsic apoptotic pathway is activated in response to stimuli that lead to a preponderance of the pro-
apoptotic Bcl2 family members (BH3-only molecules). This leads to cytochrome C leakage from 
mitochondria, formation of apoptosome complex in the cytosol and cleavage and activation of the 
initiator caspase 9. Activated initiator caspases cleave and activate the effector caspases 3,6 and 7 that 
in turn target different host molecules and lead to development of characteristic features of apoptotic 
cell death. 
 
Abbreviations: FasL – fas ligand; TRAIL – TNF related apoptosis inducing ligand; DISC – death 
inducing signaling complex; FADD – Fas associated death domain, Apaf1 – apoptosis associated factor 
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1.5.3 Regulated necrosis signaling pathways 
  Several signaling modules leading to necrotic cell death have emerged in recent 
years with some signaling pathways being initiated in response to specific stimuli in 
specific cell types. Described below are three major pathways of necrotic cell death that 
have been extensively studied in recent years.  
1.5.3.1 RIPK1 and RIPK3 mediated cell death  
 The regulated necrosis pathway dependent on RIPK1 (rest in peace kinase 1) 
and/or RIPK3 (rest in peace kinase 3) has been reported to be induced in response to 
signaling by death receptors, pattern recognition receptors as well in response to viral 
infections and was labeled necroptosis (50,53). Signaling events leading to RIPK1 and 
RIPK3 dependent cell death have been best described downstream of TNF binding to 
TNFR1. Following TNF binding, the cytosolic portion of TNFR1 recruits TRADD (TNF 
receptor associated death domain), RIPK1, TNF receptor associated factor (TRAF 2 and 
5) and cellular inhibitor of apoptosis 1 and 2 (cIAP1 and 2). RIP1 is ubiquitinated by the 
activity of TRAF 2 and 5 and recruits the transforming growth factor β activated kinase 1 
complex (TAK1) leading to NFκB activation and expression of pro-survival factors. 
Eventually, TNF bound TNFR1 is internalized and a DISC is formed comprising of 
TRADD, Fas associated death domain (FADD), deubiquitinated RIPK1, RIPK3 and 
caspase 8. RIPK1 and RIPK3 can also form a TRADD independent cytosolic complex 
termed ripoptosome with FADD and caspase 8. DISC and ripoptosome act as platforms 
for caspase 8 cleavage and activation leading to apoptosis induction (Fig 4) (50-52,62). 
In conditions where caspase 8 expression and activity is inhibited, RIPK1 and 






















































































Fig 4. Outcomes of RIPK1 and RIPK3 signaling 
 
When recruited to TNF bound TNFRI present at the cell surface, RIPK1 is ubiquitinated and 
contributes to NFκB activation and survival. Following endocytosis, the death inducing signaling 
complex (DISC) is formed which leads to caspase 8 activation and degradation of RIPKI and RIPK3. 
Alternatively, RIPK1 and RIPK3 may form part of another apoptosis inducing complex, the 
ripoptosome. In situations where caspase 8 expression and activation is inhibited, RIPK1 and RIPK3 
form a complex where they autophosphorylate and transphosphorylate each other and lead to necrotic 
cell death via different mechanisms. Upregulation of mitochondrial ROS generation, promoting 
mitochondrial fission and plasma membrane pore formation contribute to necrosis downstream of the 
necrosome.  
 
Abbreviations: TRADD – TNF receptor associated death domain; FADD – Fas associated death 
domain; TRAF- TNF receptor associated factor; cIAP1/2 – cellular inhibitor of apoptosis 1/2; RIPK1/3 
– Rest in peace kinase1/3; MLKL – mixed lineage kinase domain like; PGAM5 – phosphoglycerate 




transphosphorylate each other. Phosphorylated RIPK3 recruits and phosphorylates 
MLKL (mixed lineage kinase domain like protein) (63). Inhibition of RIP1 kinase 
activity by necrostatin-1 (Nec1), silencing RIPK3 and MLKL inhibition using 
necrosulfonamide (NSA) repressed necrosis induction in cells treated with TNF and 
cycloheximide in presence of the pan-caspase inhibitor zVAD-fmk (63,64). Thus RIPK1 
can mediate survival, apoptosis and necrosis in response to TNF. RIPK3 is required only 
for TNF mediated apoptosis and necrosis  (Fig 4).  
Multiple mechanisms have been attributed to necrosis induction downstream of 
necrosome formation. RIPK3 has been shown to interact with and activate enzymes 
participating in glycogenolysis and glutaminolysis thereby leading to an increase in 
cellular metabolic activity and consequent mitochondrial ROS generation (50,62). RIPK1 
activity has also been linked to ceramide generation. Both ROS and ceramide can cause 
lysosomal membrane permeabilization leading to cell death. The mitochondrial protein 
phosphatase phosphoglycerate mutase family member 5 (PGAM5) has been identified as 
a downstream effector of MLKL and RIPK3 (65). The PGAM5 splice variant PGAM5L 
is recruited to the necrosome and is required for the RIPK3 mediated phosphorylation of 
PGAM5S present on the mitochondrial surface. This in turn leads to dephosphorylation 
and activation of Drp1 (dynamin related protein 1), a GTPase crucial for mitochondrial 
fission and downstream necrosis induction (66). More recently MLKL has been shown to 
form trimers that translocate to the plasma membrane leading to an increase in Ca2+ 
influx and subsequent necrosis (67). Another study suggested that insertion of the MLKL 
trimers induced pore formation in the plasma membrane leading to necrosis (68) (Fig 4). 
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1.5.3.2 Inflammasome mediated cell death  
 Inflammasome mediated death shares both apoptotic and necrotic features with 
death dependent on caspase 1 activity and the dying cells exhibiting DNA fragmentation 
(apoptotic feature) as well as cell membrane rupture (necrotic feature) and is referred to 
as pyroptosis (Fig 5A) (69,70). Inflammasomes are cytosolic multi-protein complexes 
assembled in response to pathogens, toxins and danger associated molecular patterns 
(DAMP’s) and comprise of pattern recognition receptors (PRR’s) belonging to the NOD-
like receptor (NLR) and the PYHIN families and in some cases the adaptor protein ASC 
(apoptosis associated speck like protein) (33). Recruitment of pro-caspase 1 by 
inflammasomes leads to their oligomerization and auto-proteolysis generating activated 
caspase 1 (69). In case of ASC independent inflammasome NLRC4, pyroptosis induction 
has been shown to occur in the absence of caspase 1 autoproteolysis in response to 
S.typhimurium infection  (71). Apart from cell death induction, caspase 1 activation is 
also required for the cleavage and secretion of the pro-inflammatory cytokines IL1β and 
IL18 (69,70).  Cell death has also been reported to occur in a NLRP3 and ASC dependent 
but caspase 1 independent manner in S.flexneri and N.gonorrhoeae infected macrophages 
(72,73). This form of cell death was termed pyronecrosis to reflect dependence on 
inflammsome components but not caspase 1 and it required cathepsin B for its execution 
(Fig 5B) (72). In anthrax lethal toxin treated cells, cathepsins are required upstream of 
Nalp1b inflammasome for both caspase 1 activation and induction of cell death (74). 
Mechanisms involved in cell death induction downstream of caspase 1 are not 
well defined (69). Using a diagonal gel proteomics approach, 41 caspase 1 substrates 
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Fig 5. Inflammasome mediated necrosis 
 
(A) Exposure to PAMP’s and DAMP’s leads to inflammasome assembly and caspase 1 activation, 
which leads to release of IL1β and IL18 as well as cell death characterized by  large scale DNA 
fragmentation and plasma membrane permeabilization. Gram negative bacteria activate caspase 11 that 
potentiates caspase 1 mediated cytokine processing and release and induces caspase 1 independent cell 
death. 
(B) Necrosis induction downstream of inflammasome activation can also be executed by cathepsin B 
instead of caspase 1.  
 




were identified including glycolytic pathway enzymes and a lower glycolytic rate was 
detected in S.typhimurium infected wild type macrophages compared to caspase 1 
deficient cells (75). This points towards a possible perturbance of bioenergetic pathways 
in caspase 1 mediated cell death. Another possible mechanism of caspase 1 mediated cell 
death could be the formation of plasma membrane pores. Infection with S.typhimurium 
led to the formation of plasma membrane pores that rendered macrophages permeable to 
ethidium bromide but not the larger ethidium homodimer 2. Size exclusion studies using 
osmoprotectants determined the pore size to range between 1.1-2.4nm in diameter (76). 
 Macrophage treatment with LPS and infection with Gram negative bacterial 
pathogens (E.coli, C.rodentium, S.typhimurium, B.pesudomallei, L.pneumophila) leads to 
cell death dependent on the pro-inflammatory caspase 11 (Fig 5A) (77-82). Caspase 11 is 
transcriptionally upregulated downstream of TLR signaling and its activation has been 
shown to depend on IFNβ signaling (78,79,81). While caspase 11 potentiates caspase 1 
mediated proIL1β cleavage, caspase 11 mediated cell death has been shown to be 
independent of caspase 1 activity (78,79,81,82).  Mechanisms leading to cell death 
downstream of caspase 11 activation have not been elucidated.  
1.5.3.3 PARP1 and AIF mediated cell death  
 PARP1 (Poly ADP ribose polymerase 1) is a nuclear enzyme that catalyzes the 
generation of poly ADP ribose (PAR) polymers from NAD+. Although required for DNA 
repair, PARP1 has been implicated and its role extensively investigated in cell death 
induction in response to DNA damaging agents and excitotoxic stimuli (83-86). PARP1 
mediated cell death is referred to as parthanatos in literature and it is characterized by 
both apoptotic and necrotic features. PS exposure on the plasma membrane outer leaflet, 
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chromatin condensation and DNA fragmentation (albeit large scale) are apoptotic 
characteristics while caspase independence and loss of membrane permeability are 
necrotic qualities of PARP1 mediated cell death (87).  
PARP1 is activated in response to DNA damage and synthesizes linear and 
branched PAR polymer chains that are covalently attached to acceptor proteins such as 
histones and to PARP1 itself (87-89). The negatively charged PAR polymers 
accumulated near the DNA damage site act as a scaffold for the recruitment of proteins 
involved in single strand break repair. Following completion of repair, the enzyme poly 
ADP ribose glycohydrolase (PARG) degrades the PAR polymers, leading to PARP1 
release (87,88). During apoptotic cell death, PARP1 is cleaved and rendered inactive.  
Execution of cell death downstream of PARP activation can occur via two 
mechanisms – ATP depletion and nuclear translocation of apoptosis inducing factor 
(AIF) from the mitochondria. PARP1 over-activation results in NAD+ usage and eventual 
depletion of cellular NAD+ and ATP levels. This bioenergetic catastrophe could account 
for PARP1 mediated cell death (87,89). AIF is a 62KDa mitochondrial inner membrane 
anchored protein with its N-terminus exposed to the matrix and the C-terminus facing the 
intermembrane space (IMS). A small pool of unbound AIF was also shown to exist in the 
IMS (87,90). AIF contains FAD and NADH binding domains and participates in 
oxidative phosphorylation (87,90). Studies show that PARP1 mediated cell death is 
inhibited in AIF deficient cells or cells treated with an AIF antibody (83-85).  In response 
to excitotoxic stimuli, nuclear PAR generation and eventual translocation to the 
mitochondria was observed and delivery of purified PAR induced translocation of full  
! 27!
protein. Upon being imported into mitochondria, this precursor
is processed to a mature form of 62 kDa by proteolytic cleav-
age. On this configuration, AIF is an inner membrane-anchored
protein whose N-terminus part is exposed to the mitochondrial
matrix and whose C-terminal portion is exposed to the mito-
chondrial intermembrane space (1). The mature form of AIF
comprises three structural domains: a FAD-binding domain, a
NADH-binding domain, and a C-terminal domain (2–4). In the
same way as other flavoproteins, the oxydoreductase part of
AIF (composed by the NADH- and FAD-binding domains)
adopts a typical Rossmann fold conferring an electron transfer
activity to the protein. FAD-bound AIF can be reduced by
NAD(P)H without accumulation of a semiquinone intermediate.
Furthermore, reduced AIF can catalyze a NADH-dependent
reduction of small molecules, such as cytochrome c (5). Despite
important advances, the enzymatic function of AIF has not been
Figure 1. Schematic representation of AIF-mediated caspase-independent PCD. AIF is transcribed and translated in a 67 kDa pre-
cursor protein carrying a N-terminal MLS (amino acids 1–100), a spacer sequence (aa 101–121), a FAD-binding domain (aa 122–
262 and 400–477), a NADH-binding domain (aa 263–399), and a C-terminal domain (aa 478–613). Upon being imported into mito-
chondria, the MLS sequence is removed by a mitochondrial endopeptidase and AIF changes its configuration by incorporating
FAD. The mature protein (62 kDa) is then anchored to the inner mitochondrial membrane by its transmembrane domain. In this
form, AIF plays a vital function related to the respiratory chain stability and/or to maintenance of the mitochondrial structure.
Upon various stimuli, AIF is cleaved and released from mitochondria to the cytosol. Cystein proteases such as calpains (cytosolic
and/or mitochondrial) and cathepsins could cleave AIF, yielding the truncated form of the protein, tAIF (57 kDa). Different pro-
teins, such as the proapoptotic Bcl-2 member Bax, regulate tAIF release through the formation of the outer mitochondrial mem-
brane pores. Once in the cytosol, tAIF interacts with different targets. For instance, AIF may inhibit protein translation through its
association with eIF3g and it could stimulate the activity of the lipid translocase scramblase 1 (SCRM1), which is responsible for
classical PCD phosphatidyl serine exposure. In PCD, AIF is particularly known for translocating from the cytosol to the nucleus,
where it induces chromatinolysis. This relocalization is positively regulated by cyclophilin A (CypA) and negatively regulated by
heat shock protein 70 (Hsp70). Once in the nucleus, tAIF associates with phosphorylated histone H2AX (cH2AX), CypA, or endo-
nuclease G (EndoG) to provoke chromatin condensation and DNA degradation. In glutamate excitotoxicity-induced parthanatos in
brain, a 62 kDa form of AIF is associated to the outer mitochondrial membrane. When the PAR polymers generated by the nuclear
protein PARP-1 are present, this AIF pool is released from the mitochondria and reaches the nucleus to provoke chromatinolysis
via an unknown mechanism. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]


















































Fig 6. PARP1 & AIF mediated necrotic cell death  
 
PARP1 is activated in response to DNA damage to generate PAR polymers that translocate to the 
mitochondria and cause AIF present in the IMS to translocate to the nucleus. Alternatively, truncated 
AIF generated either by cathepsins or calpains translocates to the nucleus where it associates with CypA 
and phosphorylated H2AX. This complex results in DNA unwinding and fragmentation. Mechanisms 
involved in DNA fragmentation downstream of full length AIF are unknown. 
 
Abbreviations: IMS – intermembrane space; AIF – apoptosis inducing factor; tAIF – truncated AIF; 
PARP1 – poly ADP ribose polymerase 1; PAR – poly ADP ribose; CypA – cyclophilin A; H2AX – 
histone H2AX 
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 length AIF (possibly from the IMS pool) to the nucleus (84,85). PARP1 mediated cell 
death in response to alkylating DNA damage agents and enterovirus 71 infection was 
found to require calpain dependent cleavage of mitochondrial AIF to a 57KDa form prior 
to nuclear translocation (86,91). Cathepsins have also been implicated in AIF cleavage 
(92). JNK phosphorylation and activation was also shown to be required for PARP1 
mediated AIF nuclear translocation, AIF cleavage was not addressed in this study 
(93,94). Following translocation to the nucleus, truncated AIF associates with cyclophilin 
A (CypA) and phosphorylated histone H2AX to form a DNA degrading complex leading 
to DNA fragmentation (Fig 6) (60). Mechanisms involved in full length AIF mediated 
chromatinolysis are unknown.  
1.5.4 Necrosis and Mtb pathogenesis 
 Apoptosis induction is associated with a decrease in Mtb viability either via direct 
bacterial killing or by the uptake of bacteria contained within apoptotic cells by bystander 
macrophages and neutrophils and Mtb has adopted different mechanism to inhibit 
apoptotic host cell death (49). However, cell death by necrosis does not affect Mtb 
viability. No changes in Mtb recovery from infected macrophages was observed 
following treatment with the necrosis inducer hydrogen peroxide while apoptosis 
induction with ATP lead to loss of bacterial viability (95). Similarly, reduction in 
cytosolic Ca2+ levels achieved by addition of ruthenium red (a mitochondrial Ca2+ 
uniporter inhibitor) lead to an increase in necrosis of Mtb infected cells but had no effects 
on bacterial survival (96). Addition of uninfected macrophages to M.avium infected 
apoptotic cells reduced bacterial survival while a analogous treatment of infected cells 
rendered necrotic by sonication did not have a similar effect (97).  A comparative study 
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of Mtb clinical strains with the reference strain H37Rv showed that the clinical isolates 
which grew better than H37Rv ex vivo also induced higher levels of necrosis (98).  
Studies on susceptibility to Mtb of mouse mutants that lack genes contributing to 
necrosis induction or inhibition also indicate that necrosis induction is beneficial for the 
pathogen rather than the host. The sst1 (super-susceptibility to tuberculosis 1) locus has 
been associated with the varying susceptibility of different mice strains to Mtb infection 
and the ipr1 (intracellular pathogen resistance 1) gene encoded within this locus was 
identified to mediate this effect (99). Mice deficient in ipr1 were found to be more 
susceptible to Mtb. ipr1-/- BMDM’s underwent necrosis in ex vivo infections compared to 
cells from control mice in which the cell death mode was determined to be apoptotic (99). 
Mtb mediated necrosis has been shown to be dependent on production of the lipid 
mediator lipoxin A4 (LXA4) and consequent inhibition of prostaglandin E2 (PGE2) in 
infected macrophages (100).  Lipoxins and prostanoids can be generated from 
arachidonic acid by the action of lipoxygenases and cyclooxygenases respectively (100). 
Mice deficient in 5-lipoxygenase (5-LO) and subsequently in LXA4 production were 
found to be more resistant to Mtb infection. Conversely deficiency in prostaglandin E 
synthase (PTGES) and in PGE2 rendered the mice more susceptible to Mtb infection 
(101,102). Leukotriene A4 hydrolase (LTA4H) is required for the production of 
leukotriene B4 from arachidonic acid and absence of LTA4H led to an increased 
production of LXA4 in zebrafish larvae (103). LTA4H morphant zebrafish larvae had 
lower TNF, increased bacterial burdens and higher susceptibility to M.marinum infection 
compared to WT controls. This was attributed to increased production of LXA4 and 
necrosis induction in the morphant zebrafish larvae (10). Interestingly, LTA4H high 
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zebrafish larvae (generated by introduction of LTA4H mRNA) were also found to be 
hypersusceptible to M.marinum infection and this phenotype was attributable to increased 
TNF production resulting in mitochondrial ROS, RIPK1 and RIPK3 dependent necrosis 
induction (9,103). LTA4H polymorphisms were found to be associated with 
susceptibility to TB in humans as well (10). 
1.5.5 Mechanisms involved in Mtb induced necrotic cell death 
The first insight into the mechanisms of Mtb mediated necrosis induction came 
from a study comparing the effects of virulent Mtb strain H37Rv and attenuated Mtb 
strain H37Ra infection on host cell mitochondrial function. H37Rv induced necrosis was 
found to be dependent on increased loss of mitochondrial membrane potential in infected 
cells and could be inhibited by cyclosporine A (CsA), an inhibitor of mitochondrial 
permeability transition pore (MPTP) formation and by decreasing mitochondrial Ca2+ 
levels (104). Mitochondrial outer membrane permeabilization (MOMP) and CytC 
translocation to cytosol was associated with H37Ra induced apoptosis (104).  
 Modulation of eicosanoid production by Mtb leads to necrosis via three 
mechanisms – loss of mitochondrial membrane potential, inhibition of plasma membrane 
repair and inhibition of apoptotic envelope formation. Mtb infection resulted in 
production of LXA4 that inhibits expression of cyclooxygenase 2 (COX2) enzyme 
required for synthesis of PGE2. PGE2 signaling via its G-protein coupled prostanoid 
receptor 2 (EP2) and consequent activation of protein kinase A (PKA) was required to 
prevent loss of mitochondrial membrane potential and necrosis (105). PGE2 also 
upregulates expression of the lysosomal Ca2+ sensor Syt7 which is required for the 
recruitment of lysosomal vesicles to the plasma membrane for repair of microdisruptions 
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failing which necrosis occurs (102). LXA4 downregulates expression of the serpin 
protease inhibitor plasminogen activator inhibitor type 2 (PAI2), an inhibitor of  annexin-
1 cleavage. Annexin-1 is recruited to the surface of apoptotic cells and is crosslinked to 
form the apoptotic envelope, which prevents loss of plasma membrane integrity. 
Truncated annexin cannot be crosslinked and thus Mtb infected cells die via necrosis (Fig 
7) (106).  
Macrophage necrosis induction was also found to occur in response to high 
bacillary load (MOI 25-50) of Mtb (107-109).  Based on assessment of plasma membrane 
permeability and nuclear fragmentation and condensation, cell death induction by high 
MOI of Mtb was found to have both apoptotic and necrotic features (107). This was 
eventually confirmed by electron microscopy studies (108). While loss of mitochondrial 
membrane potential was observed, it was found to be independent of MPT pore (MPTP) 
formation (108). Calcium chelation, TLR and TNF signaling and caspase 3 activity were 
also found to be dispensable for high MOI Mtb induced cell death  (107,109).  High MOI 
Mtb infection was found to induce lysosomal membrane permeabilization and loss of 
mitochondrial membrane potential and necrosis induction was attributed to the activity of 
lysosomal lipase but not cathepsins (Fig 7) (108). High intracellular bacillary load was 
found to lead to necrosis of lung monocytic cells and neutrophils in in vivo mouse 
infections as well and the burst size was estimated to be between 20-40 bacilli (21).  
Infection with Mtb leads to inflammasome activation and IL1β release (27). Mtb 
mediated necrosis was found to be independent of caspase 1 and cathepsin activity, 
excluding the role of both pyroptosis and pyronecrosis (32,108,109). The inflammasome 
component NLRP3 however has been demonstrated to be required for Mtb mediated 
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Fig 7. Mechanisms of Mtb mediated necrosis induction 
 
Mtb infection upregulates production of the eicosanoid LXA4 that leads to increased annexin-1 cleavage 
and inhibition of apoptotic envelope formation. LXA4 represses production of the eicosanoid PGE2 
resulting in loss of mitochondrial membrane potential and inhibition of plasma membrane repair. These 
events lead to death of infected cells by necrosis. A high load of Mtb in host cells was found to result in 
necrotic cell death by activation of lysosomal lipases and resultant host cell membrane damage. Mtb 
mediated NLRP3 inflammasome activation and bacterial escape from the phagosome to the cytosol are 
also associated with induction of host cell necrosis.  
 
 Abbreviations: AA – arachidonic acid; COX2 – cyclooxygenase ; PGH – prostaglandin H; PGES – 
prostaglandin E2 synthase; PGE2 - prostaglandin E2 ; LXA4 – lipoxin A4 
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production and apoptosis33. However, it is 
not clear which of these mechanisms are 
important in vivo34.
One area of research in this field focuses 
on the roles of the eicosanoids prostaglandin 
E2 (PGE2) and lipoxin A4 (LXA4) in the regu-
lation of programmed macrophage death24–26. 
The cyclooxygenases COX1 (also known as 
PTGS1) and COX2 (also known as PTGS2) 
convert arachidonic acid into the central 
intermediate PGH235, which is converted 
by specific synthases into a diverse range of 
prostanoids36. Interaction of these prostanoid 
species (which include the prostaglandins 
PGD2, PGE2, PGF2!, PGI2 and thromboxane) 
with an array of specific prostanoid recep-
tors plays a part in several cellular pathways. 
In the case of PGE2, interactions with four 
PGE2 receptors, EP1, EP2, EP3 and EP4 (also 
known as PTGER1, PTGER2, PTGER3 and 
PTGER4, respectively) trigger intracellular 
pathways that either promote or inhibit 
inflammation37. Importantly, the functional 
specificity of PGE2 is largely determined by 
its interaction with these specific receptors37. 
EP1 mediates the elevation of intracellular 
Ca2+. By contrast, EP2, which is involved in 
joint inflammation and neutrophil recruit-
ment, and EP4, which induces cell migration 
in tumour invasion, are both involved in 
the upregulation of intracellular cyclic AMP 
levels. EP2 activates protein kinase A (PKA), 
and EP4 activates adenylyl cyclase and 
phospho inositide 3-kinase. Triggering EP3 
downregulates cAMP concentrations and is 
known to mediate fever and angiogenesis.
Lipid bodies form at distinct cytoplas-
mic sites following infection of mouse 
macrophages with the attenuated strain 
Mycobacterium bovis bacille Calmette-
Guérin (BCG); these lipid bodies are the 
sites of COX2 activity and PGE2 genera-
tion38. Indeed, PGE2 production has been 
a consistent finding following M. bovis 
BCG infection of mouse macrophages39. 
Macrophages infected with other attenuated 
M. tuberculosis strains also activate PGE2 
production, which prevents necrosis and 
leads to apoptosis instead26 (FIG. 2a). By con-
trast, virulent M. tuberculosis strains, such as 
M. tuberculosis str. H37Rv or M. tuberculosis 
str. Erdman, are much weaker inducers of 
PGE2 production by macrophages26. This 
raises the possibility that virulent M. tuber-
culosis actively inhibits PGE2 production. 
Thus, an important strategy that M. tuber-
culosis exploits to induce or avoid apoptotic 
cell death is the subversion of host eicosanoid 
biosynthesis pathways25,26.
Lipoxins are also generated from arachi-
donic acid but require the action of different 
enzymes, including 5-lipoxygenases and 
15-lipoxygenases40. Lipoxins are anti-inflam-
matory molecules and modulate chemokine 
and cytokine expression, monocyte traf-
ficking and efferocytosis41. In contrast to the 
attenuated M. tuberculosis str. H37Ra, which 
is a weak LXA4  inducer, virulent M. tubercu-
losis strongly induces the synthesis of LXA4, 
which inhibits COX2 production and thus 
effectively shuts down PGE2 biosynthesis25,26 
(FIG. 2b). In a PGE2-poor microenvironment, 
the macrophage cannot prevent mitochon-
drial damage or enable the repair of plasma 
membrane disruptions effectively24–26, and 
both of these processes are required to 
prevent necrosis and induce apoptosis25,26. 
Virulent M. tuberculosis in pre-necrotic mac-
rophages continues to replicate and, after the 
cells are lysed, propagates the infection by 
spreading to uninfected macrophages. Thus, 
the balance of PGE2 and LXA4 production 
by the infected macrophage regulates the 
relative amount of apoptosis and necrosis 
following M. tuberculosis infection and has 
important functional consequences for 
innate control of intracellular M. tuberculosis 
infection.
The idea that lipoxin production by 
M. tuberculosis-infected macrophages is 
associated with increased bacterial replica-
tion and greater virulence was strengthened 
by the recent genetic analysis of zebrafish 
(Danio rerio) susceptibility to Mycobacterium 
marinum infection42. Multiple mutant classes 
of D. rerio with different innate susceptibili-
ties to M. marinum were identified42, and a 
hypersusceptible zebrafish mutant was found 
with a mutation that mapped to the lta4h 
locus, which encodes leukotriene A4 hydro-
lase (Lta4h), an enzyme that is required for 
the final step of leukotriene B4 (LTB4) syn-
thesis. Although Lta4h deficiency results in 
the loss of LTB4 production, the addition of 
LTB4 did not complement the genetic defect 
nor increase host resistance. In the absence of 
Lta4h, its substrate (LTA4) accumulates and 
can lead to redirected eicosanoid synthesis 
and increased lipoxin synthesis. Therefore, it 
has been suggested that the increased suscep-
tibility of the zebrafish lta4h mutant is due to 
an increase in lipoxin production. The same 
study presents human genetic data showing 
that polymorphisms in the LTA4H gene are 
associated with susceptibility to pulmonary 
Figure 2 | The balance of prostaglandin E2 and lipoxin A4 determine the cellular fate of macro-
phages infected with Mycobacterium tuberculosis. a | Infection with attenuated Mycobacterium 







 has at least three actions: signalling through PGE
2
 receptor 2 (EP2; also 
known as PTGER2) protects mitochondria from inner-membrane damage and prevents loss of mito-
chondrial membrane potential; it also enables the repair of plasma membrane damage, an activity 




). These actions all 
prevent necrosis of the infected macrophage and, instead, trigger apoptosis, an innate defence 
mechanism. b | Virulent M. tuberculosis strongly induces the production of LXA
4
, which prevents the 
accumulation of COX2 mRNA. Consequently, prostaglandin biosynthesis falls. Without the protective 
actions of PGE
2
, the infected macrophage is more likely to undergo necrosis, a form of cell death that 
allows the bacterium to evade innate immunity and T cell-mediated immunity. AA, arachidonic acid; 
PGES, PGE synthase (also known as PTGES). Figure is modified, with permission, from REF. 26  (2008) 
The Rockefeller University Press.
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Table 1 | Benefits of cell death following a host–pathogen interaction
Benefits for the host Benefits for the pathogen
Apoptosis r Contains the infection 
r Minimizes tissue injury 
r Can promote cross-priming 
r Can lead to pathogen killing 
r Does not provoke inflammation 
r  Allows the cell to act as a Trojan Horse for the 
pathogen, which can lead to dissemination of  
the pathogen or evasion of the immune response
Necrosis (including 
pyroptosis)
r Provokes an inflammatory response 
r  Exposes the pathogen to humoral immunity (antibody and 
complement)
r Exposes the pathogen to activated phagocytes 
r Promotes T cell priming 
r  Leads to the maturation of antigen-presenting cells through danger 
signals
r  Allows the pathogen to escape intracellular 
defence mechanisms
r Allows the pathogen to disseminate
Inhibition of cell 
death
r  T cell recognition of pathogen-derived antigens presented by 
infected macrophages leads to pathogen clearance
r  Action of cytokines and other mediators on the infected cell can 
lead to immune activation and control of the pathogen
r Allows the pathogen to evade humoral immunity 
r  Provides time for the pathogen to complete its life 
cycle and replicate
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Although L. pneumophila inhibits macro-
phage apoptosis, infected DCs undergo 
rapid apoptosis, which is less permissive 
for bacterial replication. Thus, similarly to 
M. tuberculosis, virulent L. pneumophila 
inhibits macrophage apoptosis and, 
instead, leads to necrosis.
Other investigations have shown that 
the type of macrophage death following 
infection with M. tuberculosis determines 
whether a successful antimycobacterial 
defence mechanism is activated. Infection 
with attenuated M. tuberculosis induces 
apoptosis19–24. Virulent M. tuberculosis 
induces necrosis of both human and mouse 
macrophages, a property that is not shared 
with non-pathogenic mycobacterial  
species24–26; this allows the bacteria to evade 
host defence mechanisms by inducing cel-
lular lysis and spreading of the infection24 
(FIG. 1). The concept that virulent M. tuber-
culosis actively inhibits the induction of 
macrophage apoptosis27 is supported by the 
identification of mutants that induce  
apoptosis instead of necrosis28,29.
Thus, the death modality of infected 
macrophages should be considered an innate 
defence mechanism. Dissection of the cel-
lular pathways that are altered by virulent 
M. tuberculosis has exposed a key role for 
host eicosanoid biosynthesis pathways in 
regulating the death modality of infected 
macrophages24–26. Here, we discuss the selec-
tive production of specific eicosanoids that 
have important functional consequences  
for the innate control of intracellular 
M. tuberculosis infection.
Host lipids modulate macrophage death
Apoptosis and the concomitant antimyco-
bacterial activity of human macrophages 
can be triggered by M. tuberculosis through 
the activity of cytosolic phospholipase A2! 
(CPLA2!; also known as PLA2G4C), a group 
IV CPLA2 that catalyses the release of arachi-
donic acid from the sn-2 position of mem-
brane phospholipids20. Arachidonic acid 
and its diverse products regulate death in 
several cell types30. This is thought to be due 
to the fact that arachidonic acid products 
are second messengers in tumour necrosis 
factor-induced apoptosis31 and the fact that 
oxygen radicals, which are produced dur-
ing lipoxygenation of arachidonic acid, 
induce the production of reactive oxygen 
species and are involved in the induction of 
cell death32. Arachidonic acid also activates 
sphingo myelinase, leading to ceramide 
Figur  1 | Th  fate of infected macrophages affects host resistance to Mycobacterium tuber-
culosis infection. Mycobacterium tuberculosis infects macrophages and then survives and replicates 
in the phagosome. Macrophages infected with attenuated strains of M. tuberculosis undergo apop-
tosi , a death modal y that impairs bacteria  replicat on. Apoptosis of infected macrophages provides 
an important link to adaptive immunity, as apoptotic vesicles containing bacterial antigens are taken 
up by dendritic cells. The dendritic cells can efficiently present these antigens to naive T cells, leading 
to eir ac ivation. By contrast, virulent M. tuberculosis inhibits apoptosis and, instead, induces necro-
sis. We propose that damage to the phagosomal membrane facilitates bacterial translocation into the 
cytosol and is a precursor to the full-scale induction of macrophage necrosis. Necrosis leads to inter-
cellular dissemination of M. tuberculosis, as extracellular M. tuberculosis can infect other macrophages 
that have been recruited to the lung.
P E R S P E C T I V E S
NATURE REVIEWS | MICROBIOLOGY  VOLUME 8 | SEPTEMBER 2010 | 669
© 20  Macmillan Publishers Limited. All rights reserved10
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Apoptosis r Contains the infection 
r Minimizes tissue injury 
r Can promote cross-priming 
r Can lead t  pathogen killing 
r Does not provoke inflammation 
r  Allows the cell to act as a Trojan Horse for the 
pathogen, which can lead to dissemination of  
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r Provokes an inflammatory response 
r  Exposes the pathogen to humoral immunity (antibody and 
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r  Leads to the maturation of antigen-presenting cells through danger 
signals
r  Allows the pathogen to escape intracellular 
defence mechanisms
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r  T cell recognition of pathogen-derived antigens presented by 
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r  Provides time for the pathogen to complete its life 
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Although L. pneumophila inhibits macro-
phage apoptosis, infected DCs undergo 
rapid apoptosis, which is less permissive 
for bacterial replication. Thus, similarly to 
M. tuberculosis, virulent L. pneumophila 
inhibits macrophage apoptosis and, 
instead, leads to necrosis.
Other investigations have shown that 
the type of macrophage death following 
infection with M. tuberculosis determines 
whether a successful antimycobacterial 
defence mechanism is activated. Infection 
with attenuated M. tuberculosis induces 
apoptosis19–24. Virulent M. tuberculosis 
induces necrosis of both human and mouse 
macrophages, a property that is not shared 
with non-pathogenic mycobacterial  
species24–26; this allows the bacteria to evade 
host defence mechanisms by inducing cel-
lular lysis and spreading of the infection24 
(FIG. 1). The concept that virulent M. tuber-
culosis actively inhibits the induction of 
macrophage apoptosis27 is su ported by he 
identification of mutants that ind ce  
poptosis instead of necrosis28,29.
Thus, the death modality of inf cted 
macrophages should be considered an innate 
defence mechanism. Dissection of the cel-
lular pathways that are altered by virulent 
M. tuberculosis has exposed a key role for 
host eicosanoid biosynthesis pathways in 
regulating the death modality of infected 
macrophages24–26. Here, we discuss the selec-
tive production of specific eicosanoids that 
have imp rtant functional consequences  
for the innate control of intracellular 
M. tuberculosis infection.
Host lipids modulate macrophage death
Apoptosis and the concomitant antimyco-
bacterial activity of human macrophages 
can be triggered by M. tuberculosis through 
the activity of cytosolic phospholipase A2! 
(CPLA2!; also known as PLA2G4C), a group 
IV CPLA2 that catalyses the release of arachi-
donic acid from the sn-2 position of mem-
brane phospholipids20. Arachidonic acid 
and its d verse pr ducts regulate death in 
several cell types30. This is thought to be due 
to the fact that arachidonic acid products 
are second messengers in tumour necrosis 
factor-induced apoptosis31 and the fact that 
oxygen radicals, which are produced dur-
ing lipoxygenation of arachidonic acid, 
induce the production of reactive xyg n 
species and are involved in the induction of 
cell death32. Arachidonic acid also activates 
sphingo myelinase, leading to ceramide 
Figure 1 | The fate of infected macrophages affec s host resistance to My obacterium tuber-
culosis infection. Mycobacterium tuberculosis infects macrophages and then survives and replic tes 
in the phagosome. Macrophages infecte  with attenuated s rains of M. tuber ulosis und rgo apop-
tosis, a death modality that impairs bacterial replication. Apoptosis of infected macrophages provides 
an important link to adaptive immunity, as apoptotic vesicles containing bacterial antigens are taken 
up by dendritic cells. The dendritic cells can efficiently present these antigens to naive T cells, leading 
to their activation. By contrast, virulent M. tuberculosis inhibits apoptosis and, instead, induces necro-
si . We propose that damage to the phagosomal membrane facilitates bacterial translocation into the 
cytosol and is a precursor to the full-scale induction of macrophage necrosis. Necrosis leads to inter-
cellular dissemination of M. tuberculosis, as extracellular M. tuberculosis can infect other macrophages 
that have been recruited to the lung.
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necrosis (Fig 7) (32). The study identified Mtb mediated phagosomal damage and 
activation of the tyrosine kinase Syk upstream of NLRP3 activation, mediators 
downstream of NLRP3 contributing to cell death were not identified (32). 
Following entry into a macrophage, Mtb arrests phagosome-lysosome fusion and 
has been found to remain within compartments resembling the early endosome. However, 
studies have reported that Mtb eventually escapes from the phagosome to the cytosol (41-
43,110,111). Necrotic cell death was found to closely follow Mtb escape to the cytosol 
(42). Mechanisms underlying necrosis induction following Mtb escape have not been 
investigated.  
1.5.6 Mtb genes implicated in necrotic cell death induction 
 Mtb has two specialized secretion systems encoded by the ESX loci - ESX1 and 
ESX5 - in order to transport proteins across its cell wall. The EsxA protein encoded by 
the esxA gene located in the ESX1 locus has been shown to form pores in artificial lipid 
bilayers as well in RBC membranes resulting in hemolysis (112-114). Both ESX1 and 
esxA mutant strains has been shown to induce much lower levels of necrosis in infected 
macrophages compared to the wild type Mtb strain (32,42,109,115,116). Conflicting 
reports exist regarding the role of EsxA in high MOI Mtb induced cell death with one 
report attributing this phenotype to the phoPR two component regulatory system 
(108,109).  EsxA has also been implicated in apoptosis induction in other studies and the 
difference in cell death modality could be attributed to the different cell types as well as 
cell death detection techniques used in these studies (33,117,118). It must be noted that 
EsxA is required for the secretion of other ESX1 substrates as well. Therefore, it is 
difficult to determine the contribution of EsxA itself in Mtb mediated necrosis.  
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The ESX5 locus is required for the transport of PE-PPE proteins and an Mtb 
ESX5 mutant strain was found to be deficient in necrosis induction. The ESX5 locus 
induced necrosis was found to be dependent on cathepsin B (116). The requirement of the 
ESX5 locus to induce necrosis could possibly be due to its role in the secretion of the 
PE25/PPE41 complex as macrophages treated with the recombinant protein complex 
undergo necrosis (119).  Ectopic expression of PE-PGRS33 protein in mammalian cells 
led to mitochondrial localization of the protein and induction of necrosis (120).  
Mtb mediated inhibition of the eicosanoid PGE2 contributes to necrotic cell death 
via loss of mitochondrial membrane potential and inhibition of plasma membrane repair 
mechanisms and a recent study implicated Mtb phospholipase (PLC) genes to influence 
PGE2 production (102,104,106,121). Mtb encodes for four PLC genes (plc A,B,C,D). A 
comparative study of two clinical strains of Mtb showed that the strain 97-1200 in which 
all the plc genes were deleted induced lower levels of necrosis, higher COX2 mRNA 
expression and increased PGE2 production in infected alveolar macrophages compared to 
the 97-1505 strain in which plcA and plcB were expressed (121). A recent study has 
implicated the Mtb CpnT (channel protein with necrosis inducing toxin) protein encoded 
by Rv3903c in necrosis induction, decreased necrosis was observed in macrophages 
infected with the cpnT mutant compared with Mtb infected cells. Increased levels of 
caspase 1, caspase 3 and RIPK1 independent cell death was observed in Jurkat T cells 
overexpressing the C terminal fragment of CpnT compared to control cells (122). 
Another Mtb gene implicated in regulation of necrosis is Rv3364c, which contributes to 




Autophagy is an evolutionarily conserved catabolic process that involves 
sequestration of cytosolic contents into de novo generated double membrane vesicles 
termed as autophagosomes. Subsequent fusion of autophagosomes with lysosomes leads 
to degradation of autophagosomal contents (139,140). Autophagy induction is achieved 
by both intracellular and extracellular stresses such as amino acid starvation, growth 
factor deprivation, reduced ATP levels, ER stress, hypoxia, oxidative stresses and 
microbial invasion (141). Autophagy can be non-selective i.e. random areas of the 
cytosol are engulfed within the autophagosome, this process is termed macroautophagy. 
Alternatively, cargo may be specifically targeted to the autophagosomes in selective 
autophagy (Fig 8). Based on the cargo, selective autophagy may be of different types – 
mitophagy (mitochondria), reticulophagy (ER membranes), xenophagy (micro-
organisms) (142).  
 Apart from directly killing micro-organisms by directing them to lysosomal 
compartments, autophagy also serves to deliver cytosolic PAMP’s to endosomes 
harboring cytosolic PRR’s resulting in generation of innate immune responses (37). 
Autophagy also negatively regulates inflammasome activation by eliminating PAMP’s 
and by targeting ubiquitinated inflammasome complexes for destruction (143).  
1.6.1 Molecular machinery of macroautophagy 
 There are 5 distinct stages in autophagy – induction, membrane nucleation, 
vesicle expansion, lysosomal fusion and degradation of autophagosomal contents.   
! 36!
  
detect ubiquitin-dependent ‘eat-me’ signals (via either a
ZnF, UBA or UBAN domain), while NDP52 is unique in
also directing Galectin-8 labelled cargo to autophagy
[11,12!,13]. The cargo receptors also possess short
LC3-interacting regions (LIR), which bind ATG8L
proteins. With the exception of the p62 and NBR1
paralogous proteins, the cargo receptors possess
limited similarity, indicating their shared autophagy
functions are due to convergent evolution. Further
receptor-specific domains allow the proteins to engage
in diverse cellular functions. The physiological import-
ance of the cargo receptors is highlighted by disease-
causing mutations in p62 and Optineurin found in
patients with Paget’s Disease of the Bone, Amyotrophic
Lateral Sclerosis and hepatocellular carcinoma [14,15].
There is evidence for both shared and distinct autophagy
functions for the cargo receptors. For example, homo-













p62 PB1 ZnF LIR UBA 440
NBR1 PB1 ZnF CC CC LIR UBA 966
NDP52 CLIR CC ZnFGal8IRSKICH 577
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Overview of autophagy and cargo receptor domain structure. (a) Autophagosome biogenesis is initiated from crescent-shaped double membrane
structures termed phagophores, to which LC3 and related ATG8-like proteins are conjugated. Phagophore membranes subsequently elongate and
enclose cytosolic material, thereby partitioning autophagy cargo from the rest of the cell. Cytosolic material becomes encapsulated either non-
selectively or is captured selectively by cargo receptors that detect cargo-associated ‘eat-me’ signals. Autophagosome maturation results in fusion
with lysosomes causing the degradation of the autophagosome content and its inner membrane. (b) Domain structure of cargo receptors. Highlighted
are binding sites for ‘eat-me’ signals and ATG8 family members. All cargo receptors bind ubiquitin-labelled cargo; only NDP52 detects the ‘eat-me’
signal Galectin-8 (Gal8). P62, NBR1 and Optineurin (OPTN) bind non-selectively LC3 and Gabarap proteins (LC3/GBR) via their LC3-interactin regions
(LIRs), while NDP52 preferentially interacts with LC3C via a LC3C-specific binding site (CLIR). Abbreviations: CC, coiled-coil; CLIR, LC3C-specific LIR;
Gal8, Galectin-8; Gal8IR, Galectin-8 interacting region; LIR, LC3-interacting region; OPTN, Optineurin; PB1, Phox and Bem1P; SKICH, skeletal muscle
and kidney enriched inositol phosphatase carboxyl homology; Ub, ubiquitin; UBA, ubiquitin-associated domain; UBAN, ubiquitin binding in ABIN and
NEMO domain
Current Opinion in Microbiology 2013, 16:339–348 www.sciencedirect.com
Fig 8. Overview of non-selective and selective autophagy  
 
Cytosolic material is captured in a non-specific manner in non-selective or macroautophagy. Specific 
cargo receptors are involved in selective autophagy with xenophagy of a bacterium being depicted in 
this image. The captured material is encapsulated in a double membrane autophagosome that eventually 
fuses with a lysosome leading to degradation of autophagosomal contents.  
 
Adapted from (142). 
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Execution of these stages requires the participation of both Atg (Autophagy Related 
Genes) and non-Atg proteins (139,144,145).  
Autophagy induction is characterized by the formation of ULK1 complex 
consisting of Unc-51-like-kinase1 (ULK1), Atg13 and FAK family kinase-interacting 
protein of 200KDa (FIP200).  Formation of the ULK1 complex is required for the 
recruitment of Beclin1, Atg14L (ATG14-like) and PI3KR4 (phosphoinositide 3-kinase 
regulatory subunit 4) proteins to the assembly site. These proteins initiate membrane 
nucleation by recruiting the class III PI3K Vps34 to the assembly site that results in the 
production of PI3P (phosphatidylinositol 3-phosphate) and phagophore formation at the 
assembly site. Elongation of the phagophore is achieved by the action of two ubiquitin 
like conjugation systems. First, Atg12 is conjugated to Atg5 via the activity of Atg7 and 
Atg10. The Atg12-Atg5 conjugate binds to Atg16 and the entire complex is attached to 
the phagophore. The Atg12-Atg5-Atg16 complex conjugates phosphatidylethanolamine 
(PE) to Atg8 via an amide bond. Atg7 and Atg3 are also involved in this process 
(139,141,146). Conversion of soluble Atg8 (LC3I) to membrane bound Atg8-PE (LC3II) 
is monitored to study autophagy induction (147,148).   
Once vesicle formation is complete, the Atg12-Atg5-Atg16 complex is released 
from the autophagosomal membrane. A proportion of LC3II is also deconjugated from 
the autophagosomal membrane by the action of the cysteine protease Atg4b thus 
recycling LC3 for new autophagosome formation. The fusion of the autophagosome with 
lysosomes ensues; this requires the small GTPase Rab7, the autophagosomal syntaxin7   
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Fig 9. Molecular machinery of autophagy 
 
There are 5 distinct stages in autophagy – induction, membrane nucleation, expansion, fusion with 
lysosome and degradation of autophagolysosomal contents. Each stage involves formation of protein 
complexes as described in the text. SQSTM1/p62, and NBR1 are examples of cargo receptors involved 
in selective autophagy.  
 




and the VAMP8 (vesicle associated membrane protein 8) and LAMP2 (lysosomal 
associated membrane glycoprotein 2) proteins on the lysosomal membrane (139) . 
Destruction of the autophagosomal contents occurs via activity of lysosomal proteases 
and hydrolases (Fig 9).  
 More recently studies have emerged describing non-canonical autophagy 
pathways which exclude some of the core autophagic machinery components (140). 
Glucose starvation mediated autophagy has been shown to be independent of initiating 
ULK1 while Beclin1-independent autophagy has been reported to occur in response to 
treatment with apoptosis inducers. (139,140). Atg5 independent autophagy has been 
reported to be involved in mitochondrial clearance in erythrocytes (140). Another form of 
non- canonical autophagy involves the recruitment of a subset of autophagy components 
to phagosomal compartments. For example, LC3 is recruited to S.typhimurium containing 
phagosomes, a phenomenon referred to as LC3 associated phagocytosis (LAP) (149). 
Both canonical and non-canonical autophagy share a common outcome i.e. destruction of 
sequestered cargo. 
1.6.2 Molecular machinery of selective autophagy   
 Execution of selective autophagy occurs via similar mechanisms as 
macroautophagy with one important addition – recognition of substrates and their 
tethering to Atg8 either directly or via cargo receptor proteins. Currently four cargo 
receptor proteins are known to exist – p62/SQSTM1 (sequestome 1), NBR1 (neighbor of 
BRCA1 gene 1), Optineurin and NDP52 (nuclear dot protein 52KDa). All of these 
receptors possess short LC3 interacting regions (LIR’s) and ubiquitin recognition 
domains while NDP52 has an additional galectin 8 interacting region (142). Ubiquitin has 
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been shown to coat intracellular pathogens such as S.typhimurium and Mtb allowing for 
their recognition by the autophagic machinery via the cargo receptors (142,150,151). 
Damage to the Salmonella containing vacuole (SCV) leads to exposure of previously 
hidden membrane glycans and binding by galectins. Of these, galectin 8 is recognized by 
NDP52, which then recruits the SCV and its contents to autophagosomes (139,142).    
1.6.3 Regulation of macroautophagy 
  A central regulator of autophagy in response to various stimuli is the serine 
threonine kinase mTOR (mammalian target of rapamycin). mTOR is required for the 
aseembly of the ULK1 complex most likely via phosphorylation of ULK1. mTOR exists 
in 2 complexes – mTORC1 (consisting of mTOR, mLST8/GβL, RAPTOR) and 
mTORC2 (consisting of mTOR, mLST8/GβL and RICTOR) (152). Exposure to insulin 
and growth factors leads to Akt phosphorylation and activation, which in turn 
phosphorylates TSC2 (tuberous sclerosis complex 2). This results in inhibition of TSC2 
interaction with TSC1 (TSC - tuberous sclerosis complex). The TSC1-TSC2 complex 
inhibits the conversion of the Ras family small GTPase Rheb (Ras homolog enriched in 
brain) from its GDP bound form to a GTP bound form. GTP bound Rheb is required for 
the activation of mTOR. The active mTORC1 complex inhibits autophagy induction by 
preventing the formation of the ULK1 complex. Low cellular energy and high 
intracellular Ca2+ levels lead to TSC1-TSC2 complex formation through AMPK 
(adenosine monophosphate activated protein kinase) and CaMKK (calcium/calmodulin 
dependent protein kinase kinase) activation and thus feed into mTORC1 inhibition and 


















thus promoting the dissociation of Beclin 1 from Bcl-2-like
proteins, which in turn induces autophagy.23 The relationship
between Beclin 1 and other substrates of DAPK in autophagy
is unknown.
Phosphorylation of Bcl-2 by the c-Jun N-terminal kinase 1
(JNK1), located within the nonstructural loop of Bcl-2, is
another mechanism that reduces the interaction between
Beclin 1 and its inhibitor.24 We find that high mobility group
box 1 (HMGB1) promotes the phosphorylation of Bcl-2 by
extracellular signal-regulated kinase (ERK), the subsequent
dissociation of Beclin 1 from Bcl-2, and the induction of
autophagy.25 Thus, the interaction between Beclin 1 and its
inhibitors is dynamic and subject to regulation by phosphory-
lation of either one of the two partners in this complex.
Unfortunately, we know almost nothing about how these
mitogen-activated protein kinases (MAPKs, e.g., JNK1 and
ERK) might induce conformational changes between Beclin 1
and its binding partners, preventing their interaction with
one another. Autophagy is negatively regulated by the mTOR
and Ras-cAMP-PKA pathways. Interestingly, LC3 is a direct
substrate of PKA, and its phosphorylation prevents recruit-
ment of LC3 to autophagosomes (Figure 2b).26 Thus, DAPK
and PKA target individual substrates, such as Beclin 1 and
LC3 in autophagy.
The tumor necrosis factor receptor-associated factor 6
(TRAF6) and the deubiquitinating enzyme A20 control
K63-linked ubiquitination of Beclin 1 to trigger autophagy.27
The K63-linked ubiquitination of Beclin 1 facilitates oligo-
merization of Beclin 1 and the activation of PI3KC3. This helps
trigger the formation of autophagosomes. It is important
that future studies assess the state of phosphorylation and


































































































Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulates Beclin 1 expression, whereas miR30a negatively regulates Beclin 1 expression.
Conversely, miR-9 increases autophagy by regulating histone deacetylases activity in lymphoma cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosphorylation and ubiquitination modification regulates autophagy. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II regulate autophagy
and Vps, respectively. (d) In mammals, Beclin 1-Vps34-Vps15 core complexes and Beclin 1’s binding proteins. (e) Models of Beclin 1–Bcl-2 complex dissociation
in autophagy. (f) Model of the role of the three Beclin 1-Vps34-Vps15 complexes. The Atg14L complex functions positively in autophagosome formation. The UVRAG
complex functions positively in autophagosome and endosome maturation. The Rubicon complex functions negatively in autophagosome and endosome maturation
(figure modified from 49,74)
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively r gulates Beclin 1 expression, whereas miR30 n gatively r gulates Beclin 1 expression.
Conversely, miR-9 increases autophagy by re ulating histone deacetylases activity in lymphoma cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosph rylation and ubiquitination modification r gulates autophagy. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II r gulate autophagy
and Vps, respectively. (d) In mammals, Beclin 1-Vps34-Vps15 core complexes and Beclin 1’s binding prot ins. (e) M dels of Beclin 1–Bcl-2 complex dissociation
in autophagy. (f) Model of the role of th three Beclin 1-Vps34-Vps15 complex s. The Atg14L complex functions positively in aut phagoso e f rmation. The UVRAG
complex functi ns positively in aut phagosome and endosome maturation. The Rubicon complex functions n gatively in aut phagosome and endosome maturation
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulates Beclin 1 expression, whereas miR30a negatively regulates Beclin 1 expression.
Conversely, miR-9 increases autophagy by regulating histone deacetylases activity in lymphoma cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosphorylation and ubiquitination modification regulates autophagy. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II regulate autophagy
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulat s Beclin 1 expression, whereas miR30a neg tiv ly regulat s Beclin 1 expression.
Conversely, miR-9 increases autoph gy by regulatin histone deacetylases activity in lymphoma cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosphorylation and ubiquitination modification regulat s autophagy. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II regulat autophagy
and Vps, resp tively. (d) In mammals, Beclin 1-Vps34-Vps15 core complexes and Beclin 1’s binding protein . (e) Models of Beclin 1–Bcl-2 complex dissociation
in autoph gy. (f) Model of the role of th three Beclin 1-Vps34-Vps15 complexes. Th Atg14L complex functions p sitively in autophag some f rmati n. The UVRAG
complex functions positively in autoph g some and endosome maturation. The Rubicon complex functions negativ ly in autophag some and endosome maturation
(figure modified from 49,74)
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulates Beclin 1 expression, whereas miR30a negatively regulates Beclin 1 expression.
Conversely, miR-9 increases autophagy by regulating histone deacetylases activity in lymphoma cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosphorylation and ubiquitination modification regulates autophagy. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II regulate autophagy
and Vps, respectively. (d) In mammals, Beclin 1-Vps34-Vps15 core complexes and Beclin 1’s binding proteins. (e) Models of Beclin 1–Bcl-2 complex dissociation
in autophagy. (f) Model of the role of the three Beclin 1-Vps34-Vps15 complexes. The Atg14L complex functions positively in autophagosome formation. The UVRAG
complex functions positively in autophagosome and endosome maturation. The Rubicon complex functions negatively in autophagosome and endosome maturation
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between Beclin 1 and other substrates of DAPK in autophagy
is unknown.
Phosphorylation of Bcl-2 by the c-Jun N-terminal kinase 1
(JNK1), located within the nonstructural loop of Bcl-2, is
another mechanism that reduces the interaction between
Beclin 1 and its inhibitor.24 We find that high mobility group
box 1 (HMGB1) promotes the phosphorylation of Bcl-2 by
extracellular signal-regulated kinase (ERK), the subsequent
dissociation of Beclin 1 from Bcl-2, and the induction of
autophagy.25 Thus, the interaction between Beclin 1 and its
inhibitors is dynamic and subject to regulation by phosphory-
lation of either one of the two partners in this complex.
Unfortunately, we know almost nothing about how these
mitogen-activated protein kinases (MAPKs, e.g., JNK1 and
ERK) might induce conformational changes between Beclin 1
and its binding partners, preventing their interaction with
one another. Autophagy is negatively regulated by the mTOR
and Ras-cAMP-PKA pathways. Interestingly, LC3 is a direct
substrate of PKA, and its phosphorylation prevents recruit-
ment of LC3 to autophagosomes (Figure 2b).26 Thus, DAPK
and PKA target individual substrates, such as Beclin 1 and
LC3 in autophagy.
The tumor necrosis factor receptor-associated factor 6
(TRAF6) and the deubiquitinating enzyme A20 control
K63-linked ubiquitination of Beclin 1 to trigger autophagy.27
The K63-linked ubiquitination of Beclin 1 facilitates oligo-
merization of Beclin 1 and the activation of PI3KC3. This helps
trigger the formation of autophagosomes. It is important
that future studies assess the state of phosphorylation and
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulates Beclin 1 expression, whereas miR30a negatively regulates Beclin 1 expression.
Conversely, miR-9 ncreases autophagy by regulating histone deacetylases activity in lympho a cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosphorylation and ubiquitination modification regulates autophagy. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II regulate autophagy
and Vps, respectively. (d) In mammals, Beclin 1-Vps34-Vps15 core complex s and Beclin 1’s bi ding proteins. (e) Models of Beclin 1–Bcl-2 complex dissoci tion
in autophagy. (f) Model of the r le of the three Beclin 1-Vps34-Vps15 complexes. The Atg14L co plex functio s positively in autopha some f rm ti n. Th UVRAG
complex functions positively in autophagosome and endosome maturation. The Rubicon complex functions negatively in autophagosome and endosome maturation
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulates Beclin 1 expression, whereas miR30a negatively regulates Beclin 1 expression.
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and Vps, respectively. (d) In mammals, Beclin 1-Vps34-Vps15 core complexes and Beclin 1’s binding proteins. (e) Models of Beclin 1–Bcl-2 complex dissociation
in autophagy. (f) Model of the role of the three Beclin 1-Vps34-Vps15 complexes. The Atg14L complex functions positively in autophagosome formation. The UVRAG
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulates Beclin 1 expression, whereas miR30a negatively regulates Beclin 1 expression.
Conversely, miR-9 increases autophagy by regulating histone deacetylases activity in lymphoma cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
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nd Vp , respectively. (d) In m mm ls, B clin 1-Vps34-Vps15 core complexes and Beclin 1’s bi ding proteins. (e) Models of Beclin 1–B l-2 complex dissociation
in autophagy. (f) Model of the role of the three Beclin 1-Vps34-Vps15 complexes. The Atg14L complex functions positively in autophagosome formation. The UVRAG
complex functions positively in autophagosome and endosome maturation. The Rubicon complex functions negatively in autophagosome and endosome maturation
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Figure 2 The complex Beclin 1 network. (a) NF-kB and E2F positively regulates Beclin 1 expression, whereas miR30a negatively regulates Beclin 1 expression.
Conversely, miR-9 i creases autop agy by regul ting histon d acetylases activity in lymphoma cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosphorylation and ubiquitinatio modification re ulates aut pha y. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II regulate autophagy
and Vps, respectively. (d) In mammals, B clin 1-Vps34-Vps15 core complexes and Beclin 1’s binding proteins. (e) Models of Beclin 1–Bcl-2 complex dissoci tion
in autophagy. (f) Model of the role of the three Beclin 1-Vps34-Vps15 complexes. The Atg14L complex functions positively in autophagosome formation. The UVRAG
complex functions positively in autophagosome and endosome maturation. The Rubicon complex functions negatively in autophagosome and endosome maturation
(figure modified from 49,74)
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Figu 2 The complex Beclin 1 etwork. (a) NF-kB and E2F positiv ly regulates Be lin 1 xp ession, whe e miR30a negatively egulates Beclin 1 expression.
Conversely, miR-9 increases autophagy by regulating histone d acetylases activi y in lym homa cells (not shown). Structurally, Beclin 1 has a BH3 domain, a central
CCD and an ECD. (b) Phosphorylation and ubiquitination modification regulates autophagy. (c) In yeast, Atg6-Vps34-Vps15 complexes I and II regulate autophagy
and Vps, respectively. (d) In mammals, Beclin 1-Vps34-Vps15 core complexes and Beclin 1’s binding proteins. (e) Models of Beclin 1–Bcl-2 complex dissociation
in autophagy. (f) Model of the role of the three Beclin 1-Vp 34-Vps15 complexes. The Atg14L complex functions positively in utophagosome f rmation. The UVRAG
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Fig 10. Regulation of macroautophagy 
 
(A) Pathways involved in macr autophagy i duction in response t  different stimuli. 
(B) Possible modes f Beclin1-Bcl2 complex dissociation required for autophagy inductio . Adapted 
from (146). 
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 compartments containing GTP bound Rheb and thus inhibits mTOR activation (Fig 10A) 
(141,153).  
Macroautophagy is also regulated at the membrane nucleation step via Beclin1 
availability. Beclin1 has 3 structural domains – a coiled- coiled domain (utilized for self 
oligomerization), an evolutionarily conserved domain (required for interaction with other 
membrane nucleation proteins) and a BH3 domain (152). In healthy cells, Beclin1 (using 
its BH3 domain) forms a complex with the anti apoptotic Bcl2 protein, thereby rendering 
Beclin1 unavailable to participate in macroautophagy. However, following exposure to 
autophagy inducing signals, Bcl2 is phosphorylated and dissociates from Beclin1. The 
MAPK JNK has been implicated in Bcl2 phosphorylation in response to starvation, ER 
stress and hypoxic conditions (141,154). Dissociation of Beclin1-Bcl2 complex may also 
result from Beclin1 modifications such as oligomer formation, ubiquitination, 
displacement of Beclin1 following interaction of Bcl2 with BH3 containing proapoptotic 
proteins such as Bad and displacement of Bcl2 by Beclin1 binding proteins such as high 
mobility group protein B1 (HMGB1) (Fig 10B) (146).  
 Transcriptional regulation of proteins involved in autophagy has been described in 
response to nutrient stresses and cytokine signaling (155-157). IL6 has been found to 
inhibit autophagy induction by IFNγ in Mtb infected THP1 cells and this is thought to be 
due to the repression of Atg7 expression and subsequent inhibition of the Atg12-Atg5 
complex (158). Similarly the Th2 cytokines IL4 and IL13 inhibit autophagy of IFNγ 
treated, Mtb infected macrophages in a Stat6 dependent manner. Stat6 is linked to 
increased expression of Bcl2 which inhibits autophagy via Beclin1 binding (159). The 
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cathelicidin LL37 which induces mycobacterial killing in human macrophages via 
autophagy also upregulates Beclin1 and Atg5 expression (160). 
1.6.4 Mtb and autophagy  
 Initial studies on Mtb and autophagy focused on the effect of physiological, 
pharmacological and immunological autophagy inducers on mycobacteria infected cells. 
Incubation of BCG infected macrophages under serum and amino acid starvation 
conditions or treatment with the mTOR inhibitor rapamycin led to autophagy activation 
and colocalization of bacteria with LC3 and with lysosomal markers (lysotracker, 
LAMP1, cathepsin D, CD63) (158, 161). A similar effect was seen following IFNγ 
treatment of BCG-infected macrophages and the IFNγ inducible GTPase LRG47 was 
found to be responsible (161,162). More recently a novel STAT1 independent, p38 
MAPK and PI3K dependent pathway has been implicated in autophagy induction by 
IFNγ (163). IL6, IL4 and IL13 were found to inhibit IFNγ induced autophagy (158,159). 
IL1β treatment of macrophages induced autophagy and inhibited mycobacterial survival 
in a TBK1 dependent manner (164). Low serum levels of calcidiol, a precursor of 1,25 
dihydroxy vitaminD3 (VitD3) is associated with susceptibility to tuberculosis (145). 
Increased colocalization of Mtb with autophagosomes was observed in human 
macrophages following VitD3 treatment and this was found to be dependent on increased 
expression of the cathelicidin LL37 (160). ATP signaling through the P2X7 receptor and 
LPS signaling via TLR4 were also found to promote localization of mycobacteria with 
autophagosomes (165,166). 
 More recently studies have shown that Mtb in the absence of other stimuli induces 
autophagy. A comparative study of autophagy induction by mycobacterial species 
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demonstrated an inverse relationship between autophagy induction and bacterial 
virulence in macrophages (167). Co-localization of Mtb with ubiquitin, the autophagy 
adaptors p62 and NDP52 and LC3 was found to be dependent on pore formation in 
phagosomal membranes by the ESX1 secreted protein EsxA (150). Ubiquitin and p62 
were also recruited to LC3 positive, Mtb containing compartments in dendritic cells 
(168). While about 30% of intracellular Mtb were directed to autophagosomes in 
macrophages at 4hpi, in dendritic cells only about 10% of bacteria were LC3 positive at 
24hpi (150,168). 
 Autophagy induction is associated with anti-mycobacterial effects. Treatment of 
infected macrophages with additional stimuli (starvation, rapamycin, IFNγ, ATP, VitD3) 
results in increased killing of mycobacteria ex vivo as demonstrated by decreased CFU 
obtained compared to untreated infected cells (160,161,165).  Treatment of Mtb infected 
cells with autophagy inhibitors (PI3K inhibitors 3-methyladenine (3-MA) and 
wortmannin) and silencing of autophagy genes reversed the decrease in mycobacterial 
viability. First line drugs used in TB treatment, isoniazid (INH) and pyrazinamide (PZA), 
were also found to induce autophagy in Mtb infected macrophages in a ROS, Ca2+ and 
AMPK dependent manner. Silencing of Beclin1 or Atg5 was found to inhibit 
mycobacterial killing in infected cells treated with INH and PZA indicating that 
autophagy induction contributed to their optimal antibacterial activity (169).  The ability 
of autophagy to overcome the phagolysosome biogenesis block exerted by Mtb and to 
deliver bacteria to the lysosomal compartments is thought to underly the 
mycobactericidal effects of autophagy (161,167). Addition of lysosomal fractions 
obtained from starved or IFNγ treated autophagic macrophages were found to result in 
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reduced recovery of mycobacteria from infected cells. This was linked to increased 
generation of ubiquitin derived peptides in autophagic cells (170). Apart from mediating 
VitD3 induced autophagy, the cathelicidin LL37 was also found to colocalize with LC3 
positive compartments (160). LL37 has been shown to reduce mycobacterial survival in 
vitro (171). It is therefore possible that cathelicidin might exert direct anti-mycobacterial 
effects ex vivo as well.  
 The role of autophagy as an anti-mycobacterial mechanism is further strengthened 
by evidence provided by in vivo studies. Two studies demonstrated that autophagy 
deficient Atg5flox/flox Lys- Cre- mice infected via the aerosol route with a low dose of Mtb 
were extremely susceptible to infection, with mice succumbing within 4 weeks post 
infection compared to wild type controls. Increased bacterial loads were recovered from 
the lungs, liver and spleen of autophagy deficient mice and lungs from these mice 
showed abscess formation unlike the WT controls (150),(172). In addition to effects on 
bacterial load, the lung cytokine environment in Mtb infected autophagy deficient mice 
was found to be significantly pro-inflammatory with increased levels of cytokines such as 
IL1α, IL1β and chemokines such as CCL5 and CXCL1 present compared to control mice. 
No differences were observed in levels of IFNγ (150,172). Apart from the innate immune 
response, adaptive immune responses could also be modulated by autophagy. In dendritic 
cells, 30% of p62 and ubiquitin positive Mtb were found to colocalize with class II MHC 
suggesting that autophagy could promote presentation of mycobacterial peptides to CD4+ 
T cells (168). Autophagy induction via starvation, rapamycin or IFNγ treatment enhanced 
presentation of Ag85B by Mtb infected macrophages and dendritic cells ex vivo. These 
results translated in vivo as well with mice immunized with rapamycin treated, BCG 
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infected dendritic cells exhibiting better protection following challenge with Mtb 
compared to mice immunized with untreated, BCG infected dendritic cells (173).  
1.6.5 Mtb genes involved in autophagy modulation 
 The esxA gene product, EsxA is associated with the ability of Mtb to manipulate 
innate immune responses such as inflammasome activation, TLR signaling and cytokine 
production and host cell death. Additionally, EsxA is also associated with pore formation 
and phagosomal membrane damage (38). The ability of Mtb to induce autophagy in 
macrophages was linked to EsxA production; a lower percentage of esxA mutant bacteria 
colocalized with LC3 and Atg12 compared to the wild type Mtb control. Autophagy 
induction by EsxA was linked to its ability to induce phagosomal membrane damage as 
colocalization with LC3 was partially restored for an esxA mutant strain secreting the 
auto-activated form of the pore forming toxin listeriolysin O (LLO) (150). Pore formation 
by EsxA facilitated the exposure of Mtb extracellular DNA to STING, a component of 
the cytosolic DNA pathway, leading to autophagy and induction of type I IFN response 
(150,174).  
 The 19KDa mycobacterial lipoprotein LpqH has been implicated in Mtb mediated 
autophagy induction in human macrophages. Treatment of macrophages with 
recombinant LpqH led to TLR1/2/CD14 dependent increase in intracellular Ca2+ levels 
and AMPK activation, leading to downstream activation of p38 MAPK. These signaling 
pathways lead to an increase in the conversion of vitamin D3 to its active form (175). 
Active VitD3 induces autophagy by upregulating expression of the cathelicidin LL37 
(160,175). 
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While evidence exists demonstrating that Mtb induces selective autophagy, there 
are reports that indicate that the pathogen possesses the ability to inhibit autophagy. The 
eis (enhanced intracellular survival) gene encodes for an aminoacetyltransferase that 
acetylates the JNK specific phosphatase MKP7 (176). The Mtb eis mutant induces higher 
levels of autophagy compared to the WT control in a ROS and JNK dependent manner 
demonstrating that eis has an anti-autophagic function (177). Lipoarabinomannan (LAM) 
is a mycobacterial lipoglycan capped with mannose residues in pathogenic Mtb 
(ManLAM) compared to phosphatidyl-myo-inositol (PILAM) in non-pathogenic 
M.smegmatis. Latex beads coated with ManLAM did not co-localize with LC3 compared 
to PILAM coated beads indicating that ManLAM plays a role in autophagy inhibition by 
Mtb (178). While Watson et al determined EsxA to be required for Mtb mediated 
autophagy in macrophages, another study in dendritic cells indicated that Mtb induced 
autophagy was independent of EsxA, rather EsxA was required for inhibition of 
autophagosome fusion with lysosomes (179).  
1.6.6 Mechanisms involved in autophagy modulation by Mtb  
 Data for the involvement of mTOR in Mtb mediated autophagy is ambivalent. 
Both pathogenic and non-pathogenic mycobacterial species were found to induce 
autophagy in an mTOR independent fashion in macrophages. Concomitant with 
autophagy induction, increased levels of phosphorylated ribosomal S6 kinase, a 
downstream target of mTOR, was detected in Mtb infected cells compared to uninfected 
controls indicating that the bacteria induced mTOR activation (167). However, another 
study showed that Mtb upregulates microRNA-155 levels in both lungs of mice and in 
BMDM’s ex vivo which in turn post-transcriptionally inhibits expression of Rheb, an 
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activator of mTOR and a negative regulator of autophagy (180). Mtb mediated autophagy 
induction and delivery to lysosomes was shown to require phosphorylation of TBK1 in 
response to detection of bacterial DNA by STING adaptor protein (150). TBK1 induces 
selective autophagy by phosphorylating p62 at Ser403, this was previously demonstrated 
to increase affinity of p62 for ubiquitin, and is also needed for autophagosome maturation 
(142),(164) .  The DNA damage regulated autophagy modulator DRAM1 was found to 
co-localize with Mtb in primary human macrophages in a MyD88 dependent manner and 
was demonstrated to be required for p62 mediated autophagic clearance of M.marinum in 
zebrafish embryos (181). Ubiquitination of Mtb and its localization with autophagic 
markers was shown to require the ubiquitin ligase Parkin, which is required for 
mitophagy as well (151). Using a digitonin based selective membrane permeabilization 
protocol, Manzanillo et al demonstrated that ubiquitin co-localizes to bacteria present 
within intact phagosomes (151). 
 Just as Mtb possesses both pro and anti autophagic genes, studies have described 
mechanisms employed by Mtb to avoid autophagic degradation. Macrophages infected 
with the non-pathogenic M.smegmatis and M.fortuitum showed increased accumulation 
of LC3 positive vesicles compared to those infected with Mtb (167). Phagosomes 
containing live Mtb recruit the host protein coronin-1a unlike those containing heat killed 
bacteria and silencing of coronin-1a was found to inhibit Mtb survival (39). Coronin-1a 
was found to be required for inhibition of autophagy by Mtb in macrophages and 
activation of p38 MAPK was found to be essential to this process (182). Alteration of 
host lipid metabolism by the virulent Mtb strain H37Rv resulting in increased 
accumulation of triacylglycerides and lipid body formation compared to the avirulent 
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H37Ra was associated with decreased autophagy induction. Pharmacological inhibition 
of lipid body formation increased co-localization of Mtb with LC3 and lysotracker 



































Fig 11. Mechanisms involved in autophagy modulation by Mtb 
 
Within the infected macrophage, Mtb induces phagosomal membrane damage in an ESX-1 dependent 
manner. This leads to recognition of Mtb extracellular DNA by the cytosolic receptor STING and the 
downstream phosphorylation and activation of TBK1. Phosphorylated TBK1 in turn phosphorylates the 
selective autophagy adaptor p62 and increases its affinity for ubiquitin that colocalize with the bacteria. 
Activation of the TLR-MyD88-NFκB axis by mycobacteria leads to DRAM1 recruitment to the 
phagosome that also contributes to p62 mediated autophagic clearance.  TBK1 was also found to 
participate in recruitment of another selective autophagy adaptor NDP52. The ubiquitin ligase Parkin is 
required for the ubiquitination and targeting of Mtb to the autophagosome. Mtb infection also 
upregulates miRNA155 levels in the host cell which downregulate expression of Rheb, a negative 
regulator of autophagy. Atleast two mechanisms are be employed by Mtb to negatively regulate 
autophagy induction. Recruitment of coronin1a to the Mtb containing phagosome limits LC3 
accumalation. Alteration of host lipid metabolism by Mtb in an ESX1 dependent manner leads to lipid 
body accumulation that is associated with decreased autophagy induction. 
 










 Virulence is defined as the ability of a pathogen to cause morbidity and mortality 
in the host. Pathogens possess a wide variety of genes that contribute to virulence - 
deletion/disruption of these virulence genes leads to attenuation. However, there are 
numerous reports in literature of “anti-virulence genes” whose deletion or disruption 
enhances the ability of the pathogen to cause disease and results in hypervirulence as 
measured by lower infectious dose, reduced clearance and decreased host survival time. 
 Retention of anti-virulence genes by pathogens indicates possible benefits of 
moderating virulence. Two hypotheses have been proposed (204). First, genes involved 
in restraining virulence may offer a survival advantage in environmental niches or 
specific hosts in case of pathogens with complex lifecycles. For instance, the 
S.typhimurium pcgL mutant is hypervirulent in mice. However pcgL, a D-Ala-D-Ala 
dipeptidase, allows the pathogen to utilize D-Ala-D-Ala released during peptidoglycan 
turnover as a sole carbon source and possibly provides a survival advantage in nutrient 
limiting non-host environments (205). Second, virulence moderation may allow 
prolonged host survival and thus maximize transmission. Leishmania major (L.major) 
cycles between amastigote forms in the human host and the highly infectious 
promastigote forms in the sandfly vector. L.major ptr1 mutants exhibit elevated 
differentiation to promastigote forms and were found to be hypervirulent in mice. 
Retention of the ptr1 gene may allow host survival and thus maximize transmission to the 




1.7.1 Hypervirulence in Mtb 
 Hypervirulence in Mtb has been reported in clinical strains as well as in defined 
gene mutants. The main parameters of determining hypervirulence in Mtb are bacterial 
load in the lungs and median survival time of infected mice. 
1.7.1.1 Hypervirulent clinical Mtb strains 
 Mtb strains belonging to the Beijing genotype family represent approximately 
50% of the strains prevalent in southeast and east Asia and 13% of the strains present 
worldwide (206). A Beijing strain HN878 was found to be more virulent than another 
member of the same family (NHN5) in immunocompetent mice, with higher bacterial 
burden in the lungs and shorter median survival times. HN878 suppressed the in vivo pro-
inflammatory cytokine response, infected mice however were found to express higher 
levels of IFNα and intranasal administration of recombinant IFNα/β worsened the 
survival outcome (207). Increased in vivo type I IFN production has also been reported 
for another Beijing strain W4 (208). The hypervirulence of HN878 was linked to the 
presence of an intact pks1-15 gene and the production of phenolic glycolipids (PGL) by 
the bacteria. Mice infected with the pks1-15 mutant had a longer median survival time 
compared to HN878 infected animals (209). While PGL production is characteristic of 
the HN878 strain only, several members of the Beijing family were found to overproduce 
triglycerides compared to Mtb strains from other lineages and the laboratory strain 
H37Rv (210). A more recent study implicated the purinergic receptor P2X7R mediated 
macrophage necrosis in the increased virulence of the Beijing strain 1471 compared to 
H37Rv. Beijing 1471 induced higher levels of IL1β and IFNγ in macrophages ex vivo and 
increased mortality in immunocompetent mice (211).  
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1.7.1.2 Hypervirulence in defined Mtb gene mutants 
 The mammalian cell entry 1 (mce1) operon is one of the first reported anti-
virulence Mtb genes. The mce1 operon comprises of 13 genes (Rv0166-Rv0178) and is 
thought to encode for an ATP binding cassette (ABC) transporter (212). Deletion of 
either Rv0168 (yrbE1B) or Rv0169 (mce1A) leads to disruption of the entire operon (213). 
The mce1 operon mutant was found to be hypervirulent in immunocompetent BALB/c 
mice with increased lung bacterial burden and mortality observed compared to mice 
infected with Mtb (213). Another study performed in C57Bl6 mice demonstrated 
increased mortality of mce1 mutant infected mice compared to Mtb infected control 
animals as well, however no differences were detected in the lung bacterial burdens 
(212). Contrary to the well defined nodular lesions observed in lungs of Mtb infected 
mice at 10-12 weeks post infection, lungs from mce1 mutant infected mice exhibited 
poorly organized lesions (212,213). In ex vivo macrophage infections, the mce1 mutant 
was found to inhibit TNF, IL6, MCP-1 and nitrite production compared to Mtb (213). 
Phylogenomic analysis revealed the presence of operons similar to mce1 in the 
Actinomycetales family encoding for ABC transporters involved in lipid import. Using 
thin layer chromatography (TLC) and mass spectrometry approaches, the mce1 mutant 
strain was found to accumulate an excess of free mycolic acids in the cell wall compared 
to either Mtb or complemented strains (214). Accumulation of mycolic acids in the cell 
wall could improve fitness of the bacteria against host generated toxic molecules (ROS, 
RNS) as well as modulate the host immune response. The mce1 operon is negatively 
regulated in ex vivo macrophage infections (but not in vitro in liquid culture) by mce1R 
located immediately upstream of the operon (215). Paradoxically, the mce1R mutant was 
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also found to be hypervirulent in BALB/c mice. Histopathological examination of the 
lungs revealed that unlike the aberrant granulomatous response observed in mce1 mutant 
infected mice, the lungs of mce1R mutant infected mice exhibited an enhanced 
granulomatous response (216). The contrasting pathology of mice infected with the mce1 
operon mutant and the mce1R mutant illustrate the delicate balance of interactions 
between Mtb and the host required for successful infection.  
 The two component response regulator dosRS is involved in the induction of 
approximately 50 genes in response to hypoxia and nitrogen stress, with hspX being the 
most prominently up-regulated gene. Deletion of dosR rendered Mtb hypervirulent both 
in SCID mice and immunocompetent DBA/2 mice (217). Deletion of hspX also rendered 
the bacteria hypervirulent in BALB/c mice with increased bacterial burdens being 
recovered from the mutant infected animals compared to those infected with Mtb. 
However no differences in lung pathology or lung cytokine profiles were observed. 
Overexpression of hspX completely reduced dosR mutant growth to WT levels ex vivo 
indicating that at least under these conditions lack of hspX accounts for the enhanced 
growth of the dosR mutant (218). Deletion of three other two component systems 
(kdpDE, tcrXY, trcRS) has also been found to render Mtb hypervirulent (219).  
   Mtb also possesses 11 serine threonine protein kinases (STPK’s) to help respond 
to extracellular stimuli. Of these, deletion of three STPK’s (pknH, pknE, pknI) rendered 
the bacteria hypervirulent. Higher bacterial loads were recovered from lungs and spleen 
of BALB/c mice infected with the pknH mutant strain compared to organs from Mtb or 
complement infected mice during the chronic phase of infection. pknH regulates 
expression of embAB operon encoding for arabinosyl transferases required for 
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arabinogalactan and lipoarabinmannan synthesis and results in a  high 
lipoarabinomannan/lipomannan (LAM/LM) ratio in the cell wall (220). A low LAM/LM 
ratio could possibly lead to a proinflammatory response during infection with the pknH 
mutant as lipomannan is known to provoke inflammatory cytokine production. The pknH 
mutant was also found to grow better in vitro in response to nitric oxide indicating that 
the gene possibly controls bacterial growth after the onset of the adaptive immune 
response (220). Similar to the pknH mutant, the pknE mutant strain is also more resistant 
to nitrogen stress in vitro and is hypervirulent with increased bacillary loads observed in 
infected guinea pig lungs (221). The pknE mutant was also found to be pro-apoptotic and 
anti-necrotic in ex vivo macrophage infections (222). The pknI mutant was found to be 
hypervirulent in SCID mouse survival studies (223). Aside from studies performed on 
defined Mtb mutants, hypervirulent Mtb mutants have also been reported from two 
different transposon library screens (217).  
Several genes from different classes thus are reported to be involved in Mtb 
hypervirulence. Alteration of the mycobacterial cell wall appears to be a common theme 
underlying several hypervirulent mutants. Interestingly, a wide array of immuno-
pathological responses to hypervirulent Mtb mutants is observed and this highlights the 
complex relationship that exists between Mtb and the host that allows for the 






Gene name Gene number Measure of virulence 
mce1 operon Rv0166-Rv0178 Increased lung bacterial burden; 
reduced MST in i.v. infected 
Balb/C mice 
mce1R Rv0165c Increased lung bacterial burden; 
reduced MST in i.v. infected 
Balb/C mice 
dosR Rv3133c Increased lung bacterial burden 
in i.v. infected DBA/2 mice 
hspX Rv2031c Increased lung CFU in i.v. 
infected Balb/C mice 
kdpDE Rv1027c and Rv1028c Increase lung CFU in i.v. 
infected DBA/2 mice;  
Decreased MST in i.v. infected 
SCID mice 
tcrXY Rv3765c and Rv3764c Increase lung CFU in i.v. 
infected DBA/2 mice;  
Decreased MST in i.v. infected 
SCID mice 
trcRS Rv1032c Increase lung CFU in i.v. 
infected DBA/2 mice;  
Decreased MST in i.v. infected 
SCID mice 
pknH Rv1266c Increased lung CFU in i.v. 
infected Balb/C mice 
pknE Rv1743 Increased lung CFU in 
subcutaneously infected guinea 
pigs 







Table 2. List of hypervirulent Mtb gene deletion mutants 
 
Abbreviations: CFU – colony forming units; i.v. – intravenous; MST – median survival time; SCID – 
severe combined immunodeficiency 
! 57!
1.8 Summary 
Mtb possesses several strategies to avoid the innate immune response of the host, one 
such strategy is modulation of cell death outcomes. The focus of research in our lab is to 
understand mechanisms by which Mtb manipulates host cell death. A screen for anti-
apoptotic genes in Mtb led to the identification of Rv3167c, an annotated TetR like 
transcriptional regulator (unpublished data, work done by Jessica Miller and Serdar 
Gurses). The goal of this study was to identify the molecular mechanisms involved in 
Rv3167c mediated inhibition of host cell death. Work done towards this goal revealed 
that Rv3167c is required for inhibition of not apoptotic but rather necrotic host cell death 
and it does so by suppressing the generation of mitochondrial ROS and inactivation of 
Akt, these results are described in Chapter 2. Serendipitously, we also uncovered a role 
for Rv3167c in regulating Mtb mediated macroautophagy as well and explored possible 
mechanisms involved in this phenomenon, this work is described in Chapter 3. Finally 
we investigated the role of Rv3167c in Mtb virulence in mice and found that Rv3167c is 
an anti-virulence gene required for tempering virulence of Mtb, these results are 









CHAPTER 2. Rv3167c IS REQUIRED FOR NECROSIS INHIBITION 
2.1 INTRODUCTION 
 Modulation of host cell death via apoptotic and necrotic mechanisms is one of the 
several strategies Mtb employs in order to evade the host innate immune response. 
Previous studies have shown that while Mtb inhibits apoptosis, the pathogen after 
infection and multiplication induces necrosis in order to escape from infected cells 
(reviewed in 49). Modulation of host cell eicosanoid generation by Mtb favoring 
production of LXA4 over PGE2 has been found to contribute to necrosis induction via 
three mechanisms – loss of mitochondrial membrane potential, inhibition of plasma 
membrane repair and inhibition of apoptotic envelop formation (Fig 7) (102,105,106). 
Other mechanisms implicated in Mtb induced necrosis include high intracellular bacillary 
load, activation of NLRP3 inflammasome and escape of the pathogen from the 
phagosome to the cytosol of the host cell (Fig 7) (21,32,42,107,108). 
The Mtb gene Rv3167c was previously identified as an anti-apoptotic gene in our 
lab (unpublished data). In this study we determined that Rv3167c is required for the 
inhibition of Mtb induced caspase independent, necrotic cell death. The Rv3167c mutant 
strain (Δ3167c) induced higher levels of necrosis in macrophages compared to Mtb or the 
complement strain. Using a combination of chemical inhibitors and bone marrow derived 
macrophages from different knock-out mice, we screened for host factors required for 
Δ3167c mediated cell death and were able to eliminate involvement of known regulated 
necrosis pathways. Necrosis induction by Δ3167c was however found to be dependent on 
reactive oxygen species (ROS) generated by mitochondria.   
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2.2 MATERIALS AND METHODS 
2.2.1 Materials 
M.tuberculosis H37RV (ATCC 25618) was obtained from ATCC. Rv3167c 
mutant (Δ3167c) and complement strains were generated in the H37Rv background by 
Jessica Miller and Serdar Gurses respectively. C57Bl6, Nox2-/-, Casp3-/-, Harlequin mice 
and matched wildtype controls and mCAT transgenic mice were purchased from Jackson 
Laboratories. RIPK3-/- mice were sourced from Genentech. Parp1-/- mice, Casp1/11-/- 
mice, Ifnβ-/- mice were kind gifts from Dr.Ted Dawson, Dr.Denise Monack and 
Dr.Stefanie Vogel respectively. Immortalized wild type, Nlrp3-/- and Trif-/-MyD88-/-
BMDM’s were obtained from Dr.Igor Brodsky. Il1r1-/-, Tnfr1-/-, Trif-/- and MyD88-/- mice 
were kind gifts from Dr. Katrin Mayer-Barber. THP1 monocytes were obtained from 
ATCC (TIB 202). THP1shASC and THP1shASC control cells were a kind gift from 
Dr.Jenny Ting. zVAD-fmk, Ca074Me, Necrostatin 1 (Nec1) and Diphenyl iodonium 
(DPI) were purchased from Calbiochem. Chlorpormazine hydrochloride, BafilomycinA1, 
Pepstatin A, glutathione and N-acetyl cysteine (NAC) were sourced from Sigma. 
Antibodies used in this study and their sources are listed in Appendix A.  
2.2.2 Bacterial culture  
Bacterial strains were grown in 7H9 medium supplemented with 10% ADC, 0.5% 
glycerol and 0.05% Tween 80 at 37°C. Cultures were constantly shaken at 100rpm to 
inhibit bacterial clumping. Hygromycin (50µg/ml) and kanamycin (40µg/ml) were added 
to the mutant and complement cultures respectively. For infection, cultures with an OD600 
between 0.6-0.8 (corresponding to the late log phase of growth) were pelleted by 
centrifugation at 2000g for 7 minutes and resuspended in 0.05% PBS-Tween 80. 
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Following another spin at 80g for 3 minutes to pellet bacterial clumps, bacteria present in 
the supernatant were added to cells.  
2.2.3 Cell culture and infection 
THP1 monocytes were maintained in RPMI 1640 supplemented with 10% heat 
inactivated FCS. Cells were differentiated with 20ng/ml PMA for 20-24 hours, washed 
with PBS followed by addition of infection media consisting of RPMI growth medium 
supplemented with 5% human serum (Sigma-Aldrich). Bacteria were added to cells at 
MOI3 for 4 hours at 37°C, following which extracellular bacteria were removed by PBS 
washes and chase medium consisting of growth medium and 100µg/ml gentamicin was 
added.  
Human monocyte derived macrophages (HuMDM’s) were prepared from 
elutriated monocyte fractions obtained from Dr.Bruno Andrade at National Institutes of 
Health, Bethesda, MD. Monocyte fractions were washed twice in cold RPMI and seeded 
in serum free RPMI for 1 hour at 37°C. Non-adherent cells were removed and adherent 
cells were differentiated in medium containing 5% off-the-clot AB human serum 
(Gemini) and 10ng/ml human MCSF (Peprotech) for 7 days. Cells were infected as 
indicated above in RPMI containing 5% human serum and chased in growth medium 
containing gentamicin. An MOI of either 5 or 10 was used for infection of HuMDM’s 
Bone marrow derived macrophages (BMDM’s) were prepared from cells obtained 
from femurs and tibia of various mouse strains using DMEM supplemented with 10% 
heat inactivated FCS, 25% L929 supernatant and 1% Penicillin-Streptomycin (124). 
Growth medium was replaced with DMEM containing 10% non-heat inactivated FCS for 
4hrs and cells were infected in same medium in the manner described above. BMDM’s 
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were infected at MOI 10. Chase media contained 10% L929 supernatant in order to avoid 
cell death induction due to cytokine withdrawal. Immortalized BMDM’s were maintained 
in DMEM containing 10% heat inactivated FCS and infected in media similar to that 
used for primary BMDM’s.  
Inhibitors and neutralizing antibodies when used were added to cells 1 hour prior 
to infection and included in chase medium unless otherwise stated. For all experiments, 0 
hpi time point refers to end of infection period when cells have been exposed to bacteria 
for 4 hours. For all assays that required cells and bacteria to be brought out from the 
BSL-3 facility, 4% PFA fixation was performed overnight to ensure non-viability of 
bacteria. 
2.2.4 Determination of invitro bacterial growth rate 
To measure invitro bacterial growth, bacteria were added to 7H9 medium to 
obtain a starting OD600 of 0.01 and OD600 measurements were made at 24 hour intervals 
until 7 days.  
2.2.5 Determination of bacterial uptake and ex vivo bacterial growth  
For measuring bacterial uptake, at 0 hpi cells were fixed with 4% PFA and stained 
using TB Stain Kit ZN (BD Bioscience) as per manufacturers instructions. Briefly, slides 
were flooded with carbolfuchsin ZN and heated until steaming. Cells were then treated 
with TB Decolorizer for 2 minutes to get rid of excess stain and finally counterstained 
with methylene blue for 30 seconds. Cells were observed using a phase contrast 
microscope (Zeiss AxioObserver) and number of uninfected and infected cells 
enumerated. 
Ex vivo growth of bacteria was determined by infecting THP1 macrophages at 
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MOI 0.5 and chasing the infection in gentamicin free medium. At indicated time points 
post infection, cells were lysed with 0.1% Triton X 100 in PBS and appropriate dilutions 
were plated on 7H11 medium in triplicate. Inoculated plates were incubated at 37°C and 
colonies were counted approximately 2 weeks after plating. 
2.2.6 DNA fragmentation assays 
DNA fragmentation was visualized by staining cells with propidium iodide (PI) 
and Hoechst stain at 6hpi, 12hpi and 24hpi. Cells were infected on 8 well slides, stained 
with 1µg/ml PI for 10 minutes at room temperature and fixed with 4% PFA overnight. 
This was followed by staining with 10µg/ml Hoechst 33342 for 3 minutes. Cells were 
observed using a fluorescence microscope (Zeiss AxioObserver) and numbers of cells 
exhibiting nuclear fragmentation; nuclear condensation and nuclear staining with PI were 
enumerated. 
DNA laddering pattern was determined by preparing DNA from infected cells 
using the Apoptotic DNA Ladder Kit (Roche) at 24hpi. As a positive control, DNA was 
prepared from THP1 monocytes treated with 1µM of staurosporine for 4 hours. U937 cell 
extract provided in the kit was also used as a positive control. 2µg of each DNA sample 
was run on 1.8% TBE-agarose gel and stained with ethidium bromide. 
2.2.7 Cell death assays 
TUNEL assay was performed to detect DNA fragmentation in infected cells using 
the InSitu Cell Death Detection Kit (Roche). Infected cells fixed with 4% PFA overnight 
were washed and permeabilized at 4°C for 4 minutes in a 0.1% sodium citrate, 0.1% 
Triton X-100 buffer. Cells were then stained with the TUNEL stain at 37°C for 1 hour, 
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washed and resuspended in FACS buffer (2% FCS in PBS). Percentage of TUNEL 
positive cells was determined by flowcytometry (Accuri or FACSCantoII).  
During cell death, fragmented nuclear DNA is eventually lost from the cell and 
this can be detected by hypodiploid staining (125). Infected cells were fixed overnight in 
70% ethanol at -20°C, washed and stained with PI/RNase staining buffer (BD 
Pharmingen) for 10 minutes at room temperature. Percentage of hypodiploid cells was 
determined by flowcytometry (Accuri or FACSCantoII).   
Increase in plasma membrane permeability was determined by performing 
propidium iodide (PI) staining, as the stain cannot enter cells with intact plasma 
membranes. Following infection, cells were harvested at specified time points and 
resuspended in PBS containing 5% FCS and 1µg/ml PI for 10 minutes at room 
temperature. Percentage of PI positive cells was determined by flowcytometry (Accuri).   
Detection of adenylate kinase activity in cell culture supernatants using the 
ToxiLight™ Bioassay kit (Lonza) was employed to determine increase in plasma 
membrane permeability. 20µl of supernatants from infected cells were mixed with 100µl 
of adenylate kinase detection reagent and incubated at room temperature for 5 minutes. 
Changes in luminescence were measured using a Biotek Synergy 4 plate reader. 
2.2.8 DIOC6 staining 
  DIOC6 staining was utilized to determine loss of mitochondrial membrane 
potential. Cells were stained with 40nM of DIOC6 (Molecular Probes) at 37°C for 15 
minutes in complete medium. Following harvesting and PBS wash, cells were stained 
with 1µg/ml PI in FACS buffer for 10 minutes and analyzed by flowcytometry (Accuri). 
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2.2.9 Preparation of whole cell lysates, cytoplasmic, mitochondrial and nuclear 
fractions 
 Whole cell lysates were prepared by lysing cells in RIPA buffer (50mM Tris HCl, 
150mM Nacl, 1% Triton X100, 0.5% sodium deoxycholate, 0.1% SDS) followed by 
centrifugation at 12,000g for 5 minutes to remove debris. 
Mitochondrial fractions were prepared as described previously (126) by lysing 
cells in CLAMI buffer (250mM sucrose, 70mM KCl, 200µg/ml digitonin) followed by 
centrifugation at 1000g for 5 minutes. The supernatant (cytosolic fraction) was separated 
and the pellet containing intact mitochondria were lysed in RIPA buffer to obtain the 
mitochondrial fraction. 
 Nuclear fractions were prepared using the NE-PER Nuclear and Cytoplasmic 
Extraction Reagents (Thermo Scientific) as per manufacturer’s instructions. 
All fractions were prepared at 4°C and protease inhibitor cocktail (Complete, 
Mini, EDTA-Free, Roche) and phosphatase inhibitor cocktail (PhosSTOP, Roche) were 
included in the lysis buffers. 
2.2.10 Western Blotting 
 Prior to western blotting, protein concentrations of the samples were determined 
using the Pierce™ BCA Protein Assay Kit (Thermo Scientific) as per manufacturers 
instructions. Equal amounts of samples (10-20µg) were resolved on Criterion™ TGX™ 
Precast Gels (Bio-Rad). Proteins were transferred onto PVDF membrane (100V, 1 hour) 
and membranes were blocked using 5% milk in Tris buffered saline containing 0.1% 
Tween 20 (TBST) for 1 hour. All primary antibody incubations were performed 
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overnight at 4°C while secondary antibody incubations were carried out at room 
temperature for one hour. 
2.2.11 Measurement of LXA4 and PGE2 
For detection of LXA4 and PGE2 in supernatants from THP1 cells infected in 
OptiMEM were collected and ELISA’s were performed. Kits were obtained from Oxford 
Biochemicals. 
2.2.12 Measurement of cellular and mitochondrial ROS levels 
 For measurement of ROS levels in BMDM’s, cells were deprived of L929 
supernatant in phenol red free medium for 16 hours prior to infection to lower basal 
levels of ROS (127). Infection and chase were performed under these conditions as well. 
CM-H2DCFDA (Molecular Probes) was used for detection of cellular ROS and 
MitoSOX™ Red (Molecular Probes) was utilized to assess mitochondrial ROS levels. At 
indicated time points after infection, cells were harvested and stained with 10µM CM-
H2DCFDA or 1.25µM MitoSOX™ Red for 30 minutes at 37°C in HBSS. Cells were 
washed in HBSS, resuspended in FACS buffer and fluorescence intensity measured by 
flowcytometry (Accuri). For each time point, fluorescence intensity of uninfected cells 
was subtracted from that of the samples and percentage increase in fluorescence intensity 
compared to uninfected cells was calculated. 
2.2.12 Statistical analysis 
ANOVA with Tukey post-test was used for statistical analysis unless otherwise 
indicated. Data is represented as mean ± SD. p-value significance is as follows – p ≤ 0.05 
- *, p ≤ 0.01 - **, p ≤0.0001 - ***. 
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2.3 RESULTS AND DISCUSSION 
2.3.1 Characterization of the Rv3167c mutant (Δ3167c) 
2.3.1.1 Δ3167c does not have invitro growth defects 
 Rv3167c was previously identified in a gain of function genetic screen for anti-
apoptotic genes of Mtb (Velumurugan K, unpublished). The role of Rv3167c in host cell 
death inhibition was confirmed by generating the Rv3167c knockout strain in the Mtb 
H37Rv background (Δ3167c) (Miller J, Gurses S, unpublished). In order to ensure that 
any effects seen in host cells infected with Δ3167c were not due to bacterial growth 
defects, the growth of the mutant was compared with wild type Mtb. Both strains were 
inoculated into 7H9 liquid medium at a starting OD600 of 0.01 and OD600 measurements 
were made every 24 hours. No differences were observed in the invitro growth of Mtb 
and Δ3167c at any of the time points (Fig 12A).  
Therefore, any effects exerted by Δ3167c on host cells cannot be attributed to 
invitro growth differences compared to Mtb. 
2.3.1.2 Uptake of Mtb and Δ3167c by host cells is similar 
 Increased host cell death induction by Δ3167c could possibly be due to increased 
phagocytic uptake of the bacteria compared to Mtb. Therefore, the rate of infection of 
host cells by Mtb and Δ3167c was determined. HuMDM’s were infected with Mtb and 
Δ3167c at MOI 5 and at 4 hours post infection (hpi), cells were washed and fixed with 
4% PFA. Ziehl-Neelsen’s staining was performed and the numbers of uninfected and 
infected cells were enumerated. Both Mtb and Δ3167c infected approximately 80% of   
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Fig 12. Deletion of Rv3167c does not affect invitro growth of Mtb and Mtb uptake 
by macrophages 
 
(A) Growth rate of Mtb and Δ3167c in 7H9 medium was measured every 24 hours. Data is from three 
independent experiments (n=3). 
(B) Percentage of infected HuMDM’s was determined by Ziehl-Neelsen’s staining of infected 
macrophages. Atleast 400 macrophages were enumerated per condition. Data is from two 
independent experiments (n=2). 
(C) Uptake of indicated bacterial strains by THP1 cells was determined by estimating bacterial CFU’s 
at 4hpi. Data is from three independent experiments (n=9).  
 







































HuMDM’s (Fig 12B). Uptake of the bacterial strains by THP1 macrophages was also 
determined. THP1 macrophages were infected at MOI 0.5 with Mtb, Δ3167c and 
complement strains. At 4hpi, cells were lysed and appropriate dilutions were plated onto 
7H11 media. Colonies were enumerated approximately 2 weeks after plating and colony 
forming units (CFU) calculated. Similar CFU’s were recovered from cells infected with 
Mtb, Δ3167c and the complement strain (Fig 12C).  
 These results indicate that deletion of the Rv3167c gene does not affect uptake of 
Mtb by macrophages. 
2.3.1.3 Δ3167c induces cell death in both cell lines and primary macrophages 
 The gain of function genetic screen for Mtb anti apoptotic genes that led to the 
identification of Rv3167c was performed in THP1 macrophages. 83.40% of THP1 
macrophages infected with Δ3167c are TUNEL positive compared to 15.75% of Mtb 
infected macrophages. Complementation of Rv3167c reduces cell death induction to 
levels similar to that of Mtb (Fig 13A) (Gurses S, unpublished). To ensure that the ability 
of Δ3167c strain to induce cell death was not restricted to a particular cell type, cell death 
induction by Δ3167c was determined in HuMDM’s and BMDM’s. HuMDM’s were 
infected at MOI 10 and cell death levels were measured by performing hypodiploid stain 
at 48hpi. During cell death, DNA undergoes fragmentation and is eventually lost from the 
cell. The hypodiploid stain differentiates cells with normal DNA content from those with 
reduced DNA content. Δ3167c induces approximately 7 fold higher level of cell death 
compared to Mtb (63.42% vs 9.14%) in HuMDM’s and complementation of Rv3167c 
rescues the phenotype (Fig 13B). BMDM’s were infected at MOI 10 and TUNEL   
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Fig 13. Δ3167c induces cell death in both cell lines and primary macrophages 
 
(A) Cell death induction in THP1 cells at 24hpi measured by TUNEL staining and flowcytometry. Data 
is from three independent experiments (n=6). 
(B) Cell death induction in HuMDM’s at 48hpi measured by hypodiploid staining and flowcytometry. 
Data is from three independent experiments (n=6). 
(C) Cell death induction in BMDM’s at 24hpi measured by TUNEL staining and flowcytometry. Data is 
from two independent experiments (n=4). 
 
Statistical significance was estimated relative to Mtb infected cells.  
 

























staining was performed at 24hpi to determine cell death levels. Approximately 2-fold 
increase in cell death induction by Δ3167c was observed in comparison to Mtb (Fig 13C). 
 Therefore, Δ3167c is able to induce cell death in both cell lines as well as human 
and murine primary macrophages. 
2.3.1.4 Δ3167c strain replicates similar to Mtb ex vivo 
 Host cell death by apoptosis has been reported to reduce mycobacterial viability 
in ex vivo macrophage infections (49,95,97). As Rv3167c was identified in a screen for 
anti apoptotic genes, intracellular viability of Δ3167c and the complement strain was 
compared to Mtb. THP1 macrophages were infected at MOI 0.5 and chased in antibiotic 
free medium to prevent killing of any bacteria that may be released after cell death. Cells 
were lysed at indicated time points and the lysates were plated on 7H11 plates. Colonies 
were enumerated 2 weeks later and CFU’s were calculated. Similar CFU’s were 
recovered from macrophages infected with any of the three strains at all time points (Fig 
14). 
 These results demonstrate that the intracellular viability of Δ3167c is similar to 
Mtb even though the mutant strain induces much higher levels of cell death. This brings 







Fig 14. Δ3167c strain replicates similar to Mtb ex vivo 
 
THP1 cells infected at MOI 0.5 were lysed at the indicated time points and plated on 7H11 media. 
Colonies were enumerated and CFU estimated. Data is from three independent experiments (n=9). 









2.3.2 Δ3167c induces necrotic cell death 
2.3.2.1 Δ3167c induces host cell membrane rupture 
 A characteristic feature of cells undergoing apoptosis is preservation of cell 
membrane integrity. Contents of apoptotic cells are packaged in apoptotic vesicles and 
released. This is in contrast to necrotic cells that undergo membrane rupture and spill 
their contents into the extracellular milieu (55). To determine whether Δ3167c induces 
apoptotic or necrotic cell death, THP1 macrophages were infected with Mtb and Δ3167c 
at MOI 3. At the indicated time points cells were stained with the membrane 
impermeable stain PI and percentage of PI positive cells was determined by 
flowcytometry. A time dependent increase in the percentage of PI positive cells was 
observed for Δ3167c infected macrophages compared to Mtb infected macrophages (Fig 
15A). Supernatants collected from Mtb, Δ3167c and complement infected cells at the 
indicated time points were used for the toxilight assay that measures adenylate kinase 
activity. Adenylate kinase is present within healthy cells and is released upon necrotic 
cell death due to loss of membrane integrity. Results are represented as fold change in 
adenylate kinase activity with respect to uninfected (UI) cells. At 24hpi and 48hpi, an 
approximately three fold higher level of adenylate kinase activity was detected in 
supernatants of Δ3167c-infected cells compared to those infected with either Mtb or the 
complement (Fig 15B). Mtb infected macrophages also undergo necrotic cell death 
(albeit at levels lower than Δ3167c infected cells) as determined by both PI staining and 
toxilight assay (Fig 15A, 15B). Mtb has been previously shown to induce necrosis in a 
dose and time dependent manner (107) and our data supports this observation.   
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Fig 15. Δ3167c infected cells lose plasma membrane integrity 
 
(A) Infected THP1 cells were stained with PI at the indicated time points and percentage of PI positive 
cells determined by flowcytometry. Data is from three independent experiments (n=6). 
(B) Release of adenylate kinase into supernatants from uninfected and infected THP1 cells was 
measured by toxilight assay. Data is from three independent experiments (n=6). 
 
Statistical significance was estimated relative to Mtb infected control.   
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  Therefore, Δ3167c induces higher levels of host cell membrane damage compared 
to Mtb, which is indicative of necrotic cell death induction. 
2.3.2.2 Non apoptotic DNA fragmentation is seen during Δ3167c mediated cell death 
 Although apoptotic cells do not lose membrane integrity, in the absence of 
phagocytic uptake these cells can proceed to secondary necrosis. Cells undergoing 
secondary necrosis have permeable membranes (57). Therefore using state of cell 
membrane permeability as the sole indicator of primary necrotic cell death is unwise. One 
of the earliest changes detectable in a cell undergoing apoptosis are nuclear changes – 
namely condensation and fragmentation (56). To determine the kinetics of nuclear 
changes and loss of membrane permeability, macrophages infected with Δ3167c were 
stained with PI and Hoechst at 6hpi, 12hpi and 24hpi and cells were observed using a 
fluorescence microscope. Percentage of cells that exhibited nuclear condensation 
(pyknosis) and fragmentation (karyorrhexis) alone or in combination with membrane 
permeability was calculated. Infected cells exhibited nuclear changes either alone or in 
combination with increased membrane permeability as early as 6 hpi. Percentage of 
Δ3167c infected cells exhibiting these changes was higher than those infected with either 
Mtb or the complement at 24hpi. Only a minor fraction of cells detected at all the time 
points were PI positive alone (Fig 16A). 
 During apoptosis, genomic DNA is fragmented between nucleosomes to generate 
fragments that are multiples of 180-200 base pairs in size via the activity of a caspase 
activated DNAase (CAD) (54). These fragments form a ladder like pattern when run on 
an agarose gel. As Δ3167c infected cells undergo nuclear fragmentation, the pattern of 
DNA fragmentation was analyzed. Genomic DNA of Δ3167c infected cells was prepared   
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Fig 16. Δ3167c induces non – apoptotic DNA fragmentation 
 
(A) Infected THP1 cells were stained with Hoechst-PI and observed by fluorescence microscopy. 
Atleast 400 cells were counted and percentage of cells exhibiting nuclear changes and PI positivity 
alone or together was estimated. Data is from three independent experiments (n=3). Statistical 
significance was estimated relative to Mtb infected control. 
(B) Genomic DNA prepared form infected cells was run on a 1.8% agarose gel to look for DNA 
laddering. STS - staurosporine. Image is representative of three independent experiments. 
! 76!
using the Roche Apoptotic DNA Ladder Kit and resolved on a 1.8% TBE agarose gel. As 
a positive control, genomic DNA from THP1 monocytes treated with staurosporine (a 
classical apoptosis inducer) was prepared. Genomic DNA from U937 monocytes treated 
with staurosporine (provided with the kit) was also used as a positive control. DNA from 
both the positive control samples form a ladder like pattern in the agarose gel (Lane 3 and 
4, Fig 16B). In contrast, no such pattern is detected in DNA prepared from Δ3167c-
infected cells (Lane 2, Fig 16B). 
 These results indicate that genomic DNA of macrophages infected with Δ3167c 
undergoes fragmentation. However, the fragmentation pattern is not similar to that 
induced during apoptotic cell death. 
2.3.2.3 Δ3167c induced cell death is caspase independent 
 Apoptotic stimuli lead to the caspase activation cascade comprising of the 
activator caspases (caspase 8 and 9) and the effector caspases (caspase 3, 6 and 7) (52).  
Role of caspases in Δ3167c induced cell death was assessed by using Casp3-/- BMDM’s. 
Cells were infected at MOI 10 and percentage of TUNEL positive cells was determined 
by flowcytometry. Approximately 70% of both wild type and Casp3-/- BMDM’s infected 
with Δ3167c were TUNEL positive (Fig 17A). To ensure that the lack of a phenotype in 
the Casp3-/- BMDM’s was not due to redundancy of caspase 3 functions with other 
effector caspases, both wild type and Casp3-/- BMDM’s were infected with Δ3167c in the 
presence of the pan-caspase inhibitor zVAD-fmk and TUNEL staining was performed at 
24hpi. Inclusion of zVAD-fmk did not inhibit Δ3167c mediated cell death in Casp3-/- 
cells (Fig 17A). Rather, a marginal increase was seen in the percentage of TUNEL 
positive cells following addition of the inhibitor. zVAD-fmk activity was assessed by   
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Fig 17. Δ3167c induces caspase independent cell death 
 
(A) Cell death induction in WT and Casp3-/- BMDM’s was determined by TUNEL staining and 
flowcytometry at 24hpi. zVAD-fmk was used at a 40µM concentration. Data is representative of 
three independent experiments (n=3). 
(B) Efficacy of zVAD-fmk was determined in camptothecin treated THP1 cells was determined by 
TUNEL staining and flowcytometry. Data is representative of one experiment (n=3). 
(C) Cytochrome C translocation from mitochondria to cytosol was determined by western blotting. 
VDAC and tubulin are loading controls for mitochondria and cytosolic fractions respectively. Data 
is representative of two independent experiments.  
(D) PARP1 cleavage in infected THP1 cells at 24hpi. Sts – staurosporine. Data is representative of 
three independent experiments. 
 
For (A), statistical significance was estimated relative to Mtb. For (B), statistical significance was 
estimated relative to solvent control. 
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adding the inhibitor to THP1 macrophages treated with camptothecin, a widely used 
apoptosis inducer. Inclusion of the inhibitor reversed camptothecin mediated cell death as 
measured by TUNEL staining (Fig 17B).   
 Cytochrome C release from mitochondria is observed in avirulent mycobacteria 
infected macrophages undergoing caspase dependent apoptosis (104). Cytosolic 
cytochrome C in association with Apaf forms the apoptosome complex that leads to 
downstream caspase 9 processing. Translocation of mitochondrial CytC to the cytosol 
was examined by immunoblotting of mitochondrial and cytosolic fractions of infected 
THP1 macrophages at 24hpi. No CytC was detected in cytosolic fraction of either Mtb or 
Δ3167c infected macrophages (Fig 17C).  
 PARP1 is a nuclear enzyme utilized for repair of breaks in DNA and it’s cleaved 
during apoptosis. PARP1 cleavage in Mtb and Δ3167c infected THP1 cells was 
determined by preparing whole cell lysates at 24hpi and immunoblotting for PARP1. As 
expected, PARP1 cleavage was seen in THP1 macrophages treated with staurosporine. 
However, no PARP1 cleavage was seen in macrophages infected with either Mtb or 
Δ3167c (Fig 17D).  
 These results demonstrate that cell death induction by Δ3167c is caspase 
independent. 
2.3.3 Molecular mechanisms of Δ3167c induced necrosis 
2.3.3.1 Necrosis induction by Δ3167c does not involve LXA4 and PGE2 
 The balance between the host cell lipid mediators lipoxin A4 (LXA4) and 
prostaglandin E2 (PGE2) plays a critical role in determining mode of mycobacteria 
mediated cell death. Virulent Mtb upregulates LXA4 levels in infected cells that in turn 
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inhibits PGE2 production and induces necrosis (102,105,106). The role of LXA4 and 
PGE2 in Δ3167c-induced necrosis was examined by determining the levels of these lipid 
mediators in the supernatants of infected THP1 macrophages harvested at 24hpi. LXA4 
levels in supernatants of Mtb, Δ3167c and complement infected cells were similar to 
background levels detected in the supernatant of uninfected cells (Fig 18A, 18B). Higher 
PGE2 levels were detected in supernatants of infected macrophages compared to the 
uninfected control. However similar amounts of PGE2 were detected in supernatants of 
macrophages infected with Mtb, Δ3167c and the complement strain (Fig 18C). 
Contribution of LXA4 was also assessed by PI staining of Alox5-/- BMDM’s (deficient in 
5-lipoxygenase and thus unable to synthesize LXA4) infected at MOI 10. Necrosis 
induction by Δ3167c reduced marginally from 59.63% in wild type cells to 49% in  
Alox5-/- cells. Although Mtb induced higher levels of necrosis in Alox5-/- BMDM’s, 
necrosis induction by Δ3167c is still significant.  
 Therefore, necrosis induction by Δ3167c does not depend on the eicosanoids 



























































Fig 18. Δ3167c induced necrosis is independent of LXA4 and PGE2 
 
(A) LXA4 concentration in supernatants of infected cells at 24hpi was measured by ELISA. Data is 
representative of two independent experiments (n=6). 
(B) PGE2 concentration in supernatants of infected cells at 24hpi was measured by ELISA. Data is 
representative of two independent experiments (n=6). 
(C) Necrosis induction in WT and Alox5-/- BMDM’s was measured by PI staining and flowcytometry at 
24hpi. Data is representative of three independent experiments (n=3).  
 
Statistical significance is estimated relative to Mtb infected cells. 
! 81!
2.3.3.2 Cathepsins and lysosomal lipase are not involved in necrosis induction by 
Δ3167c 
 Previous studies have implicated both cathepsins and lysosomal lipase in necrosis 
induction by a high intracellular load of Mtb (107,108). The cathepsin B inhibitor 
Ca074Me (40µM) and the cathepsin D inhibitor pepstatin A (PepA) (50µM) were used to 
investigate the role of these lysosomal proteases in Δ3167c mediated necrotic cell death. 
Inhibition of neither cathepsin B nor cathepsin D individually nor in combination resulted 
in reversal of Δ3167c necrotic phenotype (Fig 19A). The inhibitors by themselves did not 
induce any cell toxicity as determined by the MTS assay that measures metabolic activity 
(Fig 19B). Treatment of Δ3167c-infected cells with 10µM of Cpz (chlorpromazine), a 
lysosomal lipase inhibitor, was found to completely inhibit necrosis to levels similar to 
that observed in uninfected cells (Fig 19C). Effect of Cpz on mycobacterial uptake was 
tested in BMDM’s pretreated with Cpz for one hour and infected with M.smegmatis 
expressing GFP for an additional two hours. Addition of Cpz reduce uptake of GFP 
expressing M.smegmatis from 60.68% to 44.15% (Fig 19D). Further, invitro growth of 
Δ3167c in 7H9 liquid media was inhibited by addition of Cpz as well (Fig 19E). These 
effects exerted by Cpz could account for the reversal in Δ3167c induced necrotic death.  
 Therefore, Δ3167c induced necrosis is independent of cathepsin B, cathepsin D 















































































Fig 19. Cathepsin B, cathepsin D and lysosomal lipase activity is not required for 
Δ3167c induced necrosis 
 
(A) Necrosis induction by Δ3167c in presence and absence of Ca074Me (40µM) and PepA (50µM) in 
BMDM’s was measured by PI staining and flowcytometry at 48hpi. Data is representative of three 
independent experiments (n=4). 
(B) Cytotoxicity of Ca074Me and PepA in BMDM’s was measured by MTS assay at 24hpt. Data is 
from two independent experiments (n=6). 
(C) Necrosis induction by Δ3167c in presence and absence of Cpz (10µM) in BMDM’s was measured 
by PI staining and flowcytometry at 4dpi. Data is representative of three independent experiments 
(n=3). 
(D) Effect of Cpz on mycobacterial uptake was measured in BMDM’s using GFP expressing 
M.smegmatis (Msmeg GFP). Data is representative of three independent experiments (n=4). 
(E) Growth of Δ3167c in 7H9 medium in presence and absence of Cpz was measured by determining 
absorbance at OD600. Data is representative of two independent experiments (n=6).  
 
Statistical significance was estimated relative to solvent control for (A) and Δ3167c and Msmeg 
GFP infected cells for (C) and (D) respectively.  
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 2.3.3.3 Δ3167c induced necrosis is independent of RIPK1 and RIPK3 
 Under conditions of caspase inhibition, RIPK1 and RIPK3 autophosphorylate and 
transphosphorylate each other and form a complex termed the necrosome. This leads to 
downstream production of ROS and cell death via necrosis (51). RIPK1 and RIPK3 have 
been implicated in TNF mediated necrosis induction during M.marinum infection (9). PI 
staining of infected Ripk3-/- BMDM’s was performed to determine whether RIPK3 was 
required for Δ3167c induced necrosis. No differences were seen in levels of necrosis 
induction by Δ3167c in wild type and Ripk3-/- BMDM’s (Fig 20A). The RIPK1 specific 
allosteric inhibitor necrostatin 1 (Nec1) was used to examine involvement of RIPK1 
(128). Inclusion of Nec1 (100µM) did not inhibit necrosis induction by Δ3167c in THP1 
cells (Fig 20B). Macrophages treated with LPS (20ng/ml) and zVAD-fmk (40µM) 
undergo RIPK1 dependent necrotic cell death (129). Activity of Nec1 was confirmed by 
its ability to inhibit the RIPK1 dependent necrosis induction in BMDM’s treated with 
LPS and zVAD-fmk (Fig 20C). Nec1 did not induce cytotoxicity in uninfected cells (Fig 
20D).  
  RIPK1 and RIPK3 mediated cell death can also be executed in a caspase 
dependent manner by formation of the ripoptosome complex which requires RIPK1 
activity (51). To test whether Δ3167c induced necrosis requires both RIPK’s and caspase 
activity, Ripk3-/- BMDM’s were infected with Mtb and Δ3167c in presence of the pan 
caspase inhibitor zVAD fmk. A 1.74 fold increase in cell death was observed in Δ3167c 
infected cells treated with zVAD fmk compared to Δ3167c- infected cells treated with 
DMSO, excluding the contribution of both caspase activity as well as RIPK3 in Δ3167c 








        



































































Fig 20. Δ3167c induced necrosis is independent of RIPK1 and RIPK3 
 
(A) Necrosis induction in infected WT and Ripk3-/- BMDM’s was measured by PI staining and 
flowcytometry at 24hpi. Data is representative of three independent experiments (n=3). 
(B)  Necrosis induction in infected THP1 cells was measured by PI staining and flowcytometry at 
24hpi. Nec1 concentration - 100µM. Data is representative of two independent experiments (n=4). 
(C) Nec1 efficacy was tested in BMDM’s treated with LPS (20ng/ml), zVAD fmk (40µM) and Nec1 
(100µM).  Data is from one experiment (n=3). 
(D) Cytotoxicity of Nec1 in THP1 cells was measured by MTS assay at 24hpt. Data is from two 
independent experiments (n=6). 
(E) Necrosis induction in infected Ripk3-/- BMDM’s was measured by PI staining and flowcytometry at 
24hpi. Data is representative of two independent experiments (n=3). 
 
Statistical significance was estimated relative to Mtb infected cells for (A) and (E) and relative to 




















These results demonstrate that necrosis induction by Δ3167c is independent of 
RIPK1 and RIPK3. 
2.3.3.4 Δ3167c induced necrosis is independent of PARP and AIF 
 As stated previously, the DNA repair enzyme PARP is cleaved by caspases 
during apoptosis. However, overactivation of PARP can also lead to necrotic cell death 
via depletion of cytosolic NAD+ and consequent mitochondrial dysfunction in response 
to DNA damaging agents (130). To evaluate role of PARP1 in Δ3167c induced cell 
death, PI staining of Parp1-/- BMDM’s was performed. No differences in Δ3167c 
necrosis induction were observed between wild type and Parp1-/- BMDM’s (49.38% vs 
57.47%) (Fig 21A). 
 PARP1 mediated necrosis has also been reported to be mediated via apoptosis 
inducing factor (AIF) in models of glutamate excitotoxicity as well as with bacterial 
infections (83). Contribution of AIF to Δ3167c induced necrosis was examined by using 
BMDM’s from Harlequin mice which exhibit an approximately 80% loss in AIF 
expression due to a retroviral insertion in Aifm1 and from matched wild type controls. 
Δ3167c mediated necrosis in BMDM’s obtained from Harlequin mice was reduced by 
approximately 1.5 fold compared to WT controls (Fig 21B). For AIF to mediate necrotic 
cell death, it needs to be translocated from the mitochondria to the nucleus where it 
participates in DNA condensation and fragmentation (87). Nuclear translocation of AIF 
in Δ3167c-infected cells was examined by immunoblotting for AIF in cytosolic and 
nuclear fractions. No differences in nuclear AIF levels of uninfected, Mtb and Δ3167c 
























































Fig 21. Δ3167c induced necrosis is independent of PARP and AIF 
 
(A) Necrosis induction in WT and Parp1-/- BMDM’s at 72hpi was determined by PI staining and 
flowcytometry. Data is from two independent experiments (n=6). 
(B) Necrosis induction in Aif WT and Aif hemizygous BMDM’s at 72hpi was determined by PI 
staining and flowcytometry. Data is representative of three independent experiments (n=3). 
(C) AIF nuclear translocation in THP1 cells at 24hpi was determined by western blotting. HDAC – 
Histone deacetylase, nuclear fraction loading control; Tubulin – cytosolic fraction loading control. 
Data is representative of two independent experiments. 
 
For (A) and (B), statistical significance was estimated relative to Mtb infected cells for each BMDM 
type.  
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  Thus involvement of AIF in Δ3167c-induced necrosis is suspect. Similar results 
for AIF translocation were obtained in BMDM’s as well (data not shown). 
2.3.3.5 Inflammasome activation and IL1R1 signaling do not contribute to Δ3167c 
induced necrosis 
 Inflammasome activation in response to microbial infection has been linked to 
induction of two different types of cell death that are differentiated based upon 
involvement of caspase 1 and cathepsin B (72,131). More recently non-canonical 
inflammasomes have been described that lead to necrotic cell death via activation of 
caspase 11 following Gram negative bacterial infection (70). PI staining of Casp1/11-/- 
BMDM’s infected at MOI10 was performed to determine whether Δ3167c induced cell 
death was dependent on either caspase 1 or caspase 11. Δ3167c induced similar levels of 
cell death in both wild type and Casp1/11-/- BMDM’s  (44.42% vs 47.5%) (Fig 22A). 
 ASC and NLRP3 have been implicated in inflammasome dependent necrotic cell 
death.  NLRP3 has been shown to be required for Mtb mediated necrosis (32). A 1.4 fold 
increase in Δ3167c-induced necrosis as measured by the toxilight assay was seen in 
THP1shASC macrophages compared to control macrophages (Fig 22B). Immortalized 
wild type and Nlrp3-/- cells were used to assess the role of NLRP3 in Δ3167c-induced 
necrosis. An increase in PI positive Δ3167c infected macrophages was seen in 
immortalized Nlrp3-/- BMDM’s compared to wild type controls (Fig 22C). Surprisingly, a 
1.5 fold increase in Mtb mediated necrosis was also observed in immortalized Nlrp3-/- 











































































Fig 22. Necrosis induction by Δ3167c is independent of inflammasomes 
 
(A) Necrosis induction in WT and Casp1/11-/- BMDM’s was determined by PI staining and 
flowcytometry at 48hpi. Data is representative of five independent experiments (n=6). 
(B) Necrosis induction in THP1 shASC and control cells was determined by toxilight assay at 48hpi. 
Data is from three independent experiments (n=9). 
(C) Necrosis induction in immortalized WT and Nlrp3-/- BMDM’s was determined by PI staining and 




Therefore, necrosis induction by Δ3167c strain is independent of both canonical 
and non-canonical inflammasome components. 
2.3.3.6 TNF signaling, TLR signaling and type I interferon signaling does not 
contribute to Δ3167c-induced necrosis 
 TNF can signal via TNFR1 located on the cell surface and lead to cell death either 
via apoptosis or necrosis (51). TNF signaling has been implicated in apoptosis induction 
by Mtb mutant strains (124). M.marinum has been shown to induce necrotic cell death in 
a TNF dependent manner (9). Role of TNF in Δ3167c induced necrosis was determined 
by infection and PI staining of Tnfr1-/- BMDM’s. No inhibition of Δ3167c induced 
necrosis was seen in Tnfr-/- BMDM’s compared to wild type controls (Fig 23A). Work 
done by previous graduate student (Gurses S, data not shown) showed no differences in 
TNF levels in supernatants of macrophages infected with Mtb, Δ3167c and complement 
strains. 
 To determine the role of TLR2 and TLR4 signaling in Δ3167c mediated necrosis, 
infected THP1 macrophages were treated with neutralizing anti-TLR2 and anti-TLR4 
antibodies and associated isotype controls. PI staining and flowcytometry was performed. 
Neutralization of neither TLR2 nor TLR4 inhibited Δ3167c-mediated necrosis (Fig 23B). 
TNF production by THP1 macrophages in response to mycobacterial arabinose capped 
lipoarabinomannan (AraLAM) and LPS was inhibited by the neutralizing anti TLR2 and 
TLR4 antibody respectively thus demonstrating efficacy of neutralizing antibodies used 
(Fig 23C, 23D). Contribution of the TLR signaling adaptors TRIF and MyD88 was 


















































































































































Fig 23. Necrosis induction by Δ3167c is independent of TNF, TLR and type I IFN 
signaling 
 
(A) Necrosis induction in WT and Tnfr1-/- BMDM’s was determined by PI staining and flowcytometry 
at 72hpi. Data is representative of two independent experiments (n=3). 
(B) Necrosis induction in THP1 cells in presence of neutralizing anti TLR antibodies (nAb) and 
associated isotype controls (IC) was determined by PI staining and flowcytometry at 24hpi. Data is 
from one experiment (n=3). 
(C) Efficacy of anti TLR4 antibody was determined by measuring TNF levels in supernatants of THP1 
cells treated with LPS. Data is from one experiment (n=3).  
(D) Efficacy of anti TLR2 antibody was determined by measuring TNF levels in supernatants of THP1 
cells treated with AraLAM. Data is from one experiment (n=3).  
(E) Necrosis induction in WT and Trif-/- BMDM’s was determined by PI staining and flowcytometry at 
48hpi. Data is representative of four independent experiments (n=3). 
(F) Necrosis induction in WT and MyD88-/- BMDM’s was determined by PI staining and 
flowcytometry at 48hpi. Data is representative of four independent experiments (n=3). 
(G) Necrosis induction in immortalized WT and Trif-/- MyD88-/- BMDM’s was determined by PI 
staining and flowcytometry at 48hpi. Data is representative of four independent experiments (n=3). 
(H) Necrosis induction in immortalized WT and Irf3-/ BMDM’s was determined by PI staining and 
flowcytometry at 48hpi. Data is representative of three independent experiments (n=3). 
(I) Necrosis induction in immortalized WT and Ifnβ-/- BMDM’s was determined by PI staining and 
flowcytometry at 48hpi. Data is from three independent experiments (n=9). 
 
For (A), (E), (F), (G), (H) and (I) statistical analysis was performed relative to Mtb infected cells. For 





























































levels of necrosis in the wild type and knock out BMDM’s (Fig 23E, 23F).   
To ensure that the lack of a phenotype in the Trif-/- and MyD88-/- BMDM’s is not 
due to redundancy between the two adaptors, immortalized Trif-/-/MyD88-/- double 
knockout BMDM’s were infected and PI staining was performed. Necrosis induction by 
both Mtb and Δ3167c was elevated in immortalized Trif-/-/MyD88-/- double knockout cells 
compared to the wild type controls (iB6). However, Δ3167c induced 2 fold higher level 
of necrosis in immortalized wildtype cells and 1.6 fold higher level of necrosis in 
immortalized Trif-/-/MyD88-/- double knockout cells compared to Mtb (Fig 23G). 
 Type I (IFN) signaling has been implicated in death of macrophages infected with 
bacterial and viral pathogens via both inflammasome dependent and independent 
mechanisms (61,132). BMDM’s from Ifnβ-/- and Irf3-/- mice were used to examine the role 
of type I IFN signaling in necrosis induction by Δ3167c. PI staining of infected BMDM’s 
revealed no differences in necrosis induction by Δ3167c in wild type and Irf3-/- and Ifnβ-/- 
BMDM’s (Fig 23H, 23I).  
 Thus TNF, TLR and type I IFN signaling do not play a role in Δ3167c induced 
necrotic cell death. 
2.3.4 Δ3167c induced necrosis is dependent on mitochondrial ROS 
2.3.4.1 Higher ROS levels are detected in Δ3167c infected macrophages 
 ROS has been implicated in both apoptotic and necrotic cell death (127). Two 
dyes were used to measure ROS levels in uninfected and Mtb, Δ3167c and complement 
infected BMDM’s. DCFDA measures cytosolic superoxide content while MitoSOX 
Red™ is targeted to the mitochondria and measures mitochondrial ROS levels. At 
indicated time points post infection, macrophages were stained with the dyes for 30 
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minutes and fluorescence intensity measured by flowcytometry. Representative 
histograms show an increase in fluorescence intensity of Δ3167c-infected macrophages 
compared to those infected with Mtb or the complement strain at 24hpi (Fig 24A). 
Percentage increase in fluorescence intensity of the samples was calculated compared to 
the uninfected control at each time point. At 0hpi, macrophages infected with any of the 
three strains have comparable cytosolic and mitochondrial ROS levels. However at 
24hpi, increased levels of both cytosolic (2.4 fold) and mitochondrial ROS 
(approximately 50 fold) are detected in Δ3167c infected macrophages compared to Mtb 
infected cells (Fig 24B, 24C). Complementation of Rv3167c restored ROS to levels 
similar to that observed in Mtb infected cells. The negative values obtained indicate 
lower levels of ROS in the infected samples compared to uninfected cells.  
 Therefore, at earlier time points post infection ROS levels are similar in 
macrophages infected with Mtb, Δ3167c or the complement strain. However at longer 
time points post infection, higher mitochondrial and cytosolic ROS levels are detected in 
Δ3167c infected cells compared to Mtb or complement infected cells. 
2.3.4.2 Necrosis induction by Δ3167c is dependent on mitochondrial ROS 
 To determine the role of ROS in Δ3167c mediated necrosis, the flavoprotein 
inhibitor DPI and the ROS scavengers glutathione and NAC were added to infected 
THP1 macrophages. Necrosis induction was assessed by either toxilight assay or by 
TUNEL staining at 24hpi. Inclusion of DPI inhibited Δ3167c mediated necrosis by 
approximately three fold compared to untreated cells (Fig 25A). Inclusion of  glutathione 
and NAC resulted in a complete inhibition of Δ3167c induced necrosis (Fig 25B). 










































































Fig" 24." Δ3167c induces higher levels of cytosolic and mitochondrial ROS 
compared to Mtb and complement strain  
 
(A) Representative histogram of cytosolic and mitochondrial ROS measurement in infected BMDM’s 
at 24hpi. 
(B) Percentage! increase! in! DCFDA! intensity! measured! by! flowcytometry! in! infected! BMDM’s!
compared!to!uninfected!cells!at!0hpi!and!24hpi! is!depicted.!Data! is! from!three! independent!
experiments!(n=6).!
(C) Percentage! increase! in! MitoSOX! Red! intensity! measured! by! flowcytometry! in! infected!




mitochondria. The NOX2 complex comprises of 5 subunits and is assembled on the 
phagosomal membrane during phagocytosis (44). To examine role of NOX2 complex 
derived ROS on necrosis induction by Δ3167c, Nox2-/- BMDM’s (lacking the gp91phox 
subunit of the NOX2 complex) were infected and necrosis levels measured by PI staining 
and flowcytometry. Δ3167c induced similar levels of necrosis in both wild type and 
Nox2-/- BMDM’s (Fig 25C).  Although Mtb induced higher levels of necrosis in Nox2-/- 
BMDM’s, necrosis induction by Δ3167c is still significant compared to Mtb. 
Contribution of mitochondrial ROS to Δ3167c-induced cell death was assessed by PI 
staining of infected BMDM’s from mCAT transgenic mice. These mice overexpress 
mitochondrial targeted catalase, an antioxidant (133). A reduction in necrosis induction 
by Δ3167c strain from 59.63 in WT BMDM’s to 15.91% in mCAT BMDM’s was 
observed (Fig 25D).  MOMP and cytosolic translocation of CytC was not observed in 
Mtb and Δ3167c infected cells (Fig 17C). To determine whether mitochondrial 
membrane potential is affected, DIOC6 staining was performed in infected THP1 cells at 
the indicated time points. Increased loss of mitochondrial membrane potential indicated 
by loss of DIOC6  was observed in Δ3167c infected cells compared to those infected with 
Mtb starting at 12hpi. By 48hpi 79.38% of Δ3167c-infected cells had lost DIOC6 stain 
compared to 16.51% of Mtb infected cells (Fig 25E).  
These results indicate that mitochondrial derived ROS is required for necrosis 
induction by Δ3167c and that Δ3167c induces higher levels of mitochondrial damage 


















Fig 25. Δ3167c induced necrosis is dependent on mitochondrial ROS 
 
(A) Necrosis induction in presence of DPI was determined by toxilight assay at 24hpi. Data is from 
three independent experiments (n=6). 
(B) Necrosis induction in presence of glutathione and NAC was determined by TUNEL staining at 
24hpi. Data is from three independent experiments (n=6). 
(C) Necrosis induction in WT and Nox2-/- BMDM’s was determined by PI staining and flowcytometry 
at 48hpi. Data is from three independent experiments (n=6). 
(D) Necrosis induction in WT and mitochondrial targeted catalase overexpressing BMDM’s was 
determined by PI staining and flowcytometry at 24hpi. Data is representative of three independent 
experiments (n=3). 
(E) Loss of mitochondrial membrane potential was determined by DIOC6 staining in infected THP1 
cells and flowcytometry. Data is from three independent experiments (n=9). 
 
Statistical significance was estimated relative to solvent control for (A) and (B); Mtb infected cells 
for (C), (D) and (E). 
 



















































































































 Following entry into a host cell, Mtb employs different mechanisms to manipulate 
the host immune response to its own advantage. One such mechanism is the modulation 
of the host cell death response. Mtb inhibits host cell death by apoptotic mechanisms in 
order to avoid direct bactericidal effects of apoptosis as well as bactericidal effects 
exerted by neighboring phagocytic cells engulfing the infected. dying cells. Further, 
apoptosis inhibition helps towards controlling the CD4+ and CD8+ T cell response (49). 
In contrast, Mtb induces necrosis allowing for escape from the infected cells. Necrosis 
induction does not exert bactericidal effects and is associated with increased 
susceptibility to Mtb infection (95-99,101,102). In this study, we demonstrate that the 
gene Rv3167c is required for controlling Mtb mediated necrosis.  
 Rv3167c was initially identified as an “anti-apoptotic” gene in a screen for Mtb 
mutants that induce cell death. Previous studies have shown that apoptosis induction in 
Mtb infected macrophages results in reduced recovery of bacteria compared to uninduced 
cells (95,97). However, we did not observe any differences in the intracellular growth of 
Δ3167c compared to Mtb in macrophages (Fig 14). As apoptosis and necrosis have 
different implications for Mtb pathogenesis, it is important to identify the exact mode of 
cell death induced by Δ3167c. The method used in the screen to identify pro-apoptotic 
mutants was TUNEL staining, a technique that labels ends of fragmented DNA and long 
considered to be specific for apoptotic cell identification. More recently cells undergoing 
necrotic cell death have been shown to stain TUNEL positive as well (60,61,134). An 
analysis of the morphological and biochemical features of Δ3167c infected dying cells 
revealed that the cells exhibit features of both apoptosis and necrosis. Nuclear 
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condensation and fragmentation, a classical apoptotic feature was observed in Δ3167c-
infected cells (Fig 16A). The absence of DNA laddering and the loss of plasma 
membrane permeability however point towards a necrotic mode of cell death (Fig 15A, 
15B, 16B). Secondary necrosis, which follows apoptosis and can exhibit similar features 
as primary necrosis was ruled out by demonstrating that Δ3167c mediated cell death is 
independent of caspases (Fig 17) (57). A mixture of apoptotic and necrotic features has 
been shown previously in dying cells infected with Mtb, S.typhimurium, S.flexneri and in 
cells undergoing AIF mediated necrosis following treatment with the DNA damage 
inducer MNNG (61,86,107,108,135).  
 Using a combination of chemical inhibitors and macrophages deficient in 
components involved in regulated necrosis induction, we attempted to identify the 
mechanism involved in Δ3167c-induced necrotic cell death. However none of the 
regulated necrosis pathways and components that we investigated were found to be 
required for Δ3167c-induced necrosis. Three mechanisms underlying necrosis induction 
by Mtb have been described – modulation of lipid mediators LXA4 and PGE2, NLRP3 
inflammasome activation and host cell membrane damage induced by high bacterial 
numbers in the macrophage. Mtb infection upregulates LXA4 production, leading to a 
decrease in PGE2 synthesis and consequently necrosis induction by different mechanisms 
targeting the mitochondria and the plasma membrane (Fig…) (102,104,106). In our 
experimental settings, Mtb did not induce any LXA4 production and only a marginal 
decrease in Δ3167c-induced necrosis was observed in Alox5-/- BMDM’s that are deficient 
in LXA4 production (Fig 18). This could possibly be due to use of THP1 cells and 
BMDM’s in our study compared to murine splenic macrophages used in the published 
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studies on lipid mediator regulation by Mtb. Studies performed on high MOI Mtb 
infection show necrosis induction occurring at an intracellular bacterial load of 20-40 
bacteria and activity of lysosomal lipases was implicated in this process using the 
lysosomal lipase inhibitor chlorpromazine (Cpz). (21,107-109).  While Cpz did inhibit 
necrosis induction by Δ3167c, we found that it also inhibited mycobacterial uptake by the 
macrophage and inhibited bacterial growth invitro (Fig 19C, 19D, 19E). The use of Cpz 
as an anti-mycobacterial agent has been reported in early literature and the MIC of the 
compound was reported to be 1.8µg/ml invitro and 0.23µg/ml ex vivo in HuMDM’s, Cpz 
concentration used in our experiments was 3.55µg/ml (136). Thus the inhibitory effect of 
Cpz on Δ3167c-induced necrosis may just be the outcome of the anti-mycobacterial 
activity of the compound. As a similar bacterial burden is detected in both Mtb and 
Δ3167c infected macrophages, necrosis induction by Δ3167c cannot be attributed to 
differences in bacterial numbers.  
 Our inability to identify a specific mechanism responsible for Δ3167c mediated 
necrosis could point towards the existence of a novel, regulated necrosis pathway. 
Alternatively, co-operation and redundancy between regulated necrosis pathways may 
also explain this result. S.typhimurium triggered necrotic cell death in macrophages was 
found to be dependent on both RIPK1-RIPK3 and caspase 1 activation. Blocking either 
one of the signaling pathways led to only a marginal inhibition of necrosis while 
neutralizing both inhibited the phenotype completely (61). In another study, 
S.typhimurium induced macrophage cell death was found to require the activities of both 
caspase 1 and caspase 11 (79). M.marinum induced TNF dependent necrosis in zebrafish 
embryos with a LTA4H high genotype requires the activities of both cyclophilin D 
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(CypD) dependent MPTP formation and acid sphingomyelinase (ASMase) dependent 
ceramide generation. Inhibition of both CypD and ASMase was needed to completely 
inhibit necrosis induction in this study (9). Mtb mediated necrosis induction was reported 
to require the activity of both the cysteine cathepsin B and the aspartic cathepsin D (107). 
Treatment of Δ3167c infected cells with the cathepsin B inhibitor (Ca074-Me) and the 
cathepsin D inhibitor (Pepstatin A) either alone or in combination did not inhibit necrosis 
induction (Fig 19A). Eukaryotic cells possess eleven cysteine cathepsins and redundancy 
between cathepsins could explain this outcome. Inhibition of one mechanism of cell 
death may induce the cell to adopt another pathway to achieve the same goal. For 
instance, treatment of certain cell types with TNF induces RIPK1 dependent necrotic cell 
death and inhibition of RIPK1 using chemical inhibitors does not rescue cells from dying, 
the cells proceed towards death by an apoptotic mechanism instead (51). To determine if 
a similar mechanism was responsible for Δ3167c-induced necrosis observed in presence 
of the RIPK1 inhibitor Nec1, Δ3167c infected Rip3k-/- macrophages were treated with the 
pan caspase inhibitor zVAD-fmk as well. However, we did not observe any changes in 
Δ3167c-mediated necrosis under these conditions (Fig 16E). Nevertheless, this does not 
exclude similar crosstalk occurring between other necrotic pathways that may be 
activated in Δ3167c-infected cells. 
 The only factor identified in our study that leads to inhibition of Δ3167c mediated 
necrosis is mitochondrial ROS. Control of the NOX2 complex generated phagosomal 
ROS levels by the Mtb nuoG gene is required for apoptosis inhibition in infected cells 
(45). None of the studies on Mtb mediated necrosis have directly implicated 
mitochondrial ROS in this phenomenon although mitochondrial involvement has been 
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shown by demonstrating loss of mitochondrial membrane potential in Mtb infected cells 
(96,104). Δ3167c induced necrosis was found to be dependent on ROS generated in 
mitochondria but not by the phagosomal NOX2 complex and this was accompanied by 
mitochondrial damage as indicated by the loss of mitochondrial membrane potential (Fig 
25C, 25D, 25E). The PE-PGRS33 protein of Mtb upon ectopic expression in mammalian 
cells was found to localize to mitochondria and induce cell death (120). Infection of 
macrophages with non-pathogenic M.smegmatis overexpressing PE-PGRS33 also 
resulted in necrotic cell death (137). A bioinformatics study identified 136 Mtb proteins 
to contain predicted mitochondrial targeting sequences out of which 19 were predicted to 
be secreted proteins. (138). It would be interesting to see if expression and/or secretion of 
these predicted mitochondrial-targeted proteins is upregulated in Δ3167c compared to 
Mtb.  
 In conclusion, this study identified the role of the gene Rv3167c in the control of 











CHAPTER 3 Rv3167c IS REQUIRED FOR AUTOPHAGY INHIBITION 
3.1 INTRODUCTION 
Autophagy is an evolutionarily conserved catabolic process that involves 
sequestration of cytosolic contents into de novo generated double membrane vesicles 
termed as autophagosomes that eventually fuse with lysosomes. Initial studies on Mtb 
and autophagy focused on the effect of physiological, pharmacological and 
immunological autophagy inducers on mycobacteria infected cells 
(145,158,159,160,161,163,164,165). More recently it was found that Mtb induced 
autophagy in an EsxA dependent manner (150). Formation of pores on the phagosomal 
membrane in an EsxA dependent manner allowed mycobacterial extracellular DNA to 
access the cytosol. This in turn led to ubiquitination of Mtb by the ubiquitin ligase Parkin 
and recruitment of the selectve autophagy markers p62 and NDP52 (Fig 11). Autophagy 
induction either by additional stimuli or by the bacteria itself results in anti-mycobacterial 
effects.  
In this study we evaluated the role of Rv3167c in Mtb induced autophagy. 
Rv3167c was determined to be required for inhibition of host cell autophagy. 
Mitochondrial ROS, inhibition of Akt activation and upregulation of JNK activation 
contributed to Δ3167c-induced autophagy. Inhibition of Akt activation was also found to 
be required for Δ3167c-induced necrosis. Previous studies on Mtb induced autophagy 
have shown that Mtb co-localizes with autophagosomes, leading to lysosomal mediated 
bacterial destruction. Surprisingly, we did not observe Mtb or Δ3167c co-localization 
with autophagosomes indicating Mtb has the ability to inhibit selective autophagy 
mediated killing. 
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3.2 MATERIALS AND METHODS 
3.2.1 Materials 
THP1 cells and BMDM’s expressing LC3 tagged with GFP (LC3GFP) were 
obtained from Dr.John Kehrl at National Institutes of Health, Bethesda, MD (143). 
SP600125 (JNK inhibitor), SB203580 (p38 MAPK inhibitor), SB202190 (p38 MAPK 
inhibitor), SC-79 (Akt activator) and DPI were purchased from Calbiochem. 
BafilomycinA1, rapamycin and 3-MA were purchased from Sigma, LC labs and Tocris 
BioSciences respectively. Antibodies used in this study and their sources are listed in 
Appendix A.  
3.2.2 Bacterial cultures 
 Bacterial cultures were maintained as described in 2.2.2. Δ3167c strains 
expressing myc tagged Eis, pore forming toxin listeriolysin O (LLO) and both myc 
tagged Eis and LLO were generated by Jeff Quigley.  
3.2.3 Cell culture and infection 
THP1 LC3GFP cells were maintained in RPMI supplemented with 10% non-heat 
inactivated FCS and 100µg/ml geneticin. Cells were differentiated and infected as 
described in 2.2.3.  
LC3GFP expressing murine monocytes were differentiated into macrophages in 
DMEM containing 10% heat inactivated FCS, 50ng/ml murine MCSF (Peprotech) and 
1% Pencillin-Streptomycin. Macrophages were infected in DMEM, 10% non-heat 
inactivated FCS and 50ng/ml MCSF for 4 hours at 37°C and chased in growth medium 
containing 100µg/ml gentamicin. Inhibitors and neutralizing antibodies when used were 
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added to cells 1 hour prior to infection and included in chase medium. 3-MA was added 
only during chase. 
3.2.4 Electron microscopy analysis 
 Infected THP1 cells were treated with 2.5% gluteraldehyde in 0.1M sodium 
cacodylate buffer (pH7.4) for 30 minutes at room temperature and 30 minutes at 4°C 
followed by fixation with 2% PFA. TEM samples were generated by Serdar Gurses. 
3.2.5 Autophagy assays 
LC3GFP expressing cells were processed for autophagy analysis by 
flowcytometry as described previously (184). At indicated time points, infected cells 
were harvested and washed with PBS prior to permeabilization with 0.05% saponin for 5 
minutes. Cells were washed once with PBS and resuspended in FACS buffer. 
Permeabilization resulted in loss of cytosolic LC3I while LC3II bound to autophagosome 
membranes was retained, which was measured by flowcytometry (Accuri).  
For immunofluorescence analysis, bacteria were stained with AF647-NHS ester 
(Molecular Probes) as per manufacturers instructions. Briefly, bacteria were pelleted and 
stained in 0.1M sodium bicarbonate solution containing 0.4mg/ml AF647-NHS ester for 
30 minutes at 37°C. Bacteria were washed, resuspended in 0.05% PBS-Tween80 and 
used for infecting BMDM LC3GFP on slides. At specified time points, cells were fixed 
with 4% paraformaldehyde overnight, stained with Hoechst 33342 and observed by 
confocal microscopy (Zeiss LSM 710) for presence of LC3 punctae.  
3.2.6 Preparation of bacterial cell lysates and culture filtrates 
 Late log phase bacterial cultures (OD600 0.6-0.8) were passaged into Sauton’s 
medium containing 0.05% Tween80 to OD600 0.05 and grown to late log phase. A second 
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passage into Sauton’s medium containing 0.005% Tween 80 to OD600 0.05 was 
performed and bacteria were grown to late log phase once again. At this point, bacterial 
pellets and culture supernatants were collected. Bacterial pellets were resuspended in 
20mM Tris HCl, pH 7.6 and lysates were prepared by bead beating. Culture filtrates were 
concentrated to a final volume of 300µl using Amicon Ultra 15 Centrifugal Filter Unit 
(Millipore). Protease inhibitor cocktail for bacterial cells (Sigma) was added to both cell 
lysates and culture filtrates at a final concentration of 0.43mg/ml. 
3.2.7 Western Blotting 
 Whole cell lysates were prepared as described in section 2.2.9. Western blotting 
of host cell lysates and bacterial lysates and culture filtrates was performed as described 
in 2.2.10. For bacterial lysates and culture filtrates, primary antibody incubation was 
carried out at room temperature for one hour. 
3.2.8 MTS assay 
 Toxicity of inhibitors on macrophages was assessed by performing the CellTiter 
96® AQueous One Solution Cell Proliferation Assay (MTS) from Promega as per 
manufacturers instructions. Briefly, 20µl of the MTS reagent was added to cells in a total 
volume of 100µl and incubated at 37°C for 1-3 hours. Cellular metabolic activity 
correlated with color development monitored by measuring absorbance at 490nm. 
3.2.9 Statistical analysis 
ANOVA with Tukey post-test was used for statistical analysis unless otherwise 
indicated. Data is represented as mean ± SD. p-value significance is as follows – p ≤ 0.05 
- *, p ≤ 0.01 - **, p ≤0.0001 - ***. 
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3.3 RESULTS AND DISCUSSION  
3.3.1 Δ3167c induces autophagy 
3.3.1.1 Δ3167c induces autophagy in both cell lines and primary macrophages 
 In order to further describe the characteristics of cell death induced by Δ3167c, 
infected THP1 macrophages were processed for TEM (Gurses S, unpublished). 
Ultrastructural analysis of the infected macrophages by electron microscopy revealed the 
presence of onion like structures characteristic of autophagic vacuoles (Fig 26C’) (148). 
To determine whether Δ3167c induced autophagy, BMDM LC3GFP cells were infected 
with Mtb and Δ3167c stained with AF647-NHS ester at MOI3. At 8hpi, cells were fixed 
with 4% PFA overnight, followed by staining of nuclei with Hoechst 33342. Cells were 
observed by confocal microscopy for LC3 aggregates and percentage of autophagic cells 
enumerated. A higher percentage of Δ3167c-infected macrophages were autophagic 
compared to macrophages infected with Mtb (Fig 26A, 26B). Mtb has been previously 
shown to induce autophagy and bacteria have been demonstrated to be present within 
autophagic vacuoles (150). However, in our experiments less than 1% of Mtb and 
Δ3167c were observed to colocalize with LC3 aggregates by confocal microscopy. 
Examination of TEM images confirmed results obtained by confocal microscopy. As 
expected a higher number of autophagosomes were found in Δ3167c-infected cells when 
compared to Mtb infected controls. Interestingly about 3-4% of both Mtb and Δ3167c 
bacteria found to colocalize with autophagosomal structures (Fig 26D). The lower 
estimates of autophagosome-bacteria co-localization obtained by confocal microscopy 
may be attributed to use of surface stained bacteria in these experiments, bacteria left 


























Fig 26. Δ3167c induces autophagy 
 
(A) Autophagy induction by AF647 NHS ester stained bacteria in THP1 LC3GFP cells at 8hpi 
examined by confocal microscopy.  
(B) Quantitative analysis of cells (A). Data is from 3 independent experiments and atleast 450 cells 
were counted per condition per experiment. Statistical analysis was performed using unpaired 
Student’s t test.  
(C) Representative TEM image of infected THP1 cells at 24hpi. (C’) and (C’’) are magnified images 
of regions marked in (C). AP- autophagosome; B- bacteria; M- mitochondria. 




















Fig 27. Δ3167c induces autophagy 
 
(A) Principle of autophagy detection by flowcytometry. Image is adapted from (184). 
(B) Autophagy induction in THP1 LC3GFP cells measured at 16hpi by flowcytometry. Data is from 
three independent experiments (n=6). 
(C) Autophagy induction in BMDM LC3GFP cells measured at 72hpi by flowcytometry. Data is from 
two independent experiments (n=4). 
(D) Conversion of GFP tagged and endogenous LC3I to LC3II detected by western blotting in whole 
cell lysates. Data is representative of three independent experiments. 
(E) Inhibition of Δ3167c-induced autophagy in presence of 3-MA (5mM) measured by 
flowcytometry. Data is representative of three independent experiments (n=4). 
 
Asterisks indicate statistically significant differences compared to Mtb except for (E) where they 
indicate statistically significant differences compared to 3-MA untreated condition. 
 
 



























































636 Autophagy Volume 6 Issue 5
LC3 staining in a diffuse pattern in the 
cells, the intensity of which was reduced 
by saponin extraction. CQ treatment 
had no effect on this staining. Finally, we 
transfected HOS cells with EGFP-LC3 
or with EGFP-LC3-G120A. 24 h post 
transfection, cells were treated with CQ 
for 4 hours or left untreated. Before analy-
sis by FACS, the cells were washed with 
PBS containing 0.05% saponin, or PBS 
alone. As expected from Figure 1, only a 
small fraction of EGFP-LC3 fluorescence 
was saponin resistant (Fig. S2C), except 
after CQ treatment which allowed most 
either washed with PBS containing 0.05% 
saponin, or PBS alone and processed for 
microscopy. Representative images are 
shown in Figure S2B. In the ATG5+/+ cells, 
LC3 was seen in a diffuse pattern through-
out the cells. Saponin treatment led to a 
reduction of the strength of this signal but 
did not lead to aggregation of the signal to 
puncta. CQ treatment led to aggregation 
of the LC3 signal into cytoplasmic foci 
and although saponin extraction appeared 
to reduce the diffuse staining, it had little 
effect on the number or intensity of these 
foci. Untreated ATG5-/- cells also displayed 
cells were starved of amino acids for 4 
hours, treated with CQ for 4 hours or left 
untreated. Before fixation for microscopy 
analysis, the cells were washed with PBS 
containing 0.05% saponin, or PBS alone 
and EGFP-LC3 puncta were quanti-
fied by manual counting. No significant 
effect of saponin on number of cyto-
plasmic EGFP-LC3 puncta was detected 
under any of the conditions analyzed (Fig. 
S2A). Next, we treated murine embryonic 
fibroblasts (MEFs) from ATG5+/+ (wild 
type) and ATG5-/- mice with CQ for 4 
hours or left them untreated. Cells were 
Figure 1. Saponin extraction allows quanti!cation of EGFP-LC3-II "uorescence by FACS. (A) HOS-EGFP-LC3 cells were starved of amino acids or CQ 
treated for 4 hours or left untreated. EGFP "uorescence was measured by FACS either without (top) or with (bottom) a wash with PBS containing 0.05% 
saponin. (B) HOS-EGFP-LC3 cells were starved of amino acids or CQ treated for 4 hours or left untreated. Following a wash with 0.05% saponin in PBS 
or with PBS, coverslips were processed for microscopy. (C) HOS-EGFP-LC3 cells were starved of amino acids or CQ treated for 8 hours or left untreated. 
Following a brief wash with 0.05% saponin in PBS or with PBS, cells were lysed and the lysates processed for immunoblotting using antibodies speci!c 
for actin or for LC3. (D) Schematic diagram of the e#ects of the saponin wash. Due to the reorganization of the EGFP-LC3 reporter protein, induction 
of autophagosome formation should not change the total levels of "uorescence in HOS-EGFP-LC3 expressing cells. However, extraction of EGFP-
LC3-I with saponin would be expected to result in a higher level of "uorescence in cells with proportionally higher levels of EGFP-LC3-II-containing 
autophagosomes.
! 109!
Conversion of LC3I to LC3II was also monitored by flowcytometry in infected 
THP1 LC3GFP and BMDM LC3GFP macrophages at 16hpi. The assay involves 
permeabilization of cells leading to loss of cytosolic LC3I and detection of LC3II bound 
to the autophagosomal membrane (Fig 27A) (184).. A two-fold increase in autophagy 
induction by Δ3167c was observed compared to either Mtb or the complement in both 
cell types (Fig 27B, 27C). Conversion of LC3I GFP to LC3II GFP was detected by 
immunoblotting as well in whole cell lysates prepared from infected THP1 LC3GFP 
macrophages at 16hpi. Higher levels of both endogenous LC3II and LC3II tagged with 
GFP were detected by this approach in Δ3167c infected cells compared to Mtb or 
complement infected cells (Fig 27D). Autophagy induction by Δ3167c was confirmed 
using 3-MA, a widely used autophagy inhibitor (177). Inclusion of the inhibitor during 
chase of infected THP1 LC3GFP macrophages reduced autophagy induction by Δ3167c 
to levels similar to that induced by Mtb (Fig 27E).   
 These data demonstrate that Δ3167c induces higher levels of autophagy compared 
to both Mtb and the complement strain. Neither Mtb nor Δ3167c were found to co-
localize with the autophagosome marker LC3 indicating that Rv3167c is required for 
controlling macroautophagy induction by Mtb. 
3.3.1.2 Autophagy induction by Δ3167c culminates in degradation 
Increased levels of LC3II can be attributed to either an increase in autophagosome 
formation or to a decrease in LC3II degradation due to inhibition of autophagosome 
maturation (147). To distinguish between these two possibilities Δ3167c infected cells 
were treated with the vacuolar proton ATPase inhibitor bafilomycin A1 (BafA1). By 
inhibiting phagosomal acidification, BafA1 inhibits degradation of lysosomal contents 
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and thus in the case of denovo autophagosome generation results in increased LC3II 
accumulation. If LC3II accumulation occurs due to a defect in autophagosome 
maturation, then BafA1 addition will not result in increased LC3II collection. Higher 
levels of LC3II were detected in Δ3167c infected and BafA1 treated macrophages 
compared to untreated controls (60% in BafA1 treated vs 40% in untreated control cells) 
(Fig 28A).  
Another way of analyzing autophagosome maturation is following the delivery of 
the LC3GFP fusion protein to the lysosomal compartment where it is degraded to yield 
free GFP (185). Whole cell lysates prepared from infected THP1 LC3GFP macrophages 
at 16hpi were utilized for the detection of GFP by immunoblotting. GFP was detected 
only in Δ3167c-infected macrophages and is indicative of higher levels of autophagy 
induction and degradation induced by Δ3167c (Fig 28B).  
In conclusion, the increased levels of LC3II observed in Δ3167c-infected cells are 
due to a stimulation of de novo formation of autophagosomes and not due to an inhibition 





Fig 28. Δ3167c does not mediate inhibition of autophagosome maturation 
 
(A) Autophagy induction by Δ3167c in presence of BafA1 (250nM) at 16hpi measured via 
flowcytometry. Data is from 3 experiments (n=6). Asterisks indicate statistical significance 
compared to DMSO treated control.   
(B) Free GFP generated during lysosomal degradation of LC3GFP detected by western blotting in 
whole cell lysates. Data is representative of three independent experiments.  























3.3.1.3 Δ3167c induced autophagy is independent of eis 
 The enhanced intracellular survival gene (eis) of Mtb encodes for a secreted 
protein that can be detected in the cytoplasm of infected macrophages (186,187). The 
Mtb eis gene has been shown to be required for autophagy inhibition (175). 
Transcriptome analysis demonstrated reduced eis expression in Δ3167c-compared to Mtb 
after macrophage infection (work done by Jeff Quigley, data not shown). To determine 
whether Δ3167c induced autophagy is linked to Eis, THP1 LC3GFP macrophages were 
infected with Δ3167c and Δ3167c transformed with either empty plasmid (pSY1) or 
plasmid encoding for eis (pSY1::eis). Autophagy induction was analyzed by 
flowcytometry at 16hpi. No inhibition of autophagy induction was observed in cells 
infected with Δ3167c overexpressing Eis compared to those infected with the parent 
Δ3167c strain (Fig 29A).  
The lack of autophagy inhibition in cells infected with Δ3167c overexpressing Eis 
could be attributed to the inability of Eis to access the host cell cytosol. Therefore an 
alternative strategy was needed to examine the contribution of Eis to Δ3167c-mediated 
autophagy in a manner dissociated from its cytosolic translocation. To do so, Δ3167c 
overexpressing Eis and the auto activated form of the pore forming toxin listerolysin O 
(LLO) was generated. Formation of pores on the phagosomal membrane by LLO should 
allow for cytosolic access of Eis within the infected macrophage. Autophagy induction 
was measured in infected THP1 LC3GFP macrophages by flowcytometry at 16hpi. No 
differences in autophagy induction were observed in cells infected with Δ3167c or the 
mutant strain overexpressing LLO and Eis  (Fig 29B). To check whether expression and 
secretion of Eis is affected in Δ3167c, cell lysates and culture filtrates prepared from Mtb   
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Fig 29. Δ3167c mediated autophagy is independent of Eis 
 
(A) Autophagy induction by Δ3167c expressing Eis at 16hpi measured by flowcytometry. Data is from 
one experiment (n=3). Statistical significance was estimated relative to Δ3167c containing pSY1. 
(B) Autophagy induction by Δ3167c expressing either LLO alone or both Eis and LLO at 16hpi 
measured by flowcytometry. Data is from one experiment (n=3). Statistical significance was 
estimated relative to Δ3167c containing pSY1-LLO. 
(C) Expression and secretion of Eis by Mtb and Δ3167c. Data is from one experiment. 
 
! 114!
and Δ3167c were immunoblotted for Eis. Contrary to previous reports, we did not detect 
Eis secretion by Mtb. Δ3167c did not secrete Eis either and no differences were observed 
in Eis expression in the cell lysates of the two strains. (Fig 29C).  
These data indicate that Eis is not involved in autophagy induction by Δ3167c.  
3.3.2 Molecular mechanisms of Δ3167c induced autophagy  
3.3.2.1 JNK activation is required for autophagy induction by Δ3167c 
 The MAPK’s JNK and p38 have been implicated in autophagy induction by Mtb 
mutants, as well as in response to cytokines and other autophagy inducers (160,163,177). 
To investigate the role of MAPK’s in Δ3167c induced autophagy, their activation in 
infected THP1 LC3GFP macrophages was assessed by immunoblotting for 
phosphorylated forms in whole cell lysates prepared 16hpi. An approximately 10-fold 
increase in phosphorylated JNK was detected in Δ3167c-infected cells at 18hpi compared 
to those infected with either Mtb or the complement (Fig 30A). About 2-fold higher 
levels of phosphorylated p38 MAPK were detected at 0hpi in Δ3167c-infected cells 
compared to those infected with Mtb and complement, which returned to Mtb levels by 
18hpi (Fig 30A). A similar result was obtained from whole cell lysates prepared from 
infected HuMDM’s at 24hpi (Fig 30B). 
 JNK and p38 MAPK inhibitors (SP600125 and SB230580 respectively) were 
utilized to assess the contribution of these MAPK’s in autophagy induction by Δ3167c. 
Inhibitors were added to THP1 LC3GFP macrophages prior to infection and were 
maintained throughout the infection and the chase. Autophagy induction was analyzed by 
flowcytometry at 16hpi. Inclusion of the JNK inhibitor SP600125 led to a dose dependent 
decrease in autophagy induction by Δ3167c while no changes were seen in macrophages 
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Fig 30. Autophagy induction by Δ3167c is dependent on JNK but not p38 MAPK 
activation 
 
(A) JNK and p38 MAPK phosphorylation in THP1 LC3GFP WCL’s at 18hpi detected by western 
blotting. Numbers below indicate fold change in band intensity compared to Mtb sample after 
normalization to loading control. Data is representative of three independent experiments. 
(B) JNK and p38 MAPK phosphorylation in HuMDM WCL’s at 24hpi detected by western blotting. 
Numbers below indicate fold change in band intensity compared to Mtb sample after 
normalization to loading control. Data is representative of three independent experiments. 
(C) Autophagy induction by Δ3167c in presence of JNK (SP600125) and p38 MAPK (SB203580) 
inhibitors detected by flowcytometry. Data is representative of three independent experiments 
(n=6). 
(D) Autophagy induction by Δ3167c in presence of p38 MAPK inhibitor (SB202190) detected by 
flowcytometry. Data is representative of two independent experiments (n=4). 
 
For (C) and (D), statistical significance was estimated relative to DMSO solvent control. 
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treated with the p38 MAPK inhibitor SB203580 (Fig 30C).  Only a partial inhibition of 
Δ3167c-induced autophagy was seen with the highest concentration (25µM) of 
SP600125, this could be due to an incomplete inhibition of JNK activation. p38 MAPK 
inhibition with another inhibitor - SB202190 did not affect Δ3167c induced autophagy as 
well (Fig 30D).  
Therefore, while Δ3167c induces activation of both JNK and p38 MAPK, only 
JNK activation is involved in autophagy induction. 
3.3.2.2 Δ3167c induced autophagy does not involve Beclin1 upregulation and Bcl2 
phosphorylation  
 During autophagy, Beclin1 is required for autophagosome membrane nucleation 
along with Atg14L and class III PI3K (139). Beclin1 transcription has been shown to be 
upregulated in Vitamin D3 treated, Mtb infected macrophages undergoing autophagy 
(160). Increased levels of Beclin1 have also been implicated in autophagy induction by 
the hepatitis C virus (188). To determine whether Δ3167c induced autophagy involves an 
increase in Beclin1 levels, whole cell lysates were prepared from infected THP1 LC3GFP 
macrophages at 16hpi and Beclin1 protein levels detected by immunoblotting. 
Macrophages infected with Mtb, Δ3167c and complement had similar levels of Beclin1 
(Fig 31A).  
The amount of Beclin1 present in the host cell is not the only factor that governs 
the role of Beclin1 in autophagy induction. Beclin1 has a BH3 domain through which it 
binds to Bcl2 and is rendered unavailable for autophagy induction. Phosphorylation of 
Bcl2 disrupts this interaction allowing Beclin1 to participate in autophagy induction 
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Fig 31. Autophagy induction by Δ3167c is independent of Beclin1 levels and Bcl2 
phosphorylation 
 
(A) Beclin1 levels in THP1 WCL’s at 16hpi detected by western blotting. Numbers below indicate fold 
change in band intensity compared to Mtb sample after normalization to loading control. Data is 
representative of three independent experiments. 
(B) Bcl2 phosphorylation in THP1 WCL’s at 16hpi detected by western blotting. Data is representative of 
three independent experiments. 
(C) Induction of Bcl2 phosphorylation by nocodazole treatment in THP1 monocytes. Numbers below 
indicate fold change in band intensity compared to untreated (UT) sample. Data is from one 
experiment. 
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induced autophagy, whole cell lysates of infected THP1 LC3GFP macrophages prepared 
at 16hpi were immunoblotted for phosphorylated Bcl2 (pBcl2). A complete absence of 
phosphorylated Bcl2 (pBcl2) was observed in both infected macrophages as well as 
uninfected controls (Fig 31B). To ensure that the antibody used could detect pBcl2, a 
positive control was established using THP1 monocytes treated with nocodazole. 
Treatment with nocodazole, a microtubule depolymerizing agent has been previously 
reported to increase Bcl2 phosphorylation (189). Following nocodazole treatment, 
increased levels of pBCl2 were detected compared to untreated control cell (Fig 31C), 
thus validating the antibody used. While no pBcl2 was detected in uninfected THP1 
macrophages (obtained by PMA treatment of monocytes), pBcl2 was present in 
uninfected THP1 monocytes. 
Thus, induction of autophagy by Δ3167c does not require an increase in Beclin1 
levels and phosphorylation of Bcl2.   
3.3.2.3 Inhibition of Akt activation is required for Δ3167c-induced autophagy 
 The serine threonine kinase Akt influences several host cell processes such as cell 
proliferation, migration and cell death. Akt is also involved in inhibition of autophagy via 
mTOR activation and via phosphorylation of Beclin1 (190). The role of Akt in Δ3167c-
induced autophagy was examined by first determining whether Akt activation is inhibited 
in infected macrophages. Whole cell lysates were prepared from uninfected and infected 
THP1 LC3GFP macrophages at16hpi and immunoblotted for total Akt and 
phosphorylated Akt. Akt phosphorylation was found to be severely inhibited in Δ3167c 
infected cells (Fig 32A). To confirm the role of Akt in autophagy induction by Δ3167c, 
THP1 LC3GFP macrophages were infected in presence and absence of sc-79 and 
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Fig 32. Autophagy induction by Δ3167c is dependent on inhibition of Akt 
activation 
 
(A) Akt phosphorylation in THP1 cells detected at 16hpi by western blotting. Numbers below indicate 
fold change in band intensity compared to Mtb sample after normalization to loading control. Data is 
representative of three independent experiments. 
(B) Autophagy induction by Δ3167c in presence of Akt activator sc-79 detected by flowcytometry 
at16hpi. Data is from 4 experiments (n=8). Statistical significance was estimated compared to DMSO 
treated solvent control. 
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autophagy induction examined by flowcytometry. sc-79 is a small molecule activator 
which binds to Akt, leading to a conformational change allowing for Akt phosphorylation 
and activation in the cytosol (191). A dose dependent decrease in Δ3167c-mediated 
autophagy was observed in macrophages treated with sc-79 (Fig 32B). 
These data indicate that autophagy induction by Δ3167c requires inhibition of Akt 
phosphorylation and activation. 
3.3.3 Crosstalk between Δ3167c induced necrosis and autophagy 
3.3.3.1 Δ3167c mediated necrosis is independent of JNK and p38 MAPK but 
requires inhibition of Akt activation while Δ3167c-induced autophagy is dependent 
on ROS. 
 Following infection with Δ3167c, increased phosphorylation of JNK and p38 
MAPK were observed and autophagy induction was found to be dependent on JNK 
activation (Fig 30A, 30B, 30C). To examine whether JNK and/or p38 MAPK were 
required for necrosis induction by Δ3167c, THP1 macrophages were infected in presence 
and absence of the inhibitors SP600125 and SB203580 and PI staining was performed at 
24hpi. Inclusion of neither the JNK nor the p38 MAPK inhibitor reversed the pro- 
necrotic phenotype of the mutant strain, rather an increase in necrosis induction was 
observed in both cases (Fig 33A, 33B). To ensure that the inhibitors are not toxic to the 
cells, metabolic activity of SP600125 and SB203580 treated THP1 macrophages was 
tested using the MTS assay. At 24-hour post treatment, SB203580 had no toxic effects on 
cells (Fig 33C). Cells treated with SP600125 at 25µM displayed a 1.4 fold decrease in 
metabolic activity (Fig 33C). This may account for the modest increase in necrosis 
induction observed in Δ3167c-infected cells in presence of the inhibitor.  
! 121!
 
   
Fig 33. Necrosis induction by Δ3167c is dependent on Akt while autophagy 
induction requires ROS 
 
(A) Necrosis induction by Δ3167c in presence of JNK inhibitor (SP600125) in THP1 macrophages 
measured by flowcytometry at 24hpi. Data is from 3 independent experiments (n=6). 
(B) Necrosis induction by Δ3167c in presence of p38 MAPK inhibitor  (SB203580) in THP1 
macrophages measured by flowcytometry at 24hpi. Data is from 3 independent experiments (n=6). 
(C) MTS assay to determine JNK and p38 MAPK inhibitor toxicity in THP1 cells at 24hpi. Data is 
from one experiment (n=3). 
(D) Necrosis induction by Δ3167c in presence of Akt activator sc-79 in THP1 macrophages measured 
by flowcytometry at 24hpi. Data is from 3 independent experiments (n=6). 
(E) Autophagy induction by Δ3167c in presence of ROS inhibitor DPI in THP1 LC3GFP macrophages 
measured by flowcytometry at 24hpi. Data is from 3 independent experiments (n=6). 
 
Statistical significance was estimated relative to the DMSO treated solvent control. 
 

























































































Inhibition of Akt activation by was found to be required for Δ3167c mediated 
autophagy (Fig 32B). The role of Akt in Δ3167c-induced necrosis was assessed by 
infecting THP1 macrophages in presence of the Akt activator sc-79 and performing PI 
stain at 24hpi. Necrosis induction by the mutant in the presence of sc-79 was inhibited to 
levels induced by Mtb (Fig 33D). 
ROS has been previously implicated in Mtb mediated autophagy induction (177). 
Mitochondrial ROS was demonstrated to be required for necrosis induction by Δ3167c 
(Fig 25D). To determine whether ROS is required for autophagy induction by Δ3167c, 
THP1 LC3GFP macrophages were infected in presence of the flavoprotein inhibitor DPI 
and autophagy induction assessed by flowcytometry at 16hpi. Inclusion of DPI led to a 
complete inhibition of autophagy induction by Δ3167c, thus demonstrating the 
requirement of ROS for this process (Fig 33E).  
In conclusion, mitochondrial ROS generation and inhibition of Akt acrivation 
underly both necrosis and autophagy induction by Δ3167c while JNK activation is 
required for Δ3167c-mediated autophagy induction alone.  
3.3.3.2 Inhibition of Δ3167c-induced autophagy does not inhibit necrosis 
 Autophagy via breakdown of cellular contents helps cells survive during 
starvation. However, excessive autophagy induction can also lead to cell death (192). To 
examine whether Δ3167c induced necrosis is dependent on autophagy induction, infected 
THP1 macrophages were treated with the autophagy inhibitor 3-MA during the chase 
period and at 24hpi necrosis induction was measured by PI staining. Inclusion of 3-MA 
resulted in increased necrosis of Δ3167c infected macrophages (Fig 34A). However, 
increased necrosis observed in 3-MA treated cells could be due to toxic effects of 3-MA 
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itself as uninfected cells treated with 3-MA undergo necrosis as measured by the toxilight 
assay (Fig 34B). As an alternative approach, autophagy deficient BMDM’s from 
Atg5flox/flox LysM-Cre+ mice were infected and at the indicated timepoints, supernatants 
used for toxilight assay. No differences were seen in necrosis induction by Δ3167c in 
autophagy deficient Atg5flox/flox LysM-Cre+ BMDM’s and associated Atg5flox/flox LysM-
Cre- control macrophages (Fig 34C).  
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Fig 34. Δ3167c induced autophagy does not result in necrosis 
 
(A) Effects of autophagy inhibitor 3-MA on necrosis induction by Δ3167c measured by PI staining. 
Data is representative of two independent experiments (n=4). Statistical significance was estimated 
relative to Δ3167c-infected cells. 
(B) Toxicity of 3-MA in uninfected THP1 macrophages measured by toxilight assay. Data is 
representative of one independent experiment (n=3). Statistical significance was estimated relative 
to untreated (UT) cells. 
(C) Necrosis induction in autophagy competent (Atg5flox/fl0x LysM-Cre-) and autophagy deficient 
(Atg5flox/flox LysM-Cre+) BMDM’s measured using Toxilight assay. Data is from 3 independent 
experiments (n=6). Statistical significance was calculated compared to autophagy competent 
control for each time point. 
 




































 While several studies detail the effects of autophagy induction by physiological, 
pharmacological and immunological stimuli on the outcome of Mtb infection, the ability 
of Mtb to manipulate autophagy by itself has only been more recently described. 
(145,150,168). At present only the eis gene of Mtb has been identified as an anti-
autophagic gene (177). This study reveals that the gene Rv3167c is required for the 
inhibition of Mtb induced autophagy in an Akt, JNK and ROS dependent manner.  
  Infection with Δ3167c results in inhibition of Akt activation and restoration of 
Akt activation resulted in inhibition of Δ3167c induced autophagy (Fig 32A, 32B). 
Inhibition of Akt activation has been implicated both in macroautophagy induction in 
response to nutritional stresses as well as in selective autophagy induction in response to 
pathogens such as T.gondii and S.typhimurium (141,193,194). Akt inhibition results in 
downstream inhibition of mTOR activation and autophagy induction (141). Alternatively, 
activated Akt has also been implicated in mTOR independent modulation of autophagy 
via phosphorylation of Beclin1, rendering Beclin1 unavailable to participate in formation 
of the autophagy nucleation complex (190). Conflicting reports exist regarding the role of 
mTOR in Mtb mediated autophagy modulation. Zullo et al demonstrated mTOR to be 
activated in Mtb infected macrophages undergoing autophagy indicating Mtb mediated 
autophagy induction to be mTOR independent (167). On the other hand, Wang et al 
implicated Mtb mediated transcriptional downregulation of Rheb, an mTOR activator, in 
induction of autophagy, indicating Mtb mediated autophagy to be mTOR dependent 
(180). Δ3167c mediated autophagy could therefore be mTOR dependent or independent 
and Akt could potentially modulate either mechanism. Increased activation of the MAPK 
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JNK was found to be associated with Δ3167c induced autophagy as well (Fig 30A, 30B, 
30C). JNK mediated autophagy has been shown to depend on phosphorylation of Bcl2 
resulting in its dissociation from Beclin1 in HeLa cells in response to starvation and in 
mouse embryonic fibroblasts (MEF’s) in response to viral infection (195,196). No Bcl2 
phosphorylation was detected in Δ3167c infected macrophages (Fig 31B).  The lack of a 
role for Bcl2 phosphorylation in Δ3167c-induced autophagy could be due to the use of 
macrophages in this study. Our study does not completely rule out the role of Beclin1 and 
Bcl2 in Δ3167c mediated autophagy as Beclin1-Bcl2 dissociation can be achieved via 
other mechanisms as well (Fig 10B) (146). Increased ROS levels in Δ3167c cells could 
contribute to autophagy induction by potentiating JNK activation. ROS has been reported 
to inactivate JNK phosphatases thereby leading to prolonged JNK activation (197). A 
feedback loop between ROS generation and JNK activation could therefore exist in 
Δ3167c-infected cells thereby leading to robust autophagy induction. Alternatively, the 
positive effect of ROS on Δ3167c-mediated autophagy could be attributed to effects of 
ROS on autophagic machinery. ROS has also been demonstrated to contribute to 
starvation-induced autophagy via regulation of Atg4, a cysteine protease that is required 
for the delipidation of LC3. In an oxidative environment, Atg4 is inactivated thereby 
leading to enhanced autophagosome formation (198), (199). 
The enhanced intracellular survival (eis) gene is currently the only known Mtb 
gene that contributes to regulation of autophagy induction by Mtb. The phenotype of eis 
mutant infected cells is very similar to cells infected with Δ3167c. Both mutants induce 
increased levels of autophagy and caspase independent cell death compared to Mtb in a 
ROS dependent manner (177). Comparative transcriptome analysis revealed decreased 
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expression of eis in Δ3167c compared to Mtb (data not shown) making eis an attractive 
gene target possibly regulated by Rv3167c. We found Δ3167c-induced autophagy to be 
independent of eis (Fig 29), indicating that Mtb possesses other genes that can regulate 
autophagy.  Caspase independent cell death induced by the eis mutant was found to be 
dependent on autophagy induction (177). However, in our experimental settings, Δ3167c-
mediated necrosis does not depend on autophagy (Fig 34C).  Mechanistically, ROS 
generation and Akt inactivation underly both autophagy and necrosis induction by 
Δ3167c, but JNK contributes only to Δ3167c-mediated autophagy (Fig 25A, 25D, 32B, 
33A, 33E). This indicates the presence of divergent signaling modules downstream of 
ROS and Akt regulating autophagy and necrosis in Δ3167c-infected cells. 
 Recent studies on Mtb induced autophagy in the absence of other external stimuli 
have shown that Mtb co-localizes with autophagosomes, leading to lysosomal mediated 
destruction of the bacteria (150,151,168). However in our studies using two different 
approaches (confocal microscopy and TEM), we found that neither Mtb nor Δ3167c co-
localized with autophagosomes. This could explain why similar numbers of Mtb and 
Δ3167c were recovered from infected THP1 macrophages at 24hpi (Fig 14) even though 
Δ3167c induces higher levels of autophagy that culminates in lysosomal degradation. A 
similar phenomenon was described in the case of the measles virus where viral infection 
lead to an increased accumulation of autophagosomes but viral proteins did not colocalize 
with these structures (200,201). Studies detailing selective autophagy of Mtb were 
performed on murine macrophages and dendritic cells and used a different strain of Mtb 
(Mtb Erdman compared to Mtb H37Rv used in this study) and this could account for the 
disparity observed. It is interesting to note that increased autophagy induction by the eis 
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mutant did not result in decreased bacterial recovery compared to Mtb in ex vivo 
macrophage infections as well (177). Treatment of M.marinum infected zebrafish 
embryos with Ar-12, an inhibitor of Akt activation resulted in increased autophagosome 
formation but not increased bacterial targeting to the autophagosomes compared to 
untreated, infected embryos (181). This suggests a role for Akt in modulation of selective 
autophagy targeting in mycobacterial infections. The host ubiquitin ligase Parkin has 
been implicated in both mitophagy as well as xenophagy of Mtb (151,202). We did not 
observe mitochondria in autophagosomes by electron microscopy in THP1 macrophages 
infected with either Mtb or Δ3167c. It is possible that in human macrophages, Mtb 
inhibits parkin expression and thus avoids co-localizing with autophagosomes. Induction 
of macroautophagy could be advantageous for Mtb via modulation of cytokine responses. 
Autophagy has been shown to negatively regulate AIM2 and NLRP3 inflammasome 
activation and IL1β production in macrophages (143). TNF production by Mtb sonicate 
treated human peripheral blood monocytic cells (PBMC’s) was reduced following 
addition of the autophagy inhibitor 3-MA (203). Additionally, autophagy may also 
control inflammatory responses by eliminating endogenous DAMP’s that could be 
released from infected necrotic cells.   
 In conclusion, data from this study indicates Mtb induces macroautophagy in 






CHAPTER 4 Rv3167c MANIPULATES Mtb VIRULENCE 
4.1 INTRODUCTION 
Pathogens possess a wide variety of genes that contribute to virulence - 
deletion/disruption of these virulence genes leads to attenuation. However, there are 
numerous reports in literature of “anti-virulence genes” whose deletion or disruption 
enhances the ability of the pathogen to cause disease and results in hypervirulence as 
measured by lower infectious dose, reduced clearance and decreased host survival time. 
Hypervirulence in Mtb has been reported in clinical strains as well as in defined gene 
mutants. 
In this study we evaluated the contribution of Rv3167c to Mtb virulence using 
C57Bl6 mice infected via aerosol route. Deletion of Rv3167c results in an increase in 
Mtb virulence as demonstrated by the higher bacterial burden in the lungs and extra-
pulmonary organs and the lower median survival time observed in Δ3167c infected mice 
compared to Mtb infected control animals. Higher cellular infiltration and increased 
levels of inflammatory cytokines and chemokines were also observed in lungs of 




4.2 MATERIALS AND METHODS 
All animals were handled in accordance with guidelines approved by the 
Institutional Animal Care and Use Committee at the University of Maryland (IACUC). 
4.2.1 Materials 
Female C57Bl6 mice were purchased from Jackson Laboratories.  
4.2.2 Aerosol infection of mice 
Mice were infected with approximately 100 CFU of H37Rv, Δ3167c and 
complement strains via the aerosol route using a Glass-Col® Full Body Inhalation 
Exposure System. 25 mice were infected with each strain. Late log phase bacterial 
cultures were pelleted and resuspended in PBS. 5ml of bacterial culture containing 
50x106 bacteria were introduced into the nebulizer gently using a syringe and the aerosol 
chamber was run using the following protocol – 
Nebulizing time: 1800 seconds 
Cloud decay time: 1800 seconds 
Decontamination time: 900 seconds 
 A new, clean, sterile nebulizer was used for infection with the different bacterial 
strains.  
4.2.3 Determination of organ bacterial loads 
 At the indicated time points, 3 infected mice were sacrificed by sedation with 
Isoflurane followed by cervical dislocation. Lungs were perfused with PBS through the 
right ventricle. The superior lobe was fixed in 10% buffered formalin for histopathology 
work. Remaining lobes were harvested, cut up in small pieces, resuspended in 3ml PBS 
and were broken down further in the Stomacher® 80 Biomaster for 10 minutes. The 
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homogenate was filtered to eliminate large tissue fragments and spun at 2000g for 15 
minutes. The supernatant was refiltered and used for determination of lung cytokine 
levels. The pellet containing bacteria was resuspended in 500µl of 7H9 medium, 
appropriate dilutions were prepared and atleast two dilutions were plated onto 7H11 
plates in duplicate. Colonies were counted approximately 2 weeks after incubation at 
37°C. 
 The uppermost left lobe of the liver and a section of spleen were fixed in 10% 
buffered formalin for histopathology work. Remainder of both liver and spleen were 
processed as described above for determination of bacterial loads. 
4.2.4 Measurement of lung homogenate cytokine levels 
 Lung homogenate supernatants were obtained as described in section 4.2.3. 
Cytokine levels were determined using magnetic bead based multiplex assays (R&D 
Systems) on the Luminex MAGPIX® platform.  
4.2.5 Histopathology work 
 AML Labs, Baltimore, MD, performed paraffin embedding, sectioning and 
hematoxilin-eosin (HE) staining of lung tissue sections. Lungs harvested from mice at 
56dpi were sectioned at 2 levels with a distance of 100 microns between them. A total of 
6 sections (3 from each level; 5 micron thickness) were stained with hematoxilin and 
eosin. This pattern of organ sectioning was followed to ensure that different regions in 
the lung could be analyzed. Total lung area and areas of inflammation in hematoxilin and 
eosin stained lung section images was determined using ImageJ. Total lung area and 
inflamed portions were outlined using the ROI tool and area of these regions was 
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measured. Percentage of inflamed area was calculated using the formula (Area of 
inflammation/Total lung area) x 100. 
4.2.6 Animal survival study 
 7 infected mice per group were observed daily and weights of the animals were 
monitored and recorded on a weekly basis. Mice were sacrificed at humane time points as 
defined in the animal study protocol R-12-55 approved by IACUC. Some of the mice 
developed ulcerative dermatitis characterized by the formation of ulcerative lesions non 
responsive to broad-spectrum antibiotic treatment. Ulcerative dermatitis is an idiopathic 
condition that occurs spontaneously amongst C57Bl6 mice (224). Mice suffering from 
dermatitis were excluded from the survival study thus leaving a total of 3 subjects in the 
complement strain infected group. 
4.2.7 Statistical analysis 
 For measurement of bacterial loads in organs and lung cytokine levels statistical 
analyses was performed on triplicate measurements obtained per animal with 3 animals 
tested per group per time point. ANOVA with Tukey post-test was used for estimation of 
statistical significance unless otherwise noted in the figure legends. Data is represented as 
mean ± SD. For comparison of survival curves the Log-Rank (Mantel-Cox) test was 







4.3 RESULTS AND DISCUSSION 
4.3.1 Higher bacterial burden is recovered from organs of Δ3167c infected mice 
The ability to induce necrosis has been linked to virulence of Mtb. Infection with 
the virulent H37Rv strain results in cell death via necrosis compared to the avirulent 
H37Ra strain that causes apoptosis (104). The hypervirulent clinical strain 1471 of the 
Beijing family was found to induce higher levels of macrophage necrosis compared to the 
virulent H37Rv strain (211). As Δ3167c induces more necrosis compared to Mtb ex vivo 
we hypothesized that this mutant would exhibit hypervirulence in vivo. To assess the 
virulence of Δ3167c, C57Bl6 mice were infected with approximately 100 CFU of Mtb, 
Δ3167c and complement strains via the aerosol route. Animals were sacrificed at the 
indicated time points and homogenates of lung, spleen and liver were plated on 7H11 
medium for estimation of CFU’s. The lung bacterial burden at 1dpi was found to be 
similar in mice infected with the three strains indicating comparable initial inoculum of 
infection  (Fig 35A). Starting at 14dpi, increased bacterial burden was recovered from the 
lungs of Δ3167c-infected mice compared to Mtb infected animals. At 28 dpi, growth of 
Mtb plateaued out, consistent with onset of the adaptive immune response. However, 
increased bacterial burdens were recovered from lungs of Δ3167c-infected mice 
compared to Mtb infected animals at both 28dpi (approximately 1 log) and 56dpi  (about 
2 logs) (Fig 35A). Lung bacterial burden in mice infected with the complement strain was 
comparable to animals infected with Mtb at all time points (Fig 35A).  
Δ3167c was not deficient in dissemination as indicated by the similar CFU’s 
recovered from spleen and liver of Mtb and mutant infected animals at 14dpi (Fig 35B, 
35C). Similar to the lung, higher bacterial burdens were recovered from the spleen 
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Fig 35. Bacillary load in organs of C57Bl6 mice  
 
C57Bl6 mice were infected with Mtb, Δ3167c and Δ3167c complement via the aerosol route with a 
starting inoculum of approximately 100 CFU. Bacterial burdens were determined at the indicated 
time points in (A) lungs (B) spleen and (C) liver by plating out homogenates on 7H11 media and 
counting colonies obtained. Three mice were sacrificed at each time point per bacterial strain. Data is 



































































 and liver of Δ3167c infected mice compared to Mtb infected mice at 28dpi and 56dpi 
(Fig 35B, 35C).   
4.3.2 Increased cellular infiltration is observed in the lungs of Δ3167c infected mice 
 Lungs of Δ3167c-infected mice had more lesions on their surface compared to 
organs from either Mtb or complement infected mice at 56dpi (Fig 36A).  Sections were 
prepared from lungs harvested from infected mice at 56dpi and stained with hematoxilin 
and eosin and imaged by light microscopy at 40X magnification. At 7dpi, lungs of mice 
infected with any of the three bacterial strains appeared similar with no observable 
cellular infiltration (Fig 36B).  At 56dpi, lungs from Δ3167c infected mice presented with 
higher levels of cellular infiltration and loss of alveolar air space compared to Mtb or 
complement infected mice (Fig 36B). Total lung area and area of inflamed regions (areas 
of intense hematoxilin and eosin staining) were measured using ImageJ and percentage of 
inflamed area calculated for lungs harvested at 56dpi. Massive inflammation was 
observed in lungs of Δ3167c-infected mice with approximately 40% of the total lung area 
involved (Fig 36C). This is in contrast to lungs of Mtb infected mice where about 15% of 
the lungs exhibited increased cellular infiltration (Fig…). Lungs from complement 
infected mice were comparable to organs obtained from Mtb infected animals – clear 
alveolar spaces were seen and only about 10% of the lung area was calculated to be 
inflamed (Fig 36C).  
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Fig 36. Appearance and histopathology of lungs harvested from infected mice 
 
(A) Superior lobe of lungs from infected mice were harvested at 56dpi and photographed prior to 
fixation in 10% formalin for histopathology analysis. Representative image from one out of three 
mice per bacterial strain. 
(B) Images of hematoxilin and eosin stained sections of lung harvested at 7dpi and 56dpi. 
Representative images from one out of three mice per bacterial strain. 
(C) Percentage of lung area exhibiting cellular infiltration. Combined data obtained from three mice 
per bacterial strain. Asterisks indicate statistically significant differences compared to Mtb. 
 























4.3.3 Increased levels of inflammatory cytokines and chemokines are detected in 
lung homogenates of Δ3167c infected mice.  
 Cytokines and chemokines are known to play a critical role in determining the 
outcome of infection with Mtb (31). Homogenates prepared from lungs of infected mice 
at 14dpi and 56dpi were used in a Luminex assay to determine levels of various cytokines 
and chemokines. None of the cytokines and chemokines assayed for were detected 
in14dpi samples. At 56dpi, amounts of IL12p70 and IFNγ detected in samples from 
Δ3167c infected mice were very close to lowest limit of detection thus making 
interpretation of this data questionable (data not shown). Increased levels of the pro-
inflammatory cytokines TNF (4.8 fold) and IL1α (4 fold) were detected in lung 
homogenates of Δ3167c-infected mice compared to those obtained from Mtb infected 
animals (Fig 37A). IL6 and IL1β were detected in Δ3167c-infected but not Mtb infected 
mouse lung homogenates (Fig 37A).  While the anti-inflammatory cytokine IL0 was 
detected only in samples from Δ3167c-infected mice, infection with the complement 
strain resulted in a similar level of IL10 production (Fig 37A). Elevated amounts of the 
chemokines CCL5 (11.9 fold), and MMP9 (2.95 fold) were also detected in lung 
homogenates from Δ3167c-infected mice compared to Mtb infected mice (Fig 37B). The 
chemokine CCL3 was detected only in samples from Δ3167c-infected and complement 
infected animals, with a three-fold reduction seen in the latter (Fig 37B).  
 Thus the lung milieu of Δ3167c infected mice has higher levels of 
proinflammatory cytokines and chemokines compared to Mtb and complement infected 
mice.  
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Fig 37.  Lung homogenate cytokine analysis 
 
Supernatants of homogenates prepared from lung tissue harvested at 56dpi were analyzed for (A) 
cytokines and (B) chemokines using a multiplex assay. Combined data obtained from three mice per 






















































































4.3.4 Δ3167c infected mice have lowered survival compared to those infected with 
Mtb  
 To determine the contribution of Rv3167c to the virulence of Mtb, a survival 
study of mice infected with Mtb, Δ3167c and the complement strain via the aerosol route 
was performed. Mouse weights were tracked and mice were sacrificed at humane end 
points as defined by the IACUC approved study protocol. Mortality in Δ3167c-infected 
mice was observed starting at 33 weeks post infection, the median survival time for this 
group of mice was 41 weeks post infection. In contrast, while one animal in the Mtb and 
complement strain infected group succumbed to infection at 39 and 52 weeks post 
infection respectively, remaining mice in these groups survived until the end of the 
experiment (Fig 38). This data along with data on organ bacterial burden indicates that 








































   




















Fig 38. Δ3167c infected mice have lower survival compared to Mtb 
 
C57Bl6 mice were infected with Mtb, Δ3167c and Δ3167c complement via the aerosol route with a 
starting inoculum of approximately 100 CFU and their survival monitored. Data is from one 
experiment. Log rank test was used for determining statistical significance. Asterisks indicate 





 Mtb virulence has been linked previously to its ability to cause necrosis. Infection 
with the virulent H37Rv strain results in cell death via necrosis compared to the avirulent 
H37Ra strain that causes apoptosis (104). Hypervirulence of Beijing 1471 strain is 
associated with its ability to induce P2X7R dependent macrophage necrosis. (211). We 
found that the necrosis inducing Δ3167c was hypervirulent in immunocompetent C57Bl6 
mice infected via the aerosol route. Mice infected with Δ3167c strain had a higher 
bacterial burden in the lungs, liver and spleen and a lower median survival time 
compared to Mtb infected mice. Both Mtb and Δ3167c replicate similarly in vitro as well 
as in ex vivo macrophage infections indicating that the increased bacterial burdens 
observed in lungs of Δ3167c-infected mice cannot be attributed to enhanced replication 
of the mutant (Fig 14). The increased pulmonary bacterial burden observed in Δ3167c-
infected mice could be a function of necrosis elicited by the mutant. In LTA4H-high 
zebrafish, high levels of TNF initially control the bacterial load. However, the high levels 
of TNF also lead to macrophage necrosis, which in turn supports M.marinum 
extracellular growth resulting in increased bacterial burden in infected animals (9). We 
detected higher levels of TNF in the lungs of Δ3167c-infected mice compared to Mtb 
infected control animals. However, Δ3167c induced necrosis was found to be 
independent of TNF signaling ex vivo (Fig 23A). This does not exclude the possibility of 
necrosis induction by the mutant (by a currently uncharacterized pathway) leading to 
similar effects on bacterial load as observed by Roca et al. Infection of mice deficient in 
putative host factors required for necrosis induction by Δ3167c could help establish the 
link between necrosis induction and increased organ bacterial loads.  
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A calibrated host immune response is needed for the establishment of successful 
Mtb infection wherein the bacterial numbers are controlled but pathogen persistence 
occurs in the host alveolar space. An uncontrolled immune response could potentially 
lead to host tissue damage (31). Analysis of the lung cytokine profile revealed that 
Δ3167c infected mice had higher levels of the pro-inflammatory cytokines and 
chemokines at 56dpi compared to Mtb infected mice (Fig 37A, 37B). IL1α has been 
implicated in neutrophilic inflammation in lungs of mice infected with L.pneumophila 
(82). Increased susceptibility of miR223-/- mice to Mtb has been associated with increased 
neutrophil recruitment by CCL3 (225). Elevated levels of CCL3 are also seen in 
susceptible Ifnγ-/- and Nos2-/- mice (226). Increased production of CCL3 was also 
observed in macrophages infected by Δ3167c compared to those infected with Mtb ex 
vivo (work done by Serdar Gurses, unpublished). Mtb infected mmp9-/- mice were found 
to recruit fewer macrophages to the lung and had a reduced lung bacterial burden 
compared to infected wild type controls (227). In zebrafish infections, M.marinum 
infected macrophages were found to upregulate MMP9 expression in neighboring 
epithelial cells and this was required for the recruitment of uninfected macrophages as 
well as an increase in bacterial burden (11). Lungs of Δ3167c-infected mice show higher 
levels of cellular infiltration (approximately 2.6 fold) compared to lungs from Mtb 
infected controls. It would be interesting to determine nature of inflammation (monocytic 
vs neutrophilic) in lungs of Δ3167c-infected mice.  
The increased cytokine and chemokine level could be reflective of the increased 
bacterial burden observed with Δ3167c at 56dpi. Alternatively, changes in the cell wall 
composition of Δ3167c could also account for the aberrant inflammatory response. RNA 
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seq analysis of intracellular bacteria revealed members of the mce1 operon (Rv0166 - 
Rv0169) to be repressed in Δ3167c compared to Mtb (work done by Jeff Quigley, 
unpublished).  An mce1 operon mutant strain accumulated higher amounts of free 
mycolic acid in the cell wall and was found to be hypervirulent in C57Bl6 mice 
(212,214). Macrophages infected with the mce1 operon mutant ex vivo however produced 
lower amounts of TNF and IL6 compared to Mtb infected controls. A different cytokine 
induction profile for the mce1 operon mutant could be observed in the more complex in 
vivo environment. The hypervirulent pknH mutant is postulated to induce a 
hyperinflammatory response based on the low cell wall lipoarabinomannan:lipomannan 
ratio (217). A comparative analysis of the cell wall lipid content of Mtb and Δ3167c 
strain will provide more insight into possible bacterial components underlying 
hypervirulence of the mutant.  
 In conclusion, data obtained from this animal study indicates that Rv3167c is an 











CHAPTER 5 GENERAL DISCUSSION AND SIGNIFICANCE 
Modulation of host cell death via apoptotic and necrotic mechanisms is one of the 
several strategies Mtb employs in order to evade the host innate immune response. 
Previous studies have shown that while Mtb inhibits apoptosis, the pathogen after 
infection and multiplication induces necrosis in order to escape from infected cells 
reviewed in (49). The Mtb gene Rv3167c was previously identified as an anti-apoptotic 
gene in our lab (unpublished data). In this study, using a combination of morphological 
and biochemical methods, we determined that Rv3167c is required for the inhibition of 
Mtb induced caspase independent, necrotic cell death (Chapter 2). Serendipitously, we 
also uncovered a role for Rv3167c in limiting host cell autophagy induction by Mtb 
(Chapter 3).  
Host cell lipid mediator modulation, high bacterial numbers, and activation of 
NLRP3 inflammasome are factors that have been shown to contribute to Mtb mediated 
necrosis (Fig 7). However the involvement of these factors and other regulated necrosis 
pathways was ruled out in Δ3167c-mediated necrosis (Fig 18-23). The classical paradigm 
of Mtb infection is that the bacteria always reside within modified phagosomal 
compartments, however more recent studies have shown that Mtb can escape into the 
host cell cytosol and that this event is followed by necrotic death of the host cell 
((41),(116),(43),(42)). Cytosolic translocation is linked to the virulence of mycobacteria 
as only pathogenic mycobacterial species (Mtb, M.leprae, M.bovis, M.marinum) escape 
to the cytosol while the non-pathogenic M.smegmatis and the BCG vaccine strain were 
found to remain within phagosomes of infected cells (43).  Other pathogens known to 
reside in modified vacuoles such as S.typhimurium and L.pneumophila also can escape 
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into the cytosol and eventually from the host cell either by non-lytic or lytic mechanisms 
(228). While for these pathogens escape to the cytosol is observed within a few hours 
after infection, cytosolic translocation is a very late event in Mtb infection (229). Kinetic 
studies on human macrophages infected with a low dose of Mtb revealed that the bacteria 
escaped to the cytosol approximately 4-5dpi and necrosis induction occurred within 24 
hours of cytosolic escape (42). Preliminary data obtained from a TEM analysis of Mtb 
and Δ3167c infected macrophages shows a higher percentage of Δ3167c to be present in 
the cytosol compared to Mtb as early as 24hpi. This indicates that Rv3167c is required for 
the temporal control of bacterial egress from the phagosome to the cytosol and ensuing 
necrotic host cell death.  
Current literature describes a role for the ESX1 secretion system in Mtb escape to 
the cytosol as Mtb mutants deficient in the RD1 region that encodes for ESX1 and the 
vaccine strain BCG in which the RD1 region is deleted fail to escape to the cytosol (41-
43,110,111). Cytosolic translocation of M.marinum also occurs in an ESX1 dependent 
manner, however bacterial escape is accomplished much earlier (approximately 24hpi) 
compared to Mtb (42,114).  The ESX1 secretion system is required for the secretion of 
the pore forming EsxA protein. In addition to being a secreted effector itself, EsxA is also 
required for the secretion of other bacterial proteins via ESX1. Rv3167c could temporally 
control either the expression or the secretion of EsxA and/or other ESX1 substrates and 
manipulate Mtb cytosolic translocation. Another potential candidate would be the 
recently identified outer membrane channel protein CpnT, the C-terminal domain of this 
protein has been shown to be secreted and to be involved in host cell necrosis induction 
(122).  Deleting the ESX1 region or CpnT encoding gene in Δ3167c and examining 
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bacterial presence in the cytosol would help evaluate the contribution of these genes to 
the early cytosolic escape of Δ3167c. 
We found Δ3167c-induced necrosis to be dependent on ROS generated in the 
mitochondria but not the NOX2 complex (Fig 24, 25). During escape of Δ3167c from the 
phagosome, the phagosomal membrane and the ROS generating NOX2 complex 
assembled on the membrane would be damaged, this would explain why NOX2 
generated ROS is dispensable for Δ3167c mediated necrosis. Presence of bacteria in the 
cytosol would allow for bacterial substrates previously restricted in the phagosomal 
compartment to access the mitochondria and result in subsequent mitochondrial damage 
and ROS generation. The PE-PGRS33 protein has been shown to localize to 
mitochondria and cause necrotic cell death (137). A bioinformatics study identified five 
PE-PGRS proteins to possess mitochondrial localization sequences (138). The ESX5 
secretion system is needed for the secretion of PE- PPE proteins in Mtb and M.marinum 
and has been shown to be required for Mtb and M.marinum mediated necrosis induction 
but not escape from the phagosome (116). The engagement of separate mechanisms for 
cytosolic escape and ensuing host cell lysis has also been shown for the pathogen 
L.pneumophila, mutants defective for host cell necrosis induction were not found to be 
deficient in cytosolic translocation (230). While we have evidence indicating that 
Rv3167c is involved in temporal regulation of Mtb phagosomal escape, it would be 
interesting to determine whether the gene also contributes to necrosis induction 
independent of its role in cytosolic translocation. Analysis of the expression and secretion 
of the predicted mitochondrial-targeting Mtb proteins and other ESX5 substrates in 
Δ3167c compared to Mtb would help answer this question. 
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Damage to vacuolar membranes and presence of bacteria in the cytosol can 
trigger selective autophagy. Higher levels of autophagy were observed in cells infected 
with Δ3167c compared to Mtb infected controls (Fig 26, 27), this could be attributed to 
the early cytosolic translocation of the mutant. The increased inhibition of Akt activation 
observed in Δ3167c-infected cells could contribute to autophagy induction via mTOR 
inhibition (Fig 32B). One would expect cytosolic Mtb to be targeted by selective 
autophagy machinery. However, in our experimental set up, we did not observe co-
localization of either Mtb or Δ3167c with autophagosomes indicating that the bacteria 
possess mechanisms to avoid being sequestered into autophagosomes. A similar 
phenomenon is seen with other bacteria known to escape to the cytosol. For example, 
S.typhimurium has been reported to escape from the salmonella containing vacuole in 
epithelial cells and induce an amino acid stress response leading to autophagy. However, 
autophagy induction was only a transient phenomenon as S.typhimurium eventually 
increased amino acid uptake by the infected cells (231,232). Cytosolic M.marinum has 
also been reported to avoid recruitment of autophagic machinery by shedding their 
ubiquitinated cell walls (233). Autophagy is known to negatively regulate IL1β 
production by targeting inflammasomes for degradation (143). Mtb is known to activate 
the NLRP3 inflammasome in an ESX1 dependent manner (32,33), this could follow 
detection of cytosolic Mtb. Autophagy induction in response to Mtb could potentially 
control inflammasome mediated cytokine production. V.parahemolyticus infection 
induced activation of the NLRC4 inflammasome in macrophages, however the bacterial 
protein VopQ inhibits consequent IL1β production by inducing autophagy (234). 
Increased pro-inflammatory cytokine production observed in response to macrophage 
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infection by the cell death and autophagy inducing Mtb eis mutant is also negatively 
regulated by autophagy (177). Macroautophagy could also target DAMP’s that are 
released by the infected, necrotic cells for destruction and thus inhibit pro-inflammatory 
cytokine generation. Comparing caspase 1 activation, secretion of IL1β and IL18 and 
release of DAMP’s such as HMGB1 in Δ3167c infected wild type and autophagy 
deficient macrophages would help determine whether autophagy observed in these cells 
contributes to regulation of proinflammatory cytokine responses. Thus the combination 
of necrosis and macroautophagy induction in Mtb infected macrophages could contribute 
to escape and dissemination of the pathogen accompanied by a controlled inflammatory 
response (Fig 39).  
Rv3167c is annotated as a TetR-like transcriptional regulator and ongoing analysis 
in our lab indicates that it behaves as a TetR-like repressor (work done by Jeff Quigley, 
unpublished data). In Δ3167c, repression of Rv3167c regulated genes would be 
eliminated resulting in their expression at all times and potentially these genes could be 
responsible for the earlier escape of the bacteria into the host cell cytosol and ensuing 
necrosis. In Mtb, one would expect Rv3167c-mediated gene repression to be inhibited at 
later stages of infection when the bacteria escape. This can be verified by analyzing the 
expression kinetics of Rv3167c in Mtb following macrophage infection as Rv3167c 
regulates its own expression. Identification of Rv3167c regulated genes specifically 
involved in Mtb cytosolic translocation and necrosis induction presents an interesting 
area of future research. Comparing of the transcriptomes of intracellular Mtb and Δ3167c 
using RNAseq technology would provide a set of genes that are differentially regulated 
between the two bacterial strains. Deletion of these genes in Δ3167c would help confirm 
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their contribution to Mtb cytosolic translocation and necrosis induction. An alternative 
approach would be to generate a transposon mutant library in Δ3167c background and 
then screening the mutants for their inability to induce or induce reduced necrosis 
compared to the parent Δ3167c strain.  
The identification of Rv3167c in the regulation of Mtb mediated necrosis provides 
more insight into a relatively unexplored area of Mtb pathogenesis. While studies have 
implicated EsxA, ESX5 locus and the phoPR two component regulatory system in 
induction of host cell necrosis, currently there are no Mtb genes known to negatively 
regulate host cell necrosis (32,42,108,109,116). The ability of Mtb to escape from the 
phagosome and induce necrosis has been known for sometime now, the delayed kinetics 
of this phenomenon made it difficult to study the contributing bacterial factors and host 
mechanisms involved. As escape and necrosis induction by Δ3167c occur within 24hpi, 
infections with Δ3167c can be used as a tool to further investigate bacterial escape and 
necrosis induction. Targeting Mtb mediated necrosis with drugs to inhibit bacterial 
dissemination could be a supplement to current TB treatment regimens, Δ3167c could be 

































Fig 39. Model for Rv3167c dependent Mtb mediated necrosis and autophagy 
 
 Following phagocytosis, Mtb arrests phagolysosomal fusion and resides in an early endosome like 
compartment. Eventually (4-5 dpi), Mtb escapes from this compartment into the cytosol. Rv3167c 
exerts temporal control over Mtb escape, Δ3167c translocates to the cytosol within 24hpi. Potential 
candidates that could be regulated by Rv3167c and contribute to cytosolic translocation include the pore 
forming proteins EsxA and CpnT. Escape to the cytosol allows Mtb proteins previously sequestered 
within the phagosome to access the host cell cytosol. Some Mtb PE-PGRS proteins possess 
mitochondrial localization signals, these could localize to and damage mitochondria and lead to 
increased mitochondrial ROS production. Cytosolic escape of Δ3167c is accompanied by decreased 
activation of Akt and increased activation of JNK. Mitochondrial ROS and Akt inhibition contribute to 
both necrosis and autophagy induction, while JNK activation contribute to autophagy alone. Autophagy 
did not lead to bacterial killing, it may be possible that the increase in autophagy induction leads to a 
reduction in proinflammatory cytokine secretion and DAMP release from the dying cells.  
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APPENDIX A: List of antibodies used in this study 
       
ANTIBODY SOURCE DILUTION 
Goat anti AIF Santa Cruz sc-9416 1:200 
Rabbit anti Akt Cell Signaling #4691 1:1000 
Rabbit anti Beclin 1 Cell Signaling #3495 1:1000 
Rabbit anti Cytochrome C Epitomics #3895-1 1:10,000 
Rabbit anti Eis Dr.Eun Kyeong Jo 1:1250 
 Rabbit anti FAP BEI resources NR-13817 1:8000 
Rabbit anti GAPDH Cell Signaling #5174 1:1000 
Mouse anti GFP Cell Signaling #2955 1:1000 
Mouse anti HDAC1 Cell Signaling#5356 1:1000 
Rabbit anti JNK Cell Signaling #9258 1:1000 
Rabbit anti LC3 Epitomics #2057-1 1:2000 
Rabbit anti p38 MAPK Cell Signaling #9212 1:1000 
Rabbit anti PARP Cell Signaling #9532 1:1000 
Rabbit anti Phospho p38MAPK Cell Signaling #4511 1:1000 
Rabbit anti Phospho Akt 
(Ser 473) 
Cell Signaling #4060 1:1000 
Rabbit anti Phospho Bcl2 
(Ser 70) 
Cell Signaling #2827 1:1000 
Rabbit anti Phospho JNK Cell Signaling #4668 1:1000 
Mouse anti Tubulin Cell Signaling #3873 1:1000 
Rabbit anti VDAC Cell Signaling #4661 1:1000 
Goat anti mouse HRP Jackson Immunoresearch 
115-035-116 
1:20,000 – 1:50,000 
Goat anti rabbit HRP Jackson Immunoresearch 
115-035-144 
1:20,000 – 1:50,000 
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